<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Computer‐assisted diagnosis techniques (dermoscopy and spectroscopy‐based) for diagnosing skin cancer in adults - Ferrante di Ruffano, L - 2018 | Cochrane Library</title> <meta content="Computer‐assisted diagnosis techniques (dermoscopy and spectroscopy‐based) for diagnosing skin cancer in adults - Ferrante di Ruffano, L - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013186/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Computer‐assisted diagnosis techniques (dermoscopy and spectroscopy‐based) for diagnosing skin cancer in adults - Ferrante di Ruffano, L - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013186/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013186" name="dc.identifier" scheme="DOI"/> <meta content="Computer‐assisted diagnosis techniques (dermoscopy and spectroscopy‐based) for diagnosing skin cancer in adults" name="citation_title"/> <meta content="Lavinia Ferrante di Ruffano" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="Yemisi Takwoingi" name="citation_author"/> <meta content="Jacqueline Dinnes" name="citation_author"/> <meta content="j.dinnes@bham.ac.uk" name="citation_author_email"/> <meta content="Naomi Chuchu" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="Susan E Bayliss" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="Clare Davenport" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="Rubeta N Matin" name="citation_author"/> <meta content="Churchill Hospital" name="citation_author_institution"/> <meta content="Kathie Godfrey" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Colette O'Sullivan" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Abha Gulati" name="citation_author"/> <meta content="Barts Health NHS Trust" name="citation_author_institution"/> <meta content="Sue Ann Chan" name="citation_author"/> <meta content="City Hospital" name="citation_author_institution"/> <meta content="Alana Durack" name="citation_author"/> <meta content="Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="Susan O'Connell" name="citation_author"/> <meta content="Cardiff and Vale University Health Board" name="citation_author_institution"/> <meta content="Matthew D Gardiner" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Jeffrey Bamber" name="citation_author"/> <meta content="Institute of Cancer Research and The Royal Marsden NHS Foundation Trust" name="citation_author_institution"/> <meta content="Jonathan J Deeks" name="citation_author"/> <meta content="Hywel C Williams" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Skin Cancer Diagnostic Test Accuracy Group" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD013186" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/12/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013186/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013186/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013186/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Electric Impedance; Algorithms; Carcinoma, Basal Cell [*diagnosis, diagnostic imaging, pathology]; Carcinoma, Squamous Cell [*diagnosis, diagnostic imaging, pathology]; Clinical Decision‐Making; Dermoscopy [*methods, standards]; Diagnosis, Computer‐Assisted [*methods, standards]; False Positive Reactions; Melanoma [*diagnosis, diagnostic imaging, pathology]; Sensitivity and Specificity; Skin Neoplasms [*diagnosis, diagnostic imaging, pathology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013186&amp;doi=10.1002/14651858.CD013186&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="u3GUW7vS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013186\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013186\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013186\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","pl","fr","th","ms","fa","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013186",title:"Computer\\u2010assisted diagnosis techniques (dermoscopy and spectroscopy\\u2010based) for diagnosing skin cancer in adults",firstPublishedDate:"Dec 4, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Skin Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=u3GUW7vS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013186&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013186';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013186/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013186/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013186%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013186/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013186/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013186/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013186/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013186" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013186/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013186" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013186/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013186/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8391 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013186" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0110"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0056"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0059"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0078"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-sec-0100"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013186/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/appendices#CD013186-sec-0115"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/table_n/CD013186StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/table_n/CD013186StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013186/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013186/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013186/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013186/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013186/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Computer‐assisted diagnosis techniques (dermoscopy and spectroscopy‐based) for diagnosing skin cancer in adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0002">Lavinia Ferrante di Ruffano</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0003">Yemisi Takwoingi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Jacqueline Dinnes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0005">Naomi Chuchu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0006">Susan E Bayliss</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0007">Clare Davenport</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0008">Rubeta N Matin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0009">Kathie Godfrey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0010">Colette O'Sullivan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0011">Abha Gulati</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0012">Sue Ann Chan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0013">Alana Durack</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0014">Susan O'Connell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0015">Matthew D Gardiner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0016">Jeffrey Bamber</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0017">Jonathan J Deeks</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0018">Hywel C Williams</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013186/information#CD013186-cr-0019">Cochrane Skin Cancer Diagnostic Test Accuracy Group</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013186/information/en#CD013186-sec-0131">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 December 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013186/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013186">https://doi.org/10.1002/14651858.CD013186</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013186-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013186-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013186-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013186-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013186-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD013186-abs-0010">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013186-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013186-abs-0001" lang="en"> <section id="CD013186-sec-0001"> <h3 class="title" id="CD013186-sec-0001">Background</h3> <p>Early accurate detection of all skin cancer types is essential to guide appropriate management and to improve morbidity and survival. Melanoma and cutaneous squamous cell carcinoma (cSCC) are high‐risk skin cancers which have the potential to metastasise and ultimately lead to death, whereas basal cell carcinoma (BCC) is usually localised with potential to infiltrate and damage surrounding tissue. Anxiety around missing early curable cases needs to be balanced against inappropriate referral and unnecessary excision of benign lesions. Computer‐assisted diagnosis (CAD) systems use artificial intelligence to analyse lesion data and arrive at a diagnosis of skin cancer. When used in unreferred settings ('primary care'), CAD may assist general practitioners (GPs) or other clinicians to more appropriately triage high‐risk lesions to secondary care. Used alongside clinical and dermoscopic suspicion of malignancy, CAD may reduce unnecessary excisions without missing melanoma cases. </p> </section> <section id="CD013186-sec-0002"> <h3 class="title" id="CD013186-sec-0002">Objectives</h3> <p>To determine the accuracy of CAD systems for diagnosing cutaneous invasive melanoma and atypical intraepidermal melanocytic variants, BCC or cSCC in adults, and to compare its accuracy with that of dermoscopy. </p> </section> <section id="CD013186-sec-0003"> <h3 class="title" id="CD013186-sec-0003">Search methods</h3> <p>We undertook a comprehensive search of the following databases from inception up to August 2016: Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; Embase; CINAHL; CPCI; Zetoc; Science Citation Index; US National Institutes of Health Ongoing Trials Register; NIHR Clinical Research Network Portfolio Database; and the World Health Organization International Clinical Trials Registry Platform. We studied reference lists and published systematic review articles. </p> </section> <section id="CD013186-sec-0004"> <h3 class="title" id="CD013186-sec-0004">Selection criteria</h3> <p>Studies of any design that evaluated CAD alone, or in comparison with dermoscopy, in adults with lesions suspicious for melanoma or BCC or cSCC, and compared with a reference standard of either histological confirmation or clinical follow‐up. </p> </section> <section id="CD013186-sec-0005"> <h3 class="title" id="CD013186-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted all data using a standardised data extraction and quality assessment form (based on QUADAS‐2). We contacted authors of included studies where information related to the target condition or diagnostic threshold were missing. We estimated summary sensitivities and specificities separately by type of CAD system, using the bivariate hierarchical model. We compared CAD with dermoscopy using (a) all available CAD data (indirect comparisons), and (b) studies providing paired data for both tests (direct comparisons). We tested the contribution of human decision‐making to the accuracy of CAD diagnoses in a sensitivity analysis by removing studies that gave CAD results to clinicians to guide diagnostic decision‐making. </p> </section> <section id="CD013186-sec-0006"> <h3 class="title" id="CD013186-sec-0006">Main results</h3> <p>We included 42 studies, 24 evaluating digital dermoscopy‐based CAD systems (Derm–CAD) in 23 study cohorts with 9602 lesions (1220 melanomas, at least 83 BCCs, 9 cSCCs), providing 32 datasets for Derm–CAD and seven for dermoscopy. Eighteen studies evaluated spectroscopy‐based CAD (Spectro–CAD) in 16 study cohorts with 6336 lesions (934 melanomas, 163 BCC, 49 cSCCs), providing 32 datasets for Spectro–CAD and six for dermoscopy. These consisted of 15 studies using multispectral imaging (MSI), two studies using electrical impedance spectroscopy (EIS) and one study using diffuse‐reflectance spectroscopy. Studies were incompletely reported and at unclear to high risk of bias across all domains. Included studies inadequately address the review question, due to an abundance of low‐quality studies, poor reporting, and recruitment of highly selected groups of participants. </p> <p>Across all CAD systems, we found considerable variation in the hardware and software technologies used, the types of classification algorithm employed, methods used to train the algorithms, and which lesion morphological features were extracted and analysed across all CAD systems, and even between studies evaluating CAD systems. Meta–analysis found CAD systems had high sensitivity for correct identification of cutaneous invasive melanoma and atypical intraepidermal melanocytic variants in highly selected populations, but with low and very variable specificity, particularly for Spectro–CAD systems. Pooled data from 22 studies estimated the sensitivity of Derm–CAD for the detection of melanoma as 90.1% (95% confidence interval (CI) 84.0% to 94.0%) and specificity as 74.3% (95% CI 63.6% to 82.7%). Pooled data from eight studies estimated the sensitivity of multispectral imaging CAD (MSI–CAD) as 92.9% (95% CI 83.7% to 97.1%) and specificity as 43.6% (95% CI 24.8% to 64.5%). When applied to a hypothetical population of 1000 lesions at the mean observed melanoma prevalence of 20%, Derm–CAD would miss 20 melanomas and would lead to 206 false‐positive results for melanoma. MSI–CAD would miss 14 melanomas and would lead to 451 false diagnoses for melanoma. Preliminary findings suggest CAD systems are at least as sensitive as assessment of dermoscopic images for the diagnosis of invasive melanoma and atypical intraepidermal melanocytic variants. We are unable to make summary statements about the use of CAD in unreferred populations, or its accuracy in detecting keratinocyte cancers, or its use in any setting as a diagnostic aid, because of the paucity of studies. </p> </section> <section id="CD013186-sec-0007"> <h3 class="title" id="CD013186-sec-0007">Authors' conclusions</h3> <p>In highly selected patient populations all CAD types demonstrate high sensitivity, and could prove useful as a back‐up for specialist diagnosis to assist in minimising the risk of missing melanomas. However, the evidence base is currently too poor to understand whether CAD system outputs translate to different clinical decision–making in practice. Insufficient data are available on the use of CAD in community settings, or for the detection of keratinocyte cancers. The evidence base for individual systems is too limited to draw conclusions on which might be preferred for practice. Prospective comparative studies are required that evaluate the use of already evaluated CAD systems as diagnostic aids, by comparison to face–to–face dermoscopy, and in participant populations that are representative of those in which the test would be used in practice. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013186-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013186-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013186-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013186-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013186-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013186-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013186-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD013186-abs-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013186-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013186-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013186-abs-0005" lang="en"> <h3>What is the diagnostic accuracy of computer‐assisted diagnosis techniques for the detection of skin cancer in adults? </h3> <p><b>Why is improving the diagnosis of skin cancer important?</b> </p> <p>There are a number of different types of skin cancer, including melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Melanoma is one of the most dangerous forms. If it is not recognised early treatment can be delayed and this risks the melanoma spreading to other organs in the body and may eventually lead to death. Cutaneous squamous cell carcinoma (cSCC) and BCC are considered less dangerous, as they are localised (less likely to spread to other parts of the body compared to melanoma). However, cSCC can spread to other parts of the body and BCC can cause disfigurement if not recognised early. Diagnosing a skin cancer when it is not actually present (a false‐positive result) might result in unnecessary surgery and other investigations and can cause stress and anxiety to the patient. Missing a diagnosis of skin cancer may result in the wrong treatment being used or lead to a delay in effective treatment. </p> <p><b>What is the aim of the review?</b> </p> <p>The aim of this Cochrane Review was to find out how accurate computer–assisted diagnosis (CAD) is for diagnosing melanoma, BCC or cSCC. The review also compared the accuracy of two different types of CAD, and compared the accuracy of CAD with diagnosis by a doctor using a handheld illuminated microscope (a dermatoscope or ‘dermoscopy’). We included 42 studies to answer these questions. </p> <p><b>What was studied in the review?</b> </p> <p>A number of tools are available to skin cancer specialists which allow a more detailed examination of the skin compared to examination by the naked eye alone. Currently a dermatoscope which magnifies the skin lesion (a mole or area of skin with an unusual appearance in comparison with the surrounding skin) using a bright light source is used by most skin cancer specialists. CAD tests are computer systems that analyse information about skin lesions obtained from a dermatoscope or other techniques that use light to describe the features of a skin lesion (spectroscopy) to produce a result indicating whether skin cancer is likely to be present. We included CAD systems that get their information from dermoscopic images of lesions (Derm–CAD), or that use data from spectroscopy. Most of the spectroscopy studies used data from multispectral imaging (MSI–CAD) and are the main focus here. When a skin cancer specialist finds a lesion is suspicious using visual examination with or without additional dermoscopy, results from CAD systems can be used alone to make a diagnosis of skin cancer (CAD–based diagnosis), or can be used by doctors in addition to their visual inspection examination of a skin lesion to help them reach a diagnosis (CAD–aided diagnosis). Researchers examined how useful CAD systems are to help diagnose skin cancers in addition to visual inspection and dermoscopy. </p> <p><b>What are the main results of the review?</b> </p> <p>The review included 42 studies looking at CAD systems for the diagnosis of melanoma. There was not enough evidence to determine the accuracy of CAD systems for the diagnosis of BCC (3 studies) or cSCC (1 study). </p> <p><i><b>Derm‐CAD results for diagnosis of melanoma</b> </i> </p> <p>The main results for Derm‐CAD are based on 22 studies including 8992 lesions.</p> <p>Applied to a group of 1000 skin lesions, of which 200 (20%) are given a final diagnosis* of melanoma, the results suggest that: </p> <p>‐ An estimated 386 people will have a Derm–CAD result suggesting that a melanoma is present, and of these 206 (53%) will not actually have a melanoma (false‐positive result) </p> <p>‐ Of the 614 people with a Derm–CAD result indicating that no melanoma is present, 20 (3%) will in fact actually have a melanoma (false‐negative result) </p> <p>There was no evidence to suggest that dermoscopy or Derm–CAD was different in its ability to detect or rule out melanoma. </p> <p><i><b>MSI‐CAD results for diagnosis of melanoma</b> </i> </p> <p>The main results for MSI–CAD are based on eight studies including 2401 lesions. In a group of 1000 people, of whom 200 (20%) actually do have melanoma*, then: </p> <p>‐ An estimated 637 people will have an MSI–CAD result suggesting that a melanoma is present, and of these 451 (71%) will not actually have a melanoma (false‐positive result) </p> <p>‐ Of the 363 people with an MSI–CAD result indicating that no melanoma is present, 14 (4%) will in fact have a melanoma (false‐negative result) </p> <p>MSI–CAD detects more melanomas, but possibly produces more false‐positive results (an increase in unnecessary surgery). </p> <p><b>How reliable are the results of the studies of this review?</b> </p> <p>Incomplete reporting of studies made it difficult for us to judge how reliable they were. Many studies had important limitations. Some studies only included particular types of skin lesions or excluded lesions that were considered difficult to diagnose. Importantly, most of the studies only included skin lesions with a biopsy result, which means that only a sample of lesions that would be seen by a doctor in practice were included. These characteristics may result in CAD systems appearing more or less accurate than they actually are. </p> <p><b>Who do the results of this review apply to?</b> </p> <p>Studies were largely conducted in Europe (29, 69%) and North America (8, 19%). Mean age (reported in 6/42 studies) ranged from 32 to 49 years for melanoma. The percentage of people with a final diagnosis of melanoma ranged from 1% to 52%. It was not always possible to tell whether suspicion of skin cancer in study participants was based on clinical examination alone, or both clinical and dermoscopic examinations. Almost all studies were done in people with skin lesions who were seen at specialist clinics rather than by doctors in primary care. </p> <p><b>What are the implications of this review?</b> </p> <p>CAD systems appear to be accurate for identification of melanomas in skin lesions that have already been selected for excision on the basis of clinical examination (visual inspection and dermoscopy). It is possible that some CAD systems identify more melanomas than doctors using dermoscopy images. However, CAD systems also produced far more false<b>‐</b>positive diagnoses than dermoscopy, and could lead to considerable increases in unnecessary surgery. The performance of CAD systems for detecting BCC and cSCC skin cancers is unclear. More studies are needed to evaluate the use of CAD by doctors for the diagnosis of skin cancer in comparison to face‐to‐face diagnosis using dermoscopy, both in primary care and in specialist skin cancer clinics. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The review authors searched for and used studies published up to August 2016.</p> <p>*In these studies, biopsy, clinical follow up, or specialist clinician diagnosis were the reference standards (means of establishing the final diagnosis). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013186-sec-0110" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013186-sec-0110"></div> <h3 class="title" id="CD013186-sec-0111">Implications for practice</h3> <section id="CD013186-sec-0111"> <p>The utility of CAD for the primary diagnosis of melanoma in patients referred to specialist care remains largely unknown, since most included studies used CAD to detect malignancy in lesions already scheduled for surgical excision, most commonly with a high clinical suspicion of melanoma. For the detection of melanoma in people with clinically suspicious lesions, the evidence consistently shows all CAD types to have high sensitivity. CAD systems could therefore be useful as a back‐up by specialists to assist in minimising the risk of missing melanomas. However, the evidence base is currently too poor to understand whether CAD system outputs translate to different clinical decision–making in practice, and our sensitivity analysis suggests sensitivity may actually decrease when CAD is used as a diagnostic aid to triage unreferred patients. In addition, any projected gains in the early detection of melanomas must be set against the costs and practicality of implementing new systems. </p> <p>Our evidence suggests MSI–CAD <i>may</i> be significantly more sensitive than dermoscopy. Given the paucity of data to allow comparison with in–person dermoscopy studies, this finding should be considered as exploratory. </p> <p>Insufficient data are available to provide conclusive comments on the accuracy of CAD in community settings, or its accuracy to detect BCC and cSCC in any setting. </p> </section> <h3 class="title" id="CD013186-sec-0112">Implications for research</h3> <section id="CD013186-sec-0112"> <p>Further prospective evaluation of the added value of CAD systems is warranted. Given the technological complexity and variation of CAD systems, it is certainly challenging to evaluate them in a rigorous manner. Nonetheless, studies are needed to evaluate CAD in its intended position in the patient care pathway in comparison to routine clinical examination and dermoscopy. For its use in specialist referral settings, studies should prospectively recruit <i>all</i> consecutive participants that have been referred for investigation of potential malignancy; for melanoma this should include all pigmented skin lesions, and for keratinocyte cancers any lesion suspected of being a BCC or cSCC. These studies should include lesions that are clinically determined to be benign and not excised, using specialist follow–up of <i>at least six months</i> as the accuracy reference standard. Comparisons with dermoscopy should consist of in–person diagnosis by dermatologists with expertise in dermoscopy. In community‐care settings, studies should prospectively recruit all participants presenting to clinic with lesions for which the clinician cannot clearly rule out malignancy, with clinical follow–up of all lesions which are not excised. To understand the clinical validity of CAD systems, studies should further evaluate how CAD system outputs are used to alter clinical decision‐making in real‐world practice settings. </p> <p>Future studies must also report CAD test results according to their final diagnosis, so that its ability to distinguish between morphologically difficult lesions can be established. Crucially, studies must report the full technological specifications of their CAD systems, including which features were analysed as well as the diagnostic criteria and thresholds used to determine the presence of malignancy. Information on the distribution of lesions used to train the CAD system in previous studies would also be a welcome addition that would enable an interpretation of the system’s accuracy. </p> <p>In terms of the development of new systems, or refinement of existing ones, cohorts of lesions should be selected so that training sets contain the range of benign and malignant lesions that would be encountered in routine clinical practice. Full descriptions of included lesions should be reported, together with an indication of how diagnostic thresholds have been selected. Validation of preliminary results should be assessed in independent populations, ideally from a different source from that used for model development. </p> <p>Any future research study needs to be clear about the diagnostic pathway followed by study participants, and should conform to the updated Standards for Reporting of Diagnostic Accuracy (STARD) guideline (<a href="./references#CD013186-bbs2-0242" title="BossuytPM , ReitsmaJB , BrunsDE , GatsonisCA , GlasziouPP , IrwigL , et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ2015;351:h5527. [DOI: 10.1136/bmj.h5527; PUBMED: 26511519] ">Bossuyt 2015</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013186-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013186-sec-0043"></div> <div class="table" id="CD013186-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Question: </b> </p> </td> <td align="" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b>What is the diagnostic accuracy of computer‐assisted diagnosis for the detection of: i) cutaneous invasive melanoma and atypical intraepidermal melanocyticvariants, ii) BCC, or iii) cSCC in adults?</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Adults with lesions suspicious for skin cancer, including:</p> <p> <ul id="CD013186-list-0001"> <li> <p>Any lesion referred for specialist investigation due to suspicion of skin cancer, and </p> </li> <li> <p>Any lesion excised due to suspicion of skin cancer</p> </li> </ul> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Index test:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Computer‐assisted diagnosis (CAD)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparator test:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Dermoscopy</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Target condition:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Cutaneous invasive melanoma and atypical intraepidermal melanocytic variants, or basal cell carcinoma (BCC), or cutaneous squamous cell carcinoma (cSCC) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference standard:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Histology with or without long‐term follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Action:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>If accurate, positive results of CAD will identify skin cancers that could otherwise be missed, while negative results will stop patients having unnecessary excision of skin lesions </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quantity of evidence</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>42<sup>a</sup> </b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Total lesions with test results</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>13,445</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Total with target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>2452</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>Limitations </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk of bias:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Patient selection methods were poorly reported, with some concern (34/42) due to use of case‐control designs, exclusion of difficult‐to‐diagnose types of lesion, and inadequate reporting to assess risks of bias. CAD was generally evaluated in independent populations (35/42). Some concern as it was not clear that the reference standard was interpreted blind to the CAD results in 19/42 studies. Differential verification was used in 6/42 studies, participants were excluded in 10/42, primarily due to technical difficulties with CAD. Timing of tests was not mentioned in 28/42. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Applicability of evidence to question:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>High concern for poor clinical applicability of included studies. Almost all studies recruited narrowly‐defined populations (41/42) or multiple lesions per participant (14/42) or both, and may not be representative of populations eligible for CAD. Studies provided little information regarding the thresholds used for presence of malignancy (16/42) and often evaluated unestablished thresholds (23/42). Studies performing training of algorithms provided scarce information on the range of conditions included in training sets. Little information was given about the expertise of the histopathologist. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>FINDINGS: All analyses are undertaken on subgroups of the studies</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>All included studies considered the detection of melanoma, three of which also looked at the detection of BCC and one at the detection of cSCC. There are therefore insufficient data to make summary statements about the accuracy of CAD for the detection of BCC or cSCC. All results below consider the detection of the primary target condition: cutaneous invasive melanoma and atypical intraepidermal melanocytic variants.</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>Test: Digital dermoscopy‐based CAD (all systems)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quantity of evidence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total lesions with test results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8992</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total with melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1063</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI):</b> </p> <p><b>Specificity (95% CI):</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.1% (84.0% to 94.0%)</p> <p>74.3% (63.6% to 82.7%)</p> </td> <td align="" class="table-header" colspan="2" rowspan="1" valign="top"></td> <td align="" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Numbers observed in a cohort of 1000 people being tested<sup>b</sup> </b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><b>Consistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>Sensitivity estimates consistent. Some heterogeneity in specificity between studies</p> </td> <td align="center" class="table-header" colspan="2" rowspan="2" valign="top"> <p><b>Consequences</b> </p> </td> <td align="center" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Prevalence</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>7%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>20%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>40%</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive necessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>360</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive unnecessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Do not receive required excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Appropriately do not receive excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>446</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>PPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70%</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>NPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>Test: Multispectral imaging‐based CAD (all systems)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quantity of evidence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>8</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total lesions with test results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2401</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total with melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>286</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI):</b> </p> <p><b>Specificity (95% CI):</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.9% (83.7% to 97.1%)</p> <p>43.6% (24.8% to 64.5%)</p> </td> <td align="" class="table-header" colspan="2" rowspan="1" valign=""></td> <td align="" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Numbers observed in a cohort of 1000 people being tested</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><b>Consistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>Sensitivity estimates consistent. High heterogeneity in specificity between studies</p> </td> <td align="center" class="table-header" colspan="2" rowspan="2" valign=""> <p><b>Consequences </b> </p> </td> <td align="center" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Prevalence </b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>7%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>20%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>40%</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive necessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>372</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive unnecessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Do not receive required excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Appropriately do not receive excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>262</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>PPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52%</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>NPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Six studies with overlapping lesions (<a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a> and <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a> and <a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> and <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>).<br/> <sup>b</sup>Numbers estimated at 25th, 50th (median) and 75% percentiles of invasive melanoma and atypical intraepidermal melanocytic variants prevalence, observed across 42 studies reporting evaluations of CAD.<br/> BCC ‐ Basal cell carcinoma; CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; cSCC ‐ cutaneous squamous cell carcinoma; NPV ‐ negative predictive value; PPV ‐ positive predictive value </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013186-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013186-sec-0044"></div> <p>This review is one of a series of Cochrane Diagnostic Test Accuracy (DTA) Reviews on the diagnosis and staging of melanoma and keratinocyte skin cancers conducted for the National Institute for Health Research (NIHR) Cochrane Systematic Reviews Programme. <a href="./appendices#CD013186-sec-0116">Appendix 1</a> shows the content and structure of the programme. <a href="#CD013186-tbl-0002">Table 1</a> provides a glossary of terms used, and a table of acronyms used is provided in <a href="./appendices#CD013186-sec-0117">Appendix 2</a>. </p> <div class="table" id="CD013186-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Artificial intelligence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Computer systems undertaking tasks that normally require human intelligence, such as decision–making or visual perception </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Atypical intraepidermal melanocytic variant</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unusual area of darker pigmentation contained within the epidermis that may progress to an invasive melanoma; includes melanoma <i>in situ</i> and lentigo maligna </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Atypical naevi</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unusual looking but noncancerous mole or area of darker pigmentation of the skin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Basaloid cells</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cells in the skin that look like those in epidermal basal layer</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>BRAF V600 mutation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>BRAF is a human gene that makes a protein called B‐Raf which is involved in the control of cell growth. BRAF mutations (damaged DNA) occur in around 40% of melanomas, which can then be treated with particular drugs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>BRAF inhibitors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapeutic agents which inhibit the serine‐threonine protein kinase BRAF mutated metastatic melanoma. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Breslow thickness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A scale for measuring the thickness of melanomas by the pathologist using a microscope, measured in mm from the top layer of skin to the bottom of the tumour. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Congenital naevi</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A type of mole found on infants at birth</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Whereby a handheld microscope is used to allow more detailed, magnified, examination of the skin compared to examination by the naked eye alone </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dermo‐epidermal junction</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The area where the lower part of the epidermis and top layer of the dermis meet</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dermis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Layer of skin below the epidermis, composed of living tissue and containing blood capillaries, nerve endings, sweat glands, hair follicles and other structures </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Desmoplastic subtypes of SCC</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An aggressive squamous cell carcinoma variant characterised by a proliferation of fibroblasts and formation of fibrous connective tissue </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Electrodesiccation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The use of high‐frequency electric currents to cut, destroy or cauterise tissue. It is performed with the use of a fine needle‐shaped instrument </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Electrical impedance spectroscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of electrical current properties as they pass through skin tissues, to retrieve information on cellular structures </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Epidermis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outer layer of the skin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negative</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An individual who is truly positive for a disease, but whom a diagnostic test classifies them as disease‐free. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positive</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An individual who is truly disease‐free, but whom a diagnostic test classifies them as having the disease. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histopathology/Histology</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study of tissue, usually obtained by biopsy or excision, for example under a microscope.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Incidence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The number of new cases of a disease in a given time period.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Index test</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A diagnostic test under evaluation in a primary study</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interferometry</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of waves of light or sound after interference in order to extract information </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lentigo maligna</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unusual area of darker pigmentation contained within the epidermis which includes malignant cells but with no invasive growth. May progress to an invasive melanoma </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lymph node</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymph nodes filter the lymphatic fluid (clear fluid containing white blood cells) that travels around the body to help fight disease; they are located throughout the body often in clusters (nodal basins). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Melanocytic naevus</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An area of skin with darker pigmentation (or melanocytes) also referred to as ‘moles’</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A form of statistical analysis used to synthesise results from a collection of individual studies. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metastases/metastatic disease</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spread of cancer away from the primary site to somewhere else through the bloodstream or the lymphatic system. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Morbidity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detrimental effects on health.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either (1) the condition of being subject to death; or (2) the death rate, which reflects the number of deaths per unit of population in relation to any specific region, age group, disease, treatment or other classification, usually expressed as deaths per 100, 1000, 10,000 or 100,000 people. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Multidisciplinary team</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A team with members from different healthcare professions and specialties (e.g. urology, oncology, pathology, radiology, and nursing). Cancer care in the National Health Service (NHS) uses this system to ensure that all relevant health professionals are engaged to discuss the best possible care for that patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Naevus</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A mole or collection of pigment cells (plural: naevi or nevi)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Optical coherence tomography (OCT)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Based on the same principle as ultrasound, OCT uses a handheld probe to measure the optical scattering of near‐infrared (1310 nm) light waves (rather than sound waves) from under the surface of the skin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prevalence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The proportion of a population found to have a condition.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prognostic factors/indicators</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specific characteristics of a cancer or the person who has it which might affect the patient’s prognosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Receiver operating characteristic (ROC) plot</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A plot of the sensitivity and 1 minus the specificity of a test at the different possible thresholds for test positivity; represents the diagnostic capability of a test with a range of binary test results </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Receiver operating characteristic (ROC) analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The analysis of a ROC plot of a test to select an optimal threshold for test positivity</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Recurrence is when new cancer cells are detected following treatment. This can occur either at the site of the original tumour or at other sites in the body. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference Standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A test or combination of tests used to establish the final or ‘true’ diagnosis of a patient in an evaluation of a diagnostic test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reflectance confocal microscopy (RCM)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A microscopic technique using infrared light (either in a handheld device or a static unit) that can create images of the deeper layers of the skin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Resolution in an imaging system refers to its ability to distinguish two points in space as being separate points; resolution is measured in two directions: axial and lateral. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In this context the term is used to mean the proportion of individuals with a disease who have that disease correctly identified by the study test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The proportion of individuals without the disease of interest (in this case with benign skin lesions) who have that absence of disease correctly identified by the study test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spectroscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study of the interaction between matter and electromagnetic radiation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spindle subtypes of SCC</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A squamous cell carcinoma variant characterised by poorly differentiated spindle cells surrounded by collagenous stroma </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Staging</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical description of the size and spread of a patient’s tumour, fitting into internationally agreed categories. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stratum corneum</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The outermost layer of the epidermis. This layer is the most superficial layer of skin, which is composed of flattened skin cells organised like a brick wall. In normal conditions cells are not nucleated at this layer </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Subclinical (disease)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disease that is usually asymptomatic and not easily observable, e.g. by clinical or physical examination. </p> </td> </tr> </tbody> </table> </div> <section id="CD013186-sec-0045"> <h3 class="title" id="CD013186-sec-0045">Target condition being diagnosed</h3> <p>There are three main forms of skin cancer. Melanoma is the most widely known amongst the general population, yet the commonest skin cancers in white populations are those arising from keratinocytes: basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) (<a href="./references#CD013186-bbs2-0275" title="GordonR . Skin cancer: an overview of epidemiology and risk factors. Seminars in Oncology Nursing2013;29(3):160‐9. [PUBMED: 23958214] ">Gordon 2013</a>; <a href="./references#CD013186-bbs2-0307" title="MadanV , LearJT , SzeimiesRM . Non‐melanoma skin cancer. Lancet2010;375(9715):673‐85. [PUBMED: 20171403] ">Madan 2010</a>). In 2003, the World Health Organization estimated that between two and three million ‘non‐melanoma’ skin cancers (of which BCC and cSCC are estimated to account for around 80% and 16% of cases, respectively) and 132,000 melanoma skin cancers occur globally each year (<a href="./references#CD013186-bbs2-0353" title="World Health Organiation. INTERSUN: The Global UV Project. A guide and compendium. www.who.int/uv/publications/en/Intersunguide.pdf 2003 (accessed 20 May 2015). ">WHO 2003</a>). </p> <p>In this DTA review there are three target conditions of interest: (a) melanoma; (b) basal cell carcinoma (BCC); and (c) cutaneous squamous cell carcinoma (cSCC). </p> <section id="CD013186-sec-0046"> <h4 class="title">Melanoma</h4> <p>Melanoma arises from uncontrolled proliferation of melanocytes, i.e. the epidermal cells that produce pigment or melanin. Cutaneous melanoma refers to any skin lesion with malignant melanocytes present in the dermis, and includes superficial spreading, nodular, acral lentiginous, and lentigo maligna melanoma variants (see <a href="#CD013186-fig-0001">Figure 1</a>). Melanoma in situ refers to malignant melanocytes that are contained within the epidermis and have not invaded the dermis, but are at risk of progression to melanoma if left untreated. Lentigo maligna, a subtype of melanoma in situ in chronically sun‐damaged skin, denotes another form of proliferation of abnormal melanocytes. Lentigo maligna can progress to invasive melanoma if its growth breaches the dermo‐epidermal junction during a vertical growth phase (when it is a 'lentigo maligna melanoma'). However its malignant transformation is both lower and slower than for melanoma in situ (<a href="./references#CD013186-bbs2-0288" title="KasprzakJM , XuYG . Diagnosis and management of lentigo maligna: a review. Drugs in Context2015;4:212281. [PUBMED: 26082796] ">Kasprzak 2015</a>). Melanoma in situ and lentigo maligna are both atypical intraepidermal melanocytic variants. Melanoma is one of the most serious forms of skin cancer, with the potential to metastasise to other parts of the body through the lymphatic system and bloodstream. It accounts for only a small proportion of skin cancer cases but is responsible for up to 75% of deaths from this disease (<a href="./references#CD013186-bbs2-0241" title="BoringCC , SquiresTS , TongT , MontgomeryS . Cancer statistics, 1994. CA: a Cancer Journal for Clinicians1994;44(1):7‐26. [PUBMED: 8281473] ">Boring 1994</a>; <a href="./references#CD013186-bbs2-0243" title="Cancer Research UK. Skin cancer statistics. www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/skin‐cancer#heading‐One (accessed prior to 19 July 2017). ">Cancer Research UK 2017</a>). </p> <div class="figure" id="CD013186-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Sample photographs of superficial spreading melanoma (left) and nodular melanoma (right). Copyright © 2010 Dr Rubeta Matin: reproduced with permission." data-id="CD013186-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Sample photographs of superficial spreading melanoma (left) and nodular melanoma (right). Copyright © 2010 Dr Rubeta Matin: reproduced with permission. </p> </div> </div> </div> <p>The incidence of melanoma rose to over 200,000 newly‐diagnosed cases worldwide in 2012 (<a href="./references#CD013186-bbs2-0263" title="ErdmannF , Lortet‐TieulentJ , SchuzJ , ZeebH , GreinertR , BreitbartEW , et al. International trends in the incidence of malignant melanoma 1953‐2008‐‐are recent generations at higher or lower risk?. International Journal of Cancer2013;132(2):385‐400. [PUBMED: 22532371] ">Erdmann 2013</a>; <a href="./references#CD013186-bbs2-0267" title="FerlayJ , SoerjomataramI , DikshitR , EserS , MathersC , RebeloM , et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer2015;136(5):E359‐86. [PUBMED: 25220842] ">Ferlay 2015</a>), with an estimated 55,000 deaths (<a href="./references#CD013186-bbs2-0267" title="FerlayJ , SoerjomataramI , DikshitR , EserS , MathersC , RebeloM , et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer2015;136(5):E359‐86. [PUBMED: 25220842] ">Ferlay 2015</a>). The highest incidence is observed in Australia with 13,134 new cases of melanoma of the skin in 2014 (<a href="./references#CD013186-bbs2-0226" title="Australian Cancer Database. Melanoma of the skin for Australia (ICD10 C43). Australian Institute of Health and Welfare (AIHW) 2017 Australian Cancer Incidence and Mortality (ACIM) books (www.aihw.gov.au/acim‐books/). Canberra: Australian Institute of Health and Welfare, 2017. ">ACIM 2017</a>) and in New Zealand with 2341 registered cases in 2010 (<a href="./references#CD013186-bbs2-0285" title="Health Promotion Agency and the Melanoma Network of New Zealand (MelNet). New Zealand Skin Cancer Primary Prevention and Early Detection Strategy 2014 to 2017. www.sunsmart.org.nz//sites/default/files/documents/NZ%20Skin%20Cancer%20PrimaryPrevention%20and%20EarlyDetection%20Strategy%202014%20to%202017%20FINAL%20VERSION%20%23406761.pdf. Cancer Society of New Zealand, (accessed 29 May 2018). ">HPA and MelNet NZ 2014</a>). For 2014 in the USA, the predicted incidence was 73,870 per annum and the predicted number of deaths was 9940 (<a href="./references#CD013186-bbs2-0337" title="SiegelR , MillerK , JemalA . Cancer statistics, 2015. CA: a Cancer Journal for Clinicians2015;65(1):5‐29. [PUBMED: 25559415] ">Siegel 2015</a>). The highest rates in Europe are seen in north‐western Europe and the Scandinavian countries, with a highest incidence reported in Switzerland: 25.8 per 100,000 in 2012. Rates in England have tripled from 4.6 and 6.0 per 100,000 in men and women, respectively, in 1990, to 18.6 and 19.6 per 100,000 in 2012 (<a href="./references#CD013186-bbs2-0265" title="EUCAN , International Agency for Research on Cancer. Malignant melanoma of skin: estimated incidence, mortality &amp; prevalence for both sexes, 2012. eco.iarc.fr/eucan/Cancer.aspx?Cancer=20. International Agency for Research on Cancer, (accessed 29 July 2015). ">EUCAN 2012</a>). Indeed, in the UK, melanoma has one of the fastest‐rising incidence rates of any cancer, and has the biggest projected increase in incidence between 2007 and 2030 (<a href="./references#CD013186-bbs2-0315" title="MistryM , ParkinDM , AhmadAS , SasieniP . Cancer incidence in the United Kingdom: projections to the year 2030. British Journal of Cancer2011;105(11):1795‐803. [PUBMED: 22033277] ">Mistry 2011</a>). In the decade leading up to 2013, age‐standardised incidence increased by 46%, with 14,500 new cases in 2013 and 2459 deaths in 2014 (<a href="./references#CD013186-bbs2-0243" title="Cancer Research UK. Skin cancer statistics. www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/skin‐cancer#heading‐One (accessed prior to 19 July 2017). ">Cancer Research UK 2017</a>). Rates are higher in women than in men, but the rate of incidence in men is increasing faster than in women (<a href="./references#CD013186-bbs2-0232" title="ArnoldM , HolterhuesC , HollesteinLM , CoeberghJW , NijstenT , PukkalaE , et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. Journal of the European Academy of Dermatology and Venereology2014;28(9):1170‐8. [PUBMED: 23962170] ">Arnold 2014</a>).The rising incidence of melanoma is thought to be primarily related to an increase in recreational sun exposure and tanning bed use and an increasingly ageing population with higher lifetime recreational ultraviolet (UV) exposure, in conjunction with possible earlier detection (<a href="./references#CD013186-bbs2-0239" title="BelbasisL , StefanakiI , StratigosAJ , EvangelouE . Non‐genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: An umbrella review of meta‐analyses. Journal of Dermatological Science2016;84(3):330‐9. [PUBMED: 27663092] ">Belbasis 2016</a>; <a href="./references#CD013186-bbs2-0302" title="LinosE , SwetterSM , CockburnMG , ColditzGA , ClarkeCA . Increasing burden of melanoma in the United States. Journal of Investigative Dermatology2009;129(7):1666‐74. [PUBMED: 19131946] ">Linos 2009</a>). Putative risk factors are reviewed in detail elsewhere (<a href="./references#CD013186-bbs2-0239" title="BelbasisL , StefanakiI , StratigosAJ , EvangelouE . Non‐genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: An umbrella review of meta‐analyses. Journal of Dermatological Science2016;84(3):330‐9. [PUBMED: 27663092] ">Belbasis 2016</a>). </p> <p>A database of over 40,000 US patients from 1998 onwards which assisted the development of the 8th American Joint Committee on Cancer (AJCC) Staging System indicated a five‐year survival of 97% to 99% for stage I melanoma, dropping to between 32% and 93% in stage III disease, depending on tumour thickness, the presence of ulceration and the number of involved nodes (<a href="./references#CD013186-bbs2-0274" title="GershenwaldJE , ScolyerRA , HessKR , SondakVK , LongGV , RossMI , et al. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians2017;67(6):472‐92. [DOI: 10.3322/caac.21409; PUBMED: 29028110] ">Gershenwald 2017</a>). While these are substantial increases relative to survival in 1975 (<a href="./references#CD013186-bbs2-0246" title="ChoH , MariottoAB , SchwartzLM , LuoJ , WoloshinS . When do changes in cancer survival mean progress? The insight from population incidence and mortality. Journal of the National Cancer Institute. Monographs2014;2014(49):187‐97. [PUBMED: 25417232] ">Cho 2014</a>), mortality rates have remained static during the same period. This observation, coupled with increasing incidence of localised disease, suggests that improvements in survival may be due to earlier detection and heightened vigilance (<a href="./references#CD013186-bbs2-0246" title="ChoH , MariottoAB , SchwartzLM , LuoJ , WoloshinS . When do changes in cancer survival mean progress? The insight from population incidence and mortality. Journal of the National Cancer Institute. Monographs2014;2014(49):187‐97. [PUBMED: 25417232] ">Cho 2014</a>). New targeted therapies for advanced (stage IV), melanoma (e.g. BRAF inhibitors), have improved survival, and immunotherapies are evolving such that long‐term survival is being documented (<a href="./references#CD013186-bbs2-0328" title="PasqualiS , HadjinicolaouAV , Chiarion SileniV , RossiCR , MocellinS . Systemic treatments for metastatic cutaneous melanoma. Cochrane Database of Systematic Reviews2018, Issue 2. [DOI: 10.1002/14651858.CD011123.pub2] ">Pasquali 2018</a>; <a href="./references#CD013186-bbs2-0334" title="RozemanEA , DekkerTJA , HaanenJBAG , BlankCU . Advanced melanoma: current treatment options, biomarkers, and future perspectives. American Journal of Clinical Dermatology 2017 Nov 21 [Epub ahead of print]. [DOI: 10.1007/s40257‐017‐0325‐6; PUBMED: 29164492] ">Rozeman 2017</a>). No new data regarding the survival prospects for patients with stage IV disease were analysed for the AJCC 8 staging guidelines due to lack of contemporary data (<a href="./references#CD013186-bbs2-0274" title="GershenwaldJE , ScolyerRA , HessKR , SondakVK , LongGV , RossMI , et al. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians2017;67(6):472‐92. [DOI: 10.3322/caac.21409; PUBMED: 29028110] ">Gershenwald 2017</a>). </p> </section> <section id="CD013186-sec-0047"> <h4 class="title">Basal cell carcinoma</h4> <p>BCC can arise from multiple stem cell populations, including from the bulge and interfollicular epidermis (<a href="./references#CD013186-bbs2-0277" title="GrachtchoukM , PeroJ , YangSH , ErmilovAN , MichaelLE , WangA , et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. Journal of Clinical Investigation2011;121(5):1768‐81. [PUBMED: 21519145] ">Grachtchouk 2011</a>). BCC growth is usually localised, but it can infiltrate and damage surrounding tissue, sometimes causing considerable destruction and disfigurement, particularly when located on the face (<a href="#CD013186-fig-0002">Figure 2</a>). The four main subtypes of BCC are superficial, nodular, morphoeic (infiltrative) and pigmented. Lesions typically present as slow‐growing, asymptomatic papules, plaques, or nodules which bleed or form ulcers that do not heal (<a href="./references#CD013186-bbs2-0270" title="FirnhaberJM . Diagnosis and treatment of basal cell and squamous cell carcinoma. American Family Physician2012;86(2):161‐8. [PUBMED: 22962928] ">Firnhaber 2012</a>). The diagnosis is often made incidentally rather than by people presenting with symptoms (<a href="./references#CD013186-bbs2-0275" title="GordonR . Skin cancer: an overview of epidemiology and risk factors. Seminars in Oncology Nursing2013;29(3):160‐9. [PUBMED: 23958214] ">Gordon 2013</a>). </p> <div class="figure" id="CD013186-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Sample photographs of BCC (left) and cSCC (right). Copyright © 2012 Dr Rubeta Matin: reproduced with permission." data-id="CD013186-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Sample photographs of BCC (left) and cSCC (right). Copyright © 2012 Dr Rubeta Matin: reproduced with permission. </p> </div> </div> </div> <p>BCC most commonly occurs on sun‐exposed sites on the head and neck (<a href="./references#CD013186-bbs2-0313" title="McCormackCJ , KellyJW , DorevitchAP . Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Archives of Dermatology1997;133(5):593‐6. [PUBMED: 9158412] ">McCormack 1997</a>) and are more common in men and in people over the age of 40. A rising incidence of BCC in younger people has been attributed to increased recreational sun exposure (<a href="./references#CD013186-bbs2-0235" title="Bath‐HextallF , Leonardi‐BeeJ , SmithC , MealA , HubbardR . Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. International Journal of Cancer2007;121(9):2105‐8. [PUBMED: 17640064] ">Bath‐Hextall 2007a</a>; <a href="./references#CD013186-bbs2-0275" title="GordonR . Skin cancer: an overview of epidemiology and risk factors. Seminars in Oncology Nursing2013;29(3):160‐9. [PUBMED: 23958214] ">Gordon 2013</a>; <a href="./references#CD013186-bbs2-0320" title="MusahA , GibsonJE , Leonardi‐BeeJ , CaveMR , AnderEL , Bath‐HextallF . Regional variations of basal cell carcinoma incidence in the UK using The Health Improvement Network database (2004‐10). British Journal of Dermatology2013;169(5):1093‐9. [PUBMED: 23701520] ">Musah 2013</a>). Other risk factors include Fitzpatrick skin types I and II (<a href="./references#CD013186-bbs2-0271" title="FitzpatrickTB . Soleil et peau. Journal de Médecine Esthétique1975;2:33‐4. ">Fitzpatrick 1975</a>; <a href="./references#CD013186-bbs2-0295" title="LearJT , SmithAG , HeagertyAH , BowersB , JonesPW , GilfordJ , et al. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma. Carcinogenesis1997;18(8):1499‐503. [PUBMED: 9276622] ">Lear 1997</a>; <a href="./references#CD013186-bbs2-0309" title="MaiaM , ProencaNG , DeMoraesJC . Risk factors for basal cell carcinoma: a case‐control study. Revista de Saude Publica1995;29(1):27‐37. [PUBMED: 8525311] ">Maia 1995</a>), previous skin cancer history, immunosuppression, arsenic exposure, and genetic predisposition such as in basal cell naevus (Gorlin) syndrome (<a href="./references#CD013186-bbs2-0276" title="GorlinRJ . Nevoid basal cell carcinoma (Gorlin) syndrome. Genetics in Medicine2004;6(6):530‐9. [PUBMED: 15545751] ">Gorlin 2004</a>; <a href="./references#CD013186-bbs2-0357" title="Zak‐PrelichM , NarbuttJ , Sysa‐JedrzejowskaA . Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatologic Surgery2004;30(2 Pt 2):248–52. [PUBMED: 14871217] ">Zak‐Prelich 2004</a>). Annual incidence is increasing worldwide; Europe has experienced an average increase of 5.5% a year over the last four decades, the USA 2% a year, while estimates for the UK show that incidence appears to be increasing more steeply at a rate of an additional 6 per 100,000 persons a year (<a href="./references#CD013186-bbs2-0305" title="LomasA , Leonardi‐BeeJ , Bath‐HextallF . A systematic review of worldwide incidence of nonmelanoma skin cancer. British Journal of Dermatology2012;166(5):1069‐80. [PUBMED: 22251204] ">Lomas 2012</a>). The rising incidence has been attributed to an ageing population, changes in the distribution of known risk factors, particularly ultraviolet radiation, and improved detection due to the increased awareness amongst both practitioners and the general population (<a href="./references#CD013186-bbs2-0350" title="VerkouterenJAC , RamdasKHR , WakkeeM , NijstenT . Epidemiology of basal cell carcinoma: scholarly review. British Journal of Dermatology2017;177(2):359‐72. [DOI: 10.1111/bjd.15321; PUBMED: 28220485] ">Verkouteren 2017</a>). <a href="./references#CD013186-bbs2-0283" title="HoorensI , VossaertK , PilL , BooneB , DeSchepperS , OngenaeK , et al. Total‐body examination vs lesion‐directed skin cancer screening. JAMA Dermatology2016;152(1):27‐34. [PUBMED: 26466155] ">Hoorens 2016</a> points to evidence for a gradual increase in the size of BCCs over time, with delays in diagnosis ranging from 19 to 25 months. </p> <p>According to National Institute for Health and Care Excellence (NICE) guidance (<a href="./references#CD013186-bbs2-0323" title="National Institute for Health and Clinical Excellence. NICE guidance on cancer services. Improving outcomes for people with skin tumours including melanoma (update): The management of low‐risk basal cell carcinomas in the community. www.nice.org.uk/guidance/csg8/resources/improving‐outcomes‐for‐people‐with‐skin‐tumours‐including‐melanoma‐2010‐partial‐update‐773380189. NICE, (accessed 27 November 2017). ">NICE 2010</a>), low‐risk BCCs that may be considered for excision are nodular lesions occurring in people older than 24 years who are not immunosuppressed and do not have Gorlin syndrome. Furthermore, low‐risk lesions should be located below the clavicle, should be small (less than 1 cm) with well‐defined margins, not recurrent following incomplete excision and are not difficult to reach surgically or in highly visible locations (<a href="./references#CD013186-bbs2-0323" title="National Institute for Health and Clinical Excellence. NICE guidance on cancer services. Improving outcomes for people with skin tumours including melanoma (update): The management of low‐risk basal cell carcinomas in the community. www.nice.org.uk/guidance/csg8/resources/improving‐outcomes‐for‐people‐with‐skin‐tumours‐including‐melanoma‐2010‐partial‐update‐773380189. NICE, (accessed 27 November 2017). ">NICE 2010</a>). Superficial BCCs are also typically low risk and may be amenable to medical treatments such as photodynamic therapy or topical chemotherapy (<a href="./references#CD013186-bbs2-0289" title="Kelleners‐SmeetsNW , MosterdK , NelemansPJ . Treatment of low‐risk basal cell carcinoma. Journal of Investigative Dermatology2017;137(3):539‐40. [PUBMED: 28235442] ">Kelleners‐Smeets 2017</a>). Assigning BCCs as low or high risk influences the management options (<a href="./references#CD013186-bbs2-0238" title="BatraRS , KelleyLC . A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer. Dermatologic Surgery2002;28(2):107‐12; discussion 112. [PUBMED: 11860418] ">Batra 2002</a>; <a href="./references#CD013186-bbs2-0330" title="RandleHW . Basal cell carcinoma. Identification and treatment of the high‐risk patient. Dermatologic Surgery1996;22(3):255‐61. [PUBMED: 8599737] ">Randle 1996</a>). </p> <p>Advanced locally‐destructive BCC can arise from longstanding untreated lesions or from a recurrence of aggressive basal cell carcinoma after primary treatment (<a href="./references#CD013186-bbs2-0296" title="LearJT . Oral hedgehog‐pathway inhibitors for basal‐cell carcinoma. New England Journal of Medicine2012;366(23):2225‐6. [PUBMED: 22670909] ">Lear 2012</a>). Very rarely, BCC metastasises to regional and distant sites resulting in death, especially cases of large neglected lesions in those who are immunosuppressed or those with Gorlin syndrome (<a href="./references#CD013186-bbs2-0314" title="McCuskerM , Basset‐SeguinN , DummerR , LewisK , SchadendorfD , SekulicA , et al. Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease. European Journal of Cancer2014;50(4):774‐83. [PUBMED: 24412051] ">McCusker 2014</a>). Rates of metastasis are reported at 0.0028% to 0.55% (<a href="./references#CD013186-bbs2-0304" title="LoJS , SnowSN , ReiznerGT , MohsFE , LarsonPO , HruzaGJ . Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. Journal of the American Academy of Dermatology1991;24(5 Pt 1):715‐9. [PUBMED: 1869642] ">Lo 1991</a>), with very poor survival rates. It is recognised that baso‐squamous carcinoma (more like a high‐risk cSCC in behaviour and not considered a true BCC) is likely to have accounted for many cases of apparent metastases of BCC, hence the spuriously high reported incidence in some studies of up to 0.55%, which is not seen in clinical practice (<a href="./references#CD013186-bbs2-0273" title="GarciaC , PolettiE , CrowsonAN . Basosquamous carcinoma. Journal of the American Academy of Dermatology2009;60(1):137‐43. [PUBMED: 19103364] ">Garcia 2009</a>). </p> </section> <section id="CD013186-sec-0048"> <h4 class="title">Squamous cell carcinoma of the skin</h4> <p>Primary cSCC arises from the keratinocytes in the epidermis or its appendages. People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (<a href="./references#CD013186-bbs2-0278" title="GriffinLL , AliFR , LearJT . Non‐melanoma skin cancer. Clinical Medicine2016;16(1):62‐5. [PUBMED: 26833519] ">Griffin 2016</a>), often with an adherent crust (<a href="./references#CD013186-bbs2-0307" title="MadanV , LearJT , SzeimiesRM . Non‐melanoma skin cancer. Lancet2010;375(9715):673‐85. [PUBMED: 20171403] ">Madan 2010</a>). cSCC can arise in the absence of a precursor lesion or it can develop from pre‐existing actinic keratosis (dysplastic epidermis) or Bowen's disease (considered by some to be cSCC in situ). The estimated annual risk of progression is from less than 1% to 20% (<a href="./references#CD013186-bbs2-0227" title="AlamM , RatnerD . Cutaneous squamous‐cell carcinoma (Review). New England Journal of Medicine2001;344(13):975‐83. [PUBMED: 11274625] ">Alam 2001</a>), and 5% for lesions developing from pre–existing dysplasia (<a href="./references#CD013186-bbs2-0287" title="KaoGF . Carcinoma arising in Bowen's disease. Archives of Dermatology1986;122(10):1124‐6. [PUBMED: 3767398] ">Kao 1986</a>). It remains locally invasive for a variable length of time, but has the potential to spread to the regional lymph nodes or through the bloodstream to distant sites, especially in immunosuppressed individuals (<a href="./references#CD013186-bbs2-0293" title="LansburyL , Leonardi‐BeeJ , PerkinsW , GoodacreT , TweedJA , Bath‐HextallFJ . Interventions for non‐metastatic squamous cell carcinoma of the skin. Cochrane Database of Systematic Reviews2010, Issue 4. [DOI: 10.1002/14651858.CD007869.pub2] ">Lansbury 2010</a>). High‐risk lesions are those arising on the lip or ear, recurrent cSCC, lesions arising on non‐exposed sites, scars or chronic ulcers, tumours larger than 20 mm in diameter or which have a histological depth of invasion greater than 4 mm or poor differentiation status on histopathological examination (<a href="./references#CD013186-bbs2-0318" title="MotleyRJ , PrestonPW , LawrenceCM . Multi‐professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. www.bsds.org.uk/uploads/pdfs/SCCguide2009.pdf (accessed 15 November 2017). ">Motley 2009</a>). </p> <p>Chronic ultraviolet light exposure through recreation or occupation is strongly linked to cSCC occurrence (<a href="./references#CD013186-bbs2-0227" title="AlamM , RatnerD . Cutaneous squamous‐cell carcinoma (Review). New England Journal of Medicine2001;344(13):975‐83. [PUBMED: 11274625] ">Alam 2001</a>). It is particularly common in people with fair skin and in less common genetic disorders of pigmentation, such as albinism, xeroderma pigmentosum, and recessive dystrophic epidermolysis bullosa (RDEB) (<a href="./references#CD013186-bbs2-0227" title="AlamM , RatnerD . Cutaneous squamous‐cell carcinoma (Review). New England Journal of Medicine2001;344(13):975‐83. [PUBMED: 11274625] ">Alam 2001</a>). Other recognised risk factors include immunosuppression; chronic wounds; arsenic or radiation exposure; certain drug treatments, such as voriconazole and BRAF mutation inhibitors; and previous skin cancer history (<a href="./references#CD013186-bbs2-0234" title="BaldurssonB , SigurgeirssonB , LindelofB . Leg ulcers and squamous cell carcinoma. An epidemiological study and a review of the literature. Acta Dermato‐Venereologica1993;73(3):171‐4. [PUBMED: 8105611] ">Baldursson 1993</a>; <a href="./references#CD013186-bbs2-0247" title="ChowdriNA , DarziMA . Postburn scar carcinomas in Kashmiris. Burns1996;22(6):477‐82. [PUBMED: 8884010] ">Chowdri 1996</a>; <a href="./references#CD013186-bbs2-0251" title="DabskiK , StollHLJr , MilgromH . Squamous cell carcinoma complicating late chronic discoid lupus erythematosus. Journal of Surgical Oncology1986;32(4):233‐7. [PUBMED: 3736067] ">Dabski 1986</a>; <a href="./references#CD013186-bbs2-0266" title="FaschingMC , MelandNB , WoodsJE , WolffBG . Recurrent squamous‐cell carcinoma arising in pilonidal sinus tract‐‐multiple flap reconstructions. Report of a case. Diseases of the Colon and Rectum1989;32(2):153‐8. [PUBMED: 2914529] ">Fasching 1989</a>; <a href="./references#CD013186-bbs2-0303" title="ListerRK , BlackMM , CalonjeE , BurnandKG . Squamous cell carcinoma arising in chronic lymphoedema. British Journal of Dermatology1997;136(3):384‐7. [PUBMED: 9115922] ">Lister 1997</a>; <a href="./references#CD013186-bbs2-0310" title="MaloneyME . Arsenic in dermatology. Dermatologic Surgery1996;22(3):301‐4. [PUBMED: 8599743] ">Maloney 1996</a>; <a href="./references#CD013186-bbs2-0327" title="O'GormanSM , MurphyGM . Photosensitizing medications and photocarcinogenesis. Photodermatology, Photoimmunology &amp; Photomedicine2014;30(1):8‐14. [PUBMED: 24393207] ">O'Gorman 2014</a>). In solid organ transplant recipients, cSCC is the most common form of skin cancer; the risk of developing cSCC has been estimated at 65 to 253 times that of the general population (<a href="./references#CD013186-bbs2-0282" title="HarteveltMM , BavinckJN , KootteAM , VermeerBJ , VandenbrouckeJP . Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation1990;49(3):506‐9. [PUBMED: 2316011] ">Hartevelt 1990</a>; <a href="./references#CD013186-bbs2-0286" title="JensenP , HansenS , MollerB , LeivestadT , PfefferP , GeiranO , et al. Skin cancer in kidney and heart transplant recipients and different long‐term immunosuppressive therapy regimens. Journal of the American Academy of Dermatology1999;40(2 Pt 1):177‐86. [PUBMED: 10025742] ">Jensen 1999</a>; <a href="./references#CD013186-bbs2-0293" title="LansburyL , Leonardi‐BeeJ , PerkinsW , GoodacreT , TweedJA , Bath‐HextallFJ . Interventions for non‐metastatic squamous cell carcinoma of the skin. Cochrane Database of Systematic Reviews2010, Issue 4. [DOI: 10.1002/14651858.CD007869.pub2] ">Lansbury 2010</a>). Overall, local and metastatic recurrence of cSCC at five years is estimated at 8% and 5% respectively. The five‐year survival rate of metastatic cSCC of the head and neck is around 60% (<a href="./references#CD013186-bbs2-0316" title="MoeckelmannN , EbrahimiA , DirvenR , LiuJ , LowTH , GuptaR , et al. Analysis and comparison of the 8th edition American Joint Committee on Cancer (AJCC) nodal staging system in cutaneous and oral squamous cell cancer of the head and neck. Annals of Surgical Oncology2018; Vol. 25, issue 6:1730‐6. [DOI: 10.1245/s10434‐018‐6340‐x] ">Moeckelmann 2018</a>). </p> </section> <section id="CD013186-sec-0049"> <h4 class="title">Treatment</h4> <p>For primary melanoma, the mainstay of definitive treatment is wide local surgical excision of the lesion, to remove both the tumour and any malignant cells that might have spread into the surrounding skin (<a href="./references#CD013186-bbs2-0272" title="GarbeC , PerisK , HauschildA , SaiagP , MiddletonM , BastholtL , et al. Diagnosis and treatment of melanoma. European consensus‐based interdisciplinary guideline ‐ Update 2016. European Journal of Cancer2016;63:201‐17. [PUBMED: 27367293] ">Garbe 2016</a>; <a href="./references#CD013186-bbs2-0312" title="MarsdenJR , Newton‐BishopJA , BurrowsL , CookM , CorriePG , CoxNH , et al. BAD Guidelines: Revised UK guidelines for the management of cutaneous melanoma 2010. British Journal of Dermatology2010;163(2):238‐56. [PUBMED: 20608932] ">Marsden 2010</a>; <a href="./references#CD013186-bbs2-0324" title="National Institute for Health and Care Excellence. Melanoma: assessment and management. www.nice.org.uk/guidance/ng14. London: National Institute for Health and Care Excellence, (accessed prior to 2 May 2018). ">NICE 2015</a>; <a href="./references#CD013186-bbs2-0338" title="Scottish Intercollegiate Guidelines Network. Cutaneous Melanoma. www.sign.ac.uk/sign‐146‐melanoma.html. Scotland: SIGN, (accessed prior to 19 July 2017). ">SIGN 2017</a>; <a href="./references#CD013186-bbs2-0339" title="SladdenMJ , BalchC , BarzilaiDA , BergD , FreimanA , HandisideT , et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database of Systematic Reviews2009, Issue 10. [DOI: 10.1002/14651858.CD004835.pub2] ">Sladden 2009</a>). Recommended lateral surgical margins vary according to tumour thickness (<a href="./references#CD013186-bbs2-0272" title="GarbeC , PerisK , HauschildA , SaiagP , MiddletonM , BastholtL , et al. Diagnosis and treatment of melanoma. European consensus‐based interdisciplinary guideline ‐ Update 2016. European Journal of Cancer2016;63:201‐17. [PUBMED: 27367293] ">Garbe 2016</a>) and stage of disease at presentation (<a href="./references#CD013186-bbs2-0324" title="National Institute for Health and Care Excellence. Melanoma: assessment and management. www.nice.org.uk/guidance/ng14. London: National Institute for Health and Care Excellence, (accessed prior to 2 May 2018). ">NICE 2015</a>). </p> <p>Treatment options for BCC and cSCC include surgery, other destructive techniques such as cryotherapy or electrodesiccation and topical chemotherapy. A Cochrane Review of 27 randomised controlled trials (RCTs) of interventions for BCC found very little good‐quality evidence for any of the interventions used (<a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>). Complete surgical excision of primary BCC has a reported five‐year recurrence rate of less than 2% (<a href="./references#CD013186-bbs2-0279" title="GriffithsRW , SuvarnaSK , StoneJ . Do basal cell carcinomas recur after complete conventional surgical excision?. British Journal of Plastic Surgery2005;58(6):795‐805. [PUBMED: 16086990] ">Griffiths 2005</a>; <a href="./references#CD013186-bbs2-0351" title="WalkerP , HillD . Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australasian Journal of Dermatology2006;47(1):1‐12. [PUBMED: 16405477] ">Walker 2006</a>), leading to significantly fewer recurrences than treatment with radiotherapy (<a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>). After apparent clear histopathological margins (serial vertical sections) after standard excision biopsy with 4 mm surgical peripheral margins taken there is a five‐year reported recurrence rate of around 4% (<a href="./references#CD013186-bbs2-0261" title="DruckerA , AdamGP , LangbergV , GazulaA , SmithB , MoustafaF , et al. Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin. Comparative Effectiveness Reviews, No. 199. Rockville (MD): Agency for Healthcare Research and Quality (US), 2017. ">Drucker 2017</a>). Mohs micrographic surgery, whereby horizontal sections of the tumour are microscopically examined intraoperatively and re‐excision is undertaken until the margins are tumour‐free, can be considered for high‐risk lesions where standard wider excision margins of surrounding healthy skin might lead to considerable functional impairment (<a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>; <a href="./references#CD013186-bbs2-0293" title="LansburyL , Leonardi‐BeeJ , PerkinsW , GoodacreT , TweedJA , Bath‐HextallFJ . Interventions for non‐metastatic squamous cell carcinoma of the skin. Cochrane Database of Systematic Reviews2010, Issue 4. [DOI: 10.1002/14651858.CD007869.pub2] ">Lansbury 2010</a>; <a href="./references#CD013186-bbs2-0318" title="MotleyRJ , PrestonPW , LawrenceCM . Multi‐professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. www.bsds.org.uk/uploads/pdfs/SCCguide2009.pdf (accessed 15 November 2017). ">Motley 2009</a>; <a href="./references#CD013186-bbs2-0344" title="StratigosA , GarbeC , LebbeC , MalvehyJ , DelMarmolV , PehambergerH , et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus‐based interdisciplinary guideline. European Journal of Cancer2015;51(14):1989‐2007. [PUBMED: 26219687] ">Stratigos 2015</a>). Bath‐Hextall and colleagues (<a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>) found a single trial comparing Mohs micrographic surgery with a 3mm standard excision in BCC (<a href="./references#CD013186-bbs2-0341" title="SmeetsNW , KrekelsGA , OstertagJU , EssersBA , DirksenCD , NiemanFH , et al. Surgical excision vs Mohs' micrographic surgery for basal‐cell carcinoma of the face: randomised controlled trial. Lancet2004;364(9447):1766‐72. [PUBMED: 15541449] ">Smeets 2004</a>); the update of this study showed non‐significantly lower recurrence at 10 years with Mohs micrographic surgery (4.4% compared to 12.2% after surgical excision, P = 0.10) (<a href="./references#CD013186-bbs2-0349" title="VanLooE , MosterdK , KrekelsGA , RoozeboomMH , OstertagJU , DirksenCD , et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow‐up. European Journal of Cancer2014;50(17):3011‐20. [PUBMED: 25262378] ">Van Loo 2014</a>). </p> <p>The main treatments for high‐risk BCC are wide local excision, Mohs micrographic surgery and radiotherapy. For low‐risk or superficial subtypes of BCC, or for small and or multiple BCCs at low‐risk sites (<a href="./references#CD013186-bbs2-0312" title="MarsdenJR , Newton‐BishopJA , BurrowsL , CookM , CorriePG , CoxNH , et al. BAD Guidelines: Revised UK guidelines for the management of cutaneous melanoma 2010. British Journal of Dermatology2010;163(2):238‐56. [PUBMED: 20608932] ">Marsden 2010</a>), destructive techniques other than excisional surgery may be used (e.g. electrodesiccation and curettage or cryotherapy (<a href="./references#CD013186-bbs2-0227" title="AlamM , RatnerD . Cutaneous squamous‐cell carcinoma (Review). New England Journal of Medicine2001;344(13):975‐83. [PUBMED: 11274625] ">Alam 2001</a>; <a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>)). Alternatively, non‐surgical (or non‐destructive) treatments may be considered (<a href="./references#CD013186-bbs2-0235" title="Bath‐HextallF , Leonardi‐BeeJ , SmithC , MealA , HubbardR . Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. International Journal of Cancer2007;121(9):2105‐8. [PUBMED: 17640064] ">Bath‐Hextall 2007a</a>; <a href="./references#CD013186-bbs2-0260" title="DrewBA , KariaPS , MoraAN , LiangCA , SchmultsCD . Treatment patterns, outcomes, and patient satisfaction of primary epidermally limited nonmelanoma skin cancer. Dermatologic Surgery2017;43(12):1423‐30. [DOI: 10.1097/DSS.0000000000001225; PUBMED: 28661992] ">Drew 2017</a>; <a href="./references#CD013186-bbs2-0290" title="KimDD , TangJY , IoannidisJP . Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. Journal of Clinical Epidemiology2014;67(4):391‐400. [PUBMED: 24491794] ">Kim 2014</a>), including topical chemotherapy such as imiquimod (<a href="./references#CD013186-bbs2-0354" title="WilliamsHC , Bath‐HextallF , OzolinsM , ArmstrongSJ , ColverGB , PerkinsW , et al. Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5‐year results of the SINS randomized controlled trial. Journal of Investigative Dermatology2017;137(3):614‐9. [PUBMED: 27932240] ">Williams 2017</a>), 5‐fluorouracil (<a href="./references#CD013186-bbs2-0231" title="AritsAH , MosterdK , EssersBA , SpoorenbergE , SommerA , DeRooijMJ , et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal‐cell carcinoma: a single blind, non‐inferiority, randomised controlled trial. Lancet Oncology2013;14(7):647‐54. [DOI: 10.1016/S1470‐2045(13)70143‐8] ">Arits 2013</a>), ingenol mebutate (<a href="./references#CD013186-bbs2-0321" title="NartIF , ArmayonesSG , MedinaFV , OrtiMB , OrpinellXB . Basal cell carcinoma treated with ingenol mebutate. Journal of the American Academy of Dermatology2015;5(Suppl 1):AB180. ">Nart 2015</a>) and photodynamic therapy (<a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>; <a href="./references#CD013186-bbs2-0333" title="RoozeboomMH , AritsAH , MosterdK , SommerA , EssersBA , DeRooijMJ , et al. Three‐year follow‐up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single‐blind, noninferiority, randomized controlled trial. Journal of Investigative Dermatology2016;136(8):1568‐74. [PUBMED: 27113429] ">Roozeboom 2016</a>). Although non‐surgical techniques are increasingly used, they do not allow histological confirmation of tumour clearance, and their use is dependent on accurate characterisation of the histological subtype and depth of tumour. The 2007 systematic review of BCC interventions found limited evidence from very small RCTs for these approaches (<a href="./references#CD013186-bbs2-0236" title="Bath‐Hextall FionaJ , PerkinsW , BongJ , WilliamsHC . Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD003412.pub2] ">Bath‐Hextall 2007b</a>), which have only partially been addressed by subsequent studies (<a href="./references#CD013186-bbs2-0237" title="Bath‐HextallF , OzolinsM , ArmstrongSJ , ColverGB , PerkinsW , MillerPS , et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal‐cell carcinoma (SINS): a multicentre, non‐inferiority, randomised controlled trial. Lancet Oncology2014;15(1):96‐105. [PUBMED: 24332516] ">Bath‐Hextall 2014</a>; <a href="./references#CD013186-bbs2-0290" title="KimDD , TangJY , IoannidisJP . Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. Journal of Clinical Epidemiology2014;67(4):391‐400. [PUBMED: 24491794] ">Kim 2014</a>; <a href="./references#CD013186-bbs2-0332" title="RoozeboomMH , AritsAH , NelemansPJ , Kelleners‐SmeetsNW . Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta‐analysis of randomized and nonrandomized trials. British Journal of Dermatology2012;167(4):733‐56. [PUBMED: 22612571] ">Roozeboom 2012</a>). Most BCC trials have compared interventions within the same treatment class, and few have compared medical versus surgical treatments (<a href="./references#CD013186-bbs2-0290" title="KimDD , TangJY , IoannidisJP . Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. Journal of Clinical Epidemiology2014;67(4):391‐400. [PUBMED: 24491794] ">Kim 2014</a>). </p> <p>Vismodegib, a first‐in‐class Hedgehog signalling pathway inhibitor, is now available for the treatment of metastatic or locally‐advanced BCC based on the pivotal study ERIVANCE BCC (<a href="./references#CD013186-bbs2-0336" title="SekulicA , MigdenMR , OroAE , DirixL , LewisKD , HainsworthJD , et al. Efficacy and safety of vismodegib in advanced basal‐cell carcinoma. New England Journal of Medicine2012;366(23):2171‐9. [PUBMED: 22670903] ">Sekulic 2012</a>). It is licensed for use in patients where surgery or radiotherapy is inappropriate, e.g. for treating locally‐advanced periocular and orbital BCCs with orbital salvage of patients who otherwise would have required exenteration (<a href="./references#CD013186-bbs2-0355" title="WongKY , FifeK , LearJT , PriceRD , DurraniAJ . Vismodegib for locally advanced periocular and orbital basal cell carcinoma: A review of 15 consecutive cases. Plastic and Reconstructive Surgery2017;5(7):e1424. [PUBMED: 28831360] ">Wong 2017</a>). However, NICE has recently recommended against the use of vismodegib, based on cost effectiveness and uncertainty of evidence (<a href="./references#CD013186-bbs2-0325" title="National Institute for Health and Care Excellence. Vismodegib for treating basal cell carcinoma. www.nice.org.uk/guidance/ta489. London: NICE, (accessed prior to 2 May 2018). ">NICE 2017</a>). </p> <p>A systematic review of interventions for primary cSCC found only one RCT eligible for inclusion (<a href="./references#CD013186-bbs2-0293" title="LansburyL , Leonardi‐BeeJ , PerkinsW , GoodacreT , TweedJA , Bath‐HextallFJ . Interventions for non‐metastatic squamous cell carcinoma of the skin. Cochrane Database of Systematic Reviews2010, Issue 4. [DOI: 10.1002/14651858.CD007869.pub2] ">Lansbury 2010</a>). Current practice therefore relies on evidence from observational studies, as reviewed in <a href="./references#CD013186-bbs2-0294" title="LansburyL , Bath‐HextallF , PerkinsW , StantonW , Leonardi‐BeeJ . Interventions for non‐metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ2013;347:f6153. [PUBMED: 24191270] ">Lansbury 2013</a>, for example. Surgical excision with predetermined margins is usually the first‐line treatment (<a href="./references#CD013186-bbs2-0318" title="MotleyRJ , PrestonPW , LawrenceCM . Multi‐professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. www.bsds.org.uk/uploads/pdfs/SCCguide2009.pdf (accessed 15 November 2017). ">Motley 2009</a>; <a href="./references#CD013186-bbs2-0344" title="StratigosA , GarbeC , LebbeC , MalvehyJ , DelMarmolV , PehambergerH , et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus‐based interdisciplinary guideline. European Journal of Cancer2015;51(14):1989‐2007. [PUBMED: 26219687] ">Stratigos 2015</a>). Estimates of recurrence after Mohs micrographic surgery, surgical excision, or radiotherapy, which are likely to have been evaluated in higher‐risk populations, have shown pooled recurrence rates of 3%, 5.4% and 6.4% respectively, with overlapping confidence intervals; the review authors advise caution when comparing results across treatments (<a href="./references#CD013186-bbs2-0294" title="LansburyL , Bath‐HextallF , PerkinsW , StantonW , Leonardi‐BeeJ . Interventions for non‐metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ2013;347:f6153. [PUBMED: 24191270] ">Lansbury 2013</a>). </p> </section> </section> <section id="CD013186-sec-0050"> <h3 class="title" id="CD013186-sec-0050">Index test(s)</h3> <p>Computer–assisted diagnosis (CAD) describes a range of artificial intelligence‐based techniques that automate the diagnosis of skin cancer by using a computer to analyse lesion images, and determine the likelihood of malignancy, or the need for excision. Each CAD system has a data collection component, which collects imaging or non‐visual data (e.g. electrical impedance measurements) from the suspicious lesion and feeds it to the data processing component, which then performs a series of analyses to arrive at a diagnostic classification. </p> <p>Images are acquired using a number of different techniques, although most commonly by digital dermoscopy (Derm–CAD) which creates digital subsurface images of the skin using a computer coupled with a dermatoscope, videocamera and digital television (<a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a>; <a href="./references#CD013186-bbs2-0264" title="EstevaA , KuprelB , NovoaRA , KoJ , SwetterSM , BlauHM , et al. Dermatologist‐level classification of skin cancer with deep neural networks. Nature2017;542(7639):115‐8. [doi: 10.1038/nature21056; PUBMED: 28117445] ">Esteva 2017</a>). Commercially‐available systems include the DB–MIPS® (DB–Dermo MIPS) (Biomips Engineering SRL, Sienna Italy), MicroDERM (Visiomed AG, Germany), SolarScan (Polartechnics Ltd, Australia) and MoleExpert (DermoScan GmbH, Germany), all of which are hand–held digital or video dermatoscopes that communicate with CAD analysis software (see <a href="#CD013186-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD013186-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Examples of commercially available CAD systems using digital dermoscopy (A), electrical impedance spectroscopy (B) and multispectral imaging (C and D). Reproduced with permission of the manufacturers. Copyright © 2018 MedX Corp, Canada; DermoScanGmbH, Germany; SciBase III, Sweden: reproduced with permission." data-id="CD013186-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Examples of commercially available CAD systems using digital dermoscopy (A), electrical impedance spectroscopy (B) and multispectral imaging (C and D). Reproduced with permission of the manufacturers. Copyright © 2018 MedX Corp, Canada; DermoScanGmbH, Germany; SciBase III, Sweden: reproduced with permission. </p> </div> </div> </div> <p>Other systems use spectroscopy (Spectro‐CAD), whereby information on cell characteristics (such as cell shape or size) is gathered by measuring how electromagnetic waves pass through skin lesions. This information is most commonly acquired using multispectral imaging (MSI–CAD) that enables computer–generated graphic representations of lesion morphology to be produced from detecting light reflected at several wavelengths across the lesion. By far the most common of these is diffuse reflectance spectrophotometry imaging (DRSi), which uses light that diffusely penetrates the skin to a depth of 2 to 2.5 mm beneath the surface to produce light reflectance images at a number of specific wavelengths across the visible near‐infrared light spectrum (approximately 400 to 1000 nm) to capture variations in light attenuation and scattering from melanin, collagen and blood vessel structures. </p> <p>DRSi developed from diffuse reflectance spectroscopy, a non‐visual spectroscopic technique which uses optical reflectance to distinguish between lesion types based on spectral shape and calibrated level of reflected light for wavelengths continuously varying from the ultraviolet (320 nm) to the near‐infrared (1100 nm) with a high spectral resolution (4 nm) (e.g. <a href="./references#CD013186-bbs2-0147" title="MarchesiniR , CascinelliN , BrambillaM , ClementeC , MascheroniL , PignoliE , et al. In vivo spectrophotometric evaluation of neoplastic and non‐neoplastic skin pigmented lesions. II: discriminant analysis between nevus and melanoma. Photochemistry and Photobiology1992;55(4):515‐22. ">Marchesini 1992</a>; <a href="./references#CD013186-bbs2-0207" title="WallaceVP , CrawfordDC , MortimerPS , OttRJ , BamberJC . Spectrophotometric assessment of pigmented skin lesions: methods and feature selection for evaluation of diagnostic performance. Physics in Medicine and Biology2000;45(3):735. ">Wallace 2000b</a>). Commercially available DRSi computer‐assisted diagnosis systems include the SIAscope™ (MedX Health Corp, Canada), a hand–held unit that communicates with CAD analysis software (<a href="#CD013186-fig-0003">Figure 3</a>). The MelaFind® system (Strata Skin Sciences (formerly Mela Sciences Inc), Horsham, PA, USA) was Food and Drug Administration (FDA)‐approved; however, it no longer appears to be commercially available. </p> <p>The Nevisense™ system (SciBase III, Sweden; <a href="#CD013186-fig-0003">Figure 3</a>) is also commercially available, but is based on electrical impedance spectroscopy (EIS), a non‐optical method which seeks to provide information on cellular features by measuring the feedback from an electrical current once it has passed through the intended tissue. With Nevisense™, an alternating applied voltage (electrical current) is passed by a probe through a skin lesion and the current that is bounced back is measured by the same probe, which measures a combination of tissue resistance and capacitance. At high frequencies, conduction occurs easily through all tissue components, including cells, but at low frequencies current tends to flow only through the extracellular space. The spectral shape is therefore sensitive to cellular components and dimensions, internal structure and cellular arrangements. The Nevisense™ EIS system measures at four multiple depths and at 35 frequencies logarithmically distributed from 1.0 kHz to 2.5 MHz using a 5 x 5 mm area electrode covered in tiny pins that penetrate into the stratum corneum. </p> <p>Other non‐visual sources of lesion data include Raman spectroscopy, in which a laser is used to excite vibrations in molecules which then impart wavelength shifts to some of the scattered light waves, creating spectral patterns that are related to the molecular structure of lesions (<a href="./references#CD013186-bbs2-0308" title="MaglogiannisI , DoukasCN . Overview of advanced computer vision systems for skin lesion characterization. IEEE Transactions on Information Technology in Biomedicine2009;13(5):721‐33. [DOI: 10.1109/TITB.2009.2017529] ">Maglogiannis 2009</a>), and fluorescence spectroscopy which uses a laser to excite electrons, causing molecules to absorb and then re‐emit light in spectral patterns that are also related to the molecular structure of lesions (<a href="./references#CD013186-bbs2-0329" title="RallanD , HarlandCC . Skin imaging: is it clinically useful?. Clinical Dermatology2004;29(5):453‐59. [PUBMED: 15347322] ">Rallan 2004</a>). </p> <p>All CAD systems use machine learning, where a classification algorithm learns features of groups of lesions (i.e. diagnostic types) by exposure to a ‘training set’ of lesions of known histological diagnosis. This process creates a model which is designed to distinguish between these lesion types in future observations. Examples of machine learning algorithms include discriminant analysis, decision trees, neural networks, fuzzy logic, nearest k‐neighbours, logistic regression and support vector machines (SVMs), and all use different mathematical equations to set out how observed features relate to a given diagnosis (<a href="./references#CD013186-bbs2-0308" title="MaglogiannisI , DoukasCN . Overview of advanced computer vision systems for skin lesion characterization. IEEE Transactions on Information Technology in Biomedicine2009;13(5):721‐33. [DOI: 10.1109/TITB.2009.2017529] ">Maglogiannis 2009</a>; <a href="./references#CD013186-bbs2-0148" title="MasoodA , Al JumailyAA , HoshyarAN , MasoodO . Automated segmentation of skin lesions: modified Fuzzy C mean thresholding based level set method. 16th International Multi Topic Conference (INMIC). IEEE, 2013:201‐6. [DOI: 10.1109/INMIC.2013.6731350] ">Masood 2013</a>). Model outputs also vary, in part according to the type of data used to acquire lesion information, and can take the form of binary outputs indicating the presence of malignancy versus benignity (e.g. the Melafind® system), risk scores which can be used at varying thresholds (e.g. the DANAOS system used by MicroDerm), or graphical representations of the CAD pattern analysis which highlight areas of concern within a lesion (e.g. the SIAgraphs produced by SIAscope™). Artificial intelligence systems using continuous learning algorithms, where computer systems continuously develop their classification algorithm as each new case is examined, and do not stop learning at the end of a training period, are not addressed in this review. </p> </section> <section id="CD013186-sec-0051"> <h3 class="title" id="CD013186-sec-0051">Clinical pathway</h3> <p>The diagnosis of skin lesions occurs in primary‐, secondary‐, and tertiary‐care settings by both generalist and specialist healthcare providers. In the UK, people with concerns about a new or changing lesion will present to their general practitioner (GP) rather than directly to a specialist in secondary care. A GP with clinical concerns usually refers a patient to a specialist in secondary care – usually a dermatologist, but sometimes to a surgical specialist such as a plastic surgeon or an ophthalmic surgeon. Suspicious skin lesions may also be identified in a referral setting, for example by a general surgeon, and referred for a consultation with a skin cancer specialist (<a href="#CD013186-fig-0004">Figure 4</a>). Skin cancers identified by other specialist surgeons (such as an ear, nose, and throat (ENT) specialist or maxillofacial surgeon) will usually be diagnosed and treated without further referral. </p> <div class="figure" id="CD013186-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Current clinical pathway for people with skin lesions." data-id="CD013186-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Current clinical pathway for people with skin lesions.</p> </div> </div> </div> <p>Current UK guidelines recommend that all suspicious pigmented lesions presenting in primary care should be assessed by taking a clinical history and visual inspection (VI) using the seven‐point checklist (<a href="./references#CD013186-bbs2-0306" title="MacKieRM . Clinical recognition of early invasive malignant melanoma. BMJ1990;301(6759):1005‐6. [PUBMED: 2249043] ">MacKie 1990</a>); lesions suspected to be melanoma or cSCC should be referred for appropriate specialist assessment within two weeks (<a href="./references#CD013186-bbs2-0245" title="ChaoD , London Cancer North and East. London Cancer, Guidelines for Cutaneous Malignant Melanoma Management August 2014. www.londoncancer.org/media/76373/london‐cancer‐melanoma‐guidelines‐2013‐v1.0.pdf. London: London Cancer North and East Alliance, (accessed 12 August 2018). ">Chao 2013</a>; <a href="./references#CD013186-bbs2-0312" title="MarsdenJR , Newton‐BishopJA , BurrowsL , CookM , CorriePG , CoxNH , et al. BAD Guidelines: Revised UK guidelines for the management of cutaneous melanoma 2010. British Journal of Dermatology2010;163(2):238‐56. [PUBMED: 20608932] ">Marsden 2010</a>; <a href="./references#CD013186-bbs2-0324" title="National Institute for Health and Care Excellence. Melanoma: assessment and management. www.nice.org.uk/guidance/ng14. London: National Institute for Health and Care Excellence, (accessed prior to 2 May 2018). ">NICE 2015</a>). Evidence is emerging, however, to suggest that excision of melanoma by GPs is not associated with increased risk compared with outcomes in secondary care (<a href="./references#CD013186-bbs2-0319" title="MurchieP , Amalraj RajaE , BrewsterDH , IversenL , LeeAJ . Is initial excision of cutaneous melanoma by General Practitioners (GPs) dangerous? Comparing patient outcomes following excision of melanoma by GPs or in hospital using national datasets and meta‐analysis. European Journal of Cancer2017;86:373‐84. [PUBMED: 29100192] ">Murchie 2017</a>). In the UK, low‐risk BCCs are usually recommended for routine referral, with urgent referral for those in whom a delay could have a significant impact on outcomes, for example due to large lesion size or critical site (<a href="./references#CD013186-bbs2-0324" title="National Institute for Health and Care Excellence. Melanoma: assessment and management. www.nice.org.uk/guidance/ng14. London: National Institute for Health and Care Excellence, (accessed prior to 2 May 2018). ">NICE 2015</a>). Appropriately‐qualified generalist care providers increasingly undertake management of low‐risk BCC in the UK, such as by excision of low‐risk lesions (<a href="./references#CD013186-bbs2-0323" title="National Institute for Health and Clinical Excellence. NICE guidance on cancer services. Improving outcomes for people with skin tumours including melanoma (update): The management of low‐risk basal cell carcinomas in the community. www.nice.org.uk/guidance/csg8/resources/improving‐outcomes‐for‐people‐with‐skin‐tumours‐including‐melanoma‐2010‐partial‐update‐773380189. NICE, (accessed 27 November 2017). ">NICE 2010</a>). Similar guidance is in place in Australia (<a href="./references#CD013186-bbs2-0244" title="Cancer Council Australia &amp; Australian Cancer Network. Basal Cell Carcinoma, Squamous Cell Carcinoma (and related lesions) ‐ a guide to clinical management in Australia. www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/Basal_cell_carcinoma_Squamous_cell_carcinoma_Guide_Nov_2008‐Final_with_Corrigendums.pdf. Sydney: Cancer Council Australia &amp; Australian Cancer Network, (accessed 19 May 2015). ">CCAAC Network 2008</a>). </p> <p>For referred lesions, the specialist clinician will use history‐taking, visual inspection of the lesion (in conjunction with other skin lesions), palpation of the lesion and associated lymph nodes in conjunction with dermoscopic examination to inform a clinical decision. If melanoma is suspected, then urgent 2 mm excision biopsy is recommended (<a href="./references#CD013186-bbs2-0297" title="LedermanJS , SoberAJ . Does biopsy type influence survival in clinical stage I cutaneous melanoma?. Journal of the American Academy of Dermatology1985;13(6):983‐7. [PUBMED: 4078105] ">Lederman 1985</a>; <a href="./references#CD013186-bbs2-0299" title="LeesVC , BriggsJC . Effect of initial biopsy procedure on prognosis in stage I invasive cutaneous malignant melanoma: review of1086 patients. British Journal of Surgery1991;78(9):1108‐10. [PUBMED: 1933198] ">Lees 1991</a>); for cSCC predetermined surgical margin excision or a diagnostic biopsy may be considered. BCC and pre‐malignant lesions potentially eligible for nonsurgical treatment may undergo a diagnostic biopsy before initiation of therapy if there is diagnostic uncertainty. Equivocal melanocytic lesions for which a definitive clinical diagnosis cannot be reached may undergo surveillance to identify any lesion changes that would indicate excision biopsy or reassurance, and discharge for those lesions that remain stable over a period of time. </p> <p>Theoretically, teledermatology consultations may aid appropriate triage of lesions into urgent referral; non‐urgent secondary‐care referral (e.g. for suspected basal cell carcinoma); or where available, referral to an intermediate care setting, e.g. clinics run by GPs with a special interest in dermatology. The distinction between setting and examiner qualifications and experience is important, as specialist clinicians might work in primary‐care settings (for example, in the UK, GPs with a special interest in dermatology and skin surgery who have undergone appropriate training), and generalists might practice in secondary‐care settings (for example, plastic surgeons who do not specialise in skin cancer). The level of skill and experience in skin cancer diagnosis will vary for both generalist and specialist care providers and will also impact on test accuracy. </p> <section id="CD013186-sec-0052"> <h4 class="title">Prior test(s)</h4> <p>Although smartphone applications and community‐based teledermatology services can increasingly be directly accessed by people who have concerns about a skin lesion (<a href="./references#CD013186-bbs2-0250" title="ChuchuN , TakwoingiY , DinnesJ , MatinRN , BassettO , MoreauJF , et al. Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013192] ">Chuchu 2018b</a>), visual inspection of a suspicious lesion by a clinician is usually the first in a series of tests to diagnose skin cancer. In the UK this usually takes place in primary care, but in many countries people with suspicious lesions can present directly to a specialist setting. </p> <p>A range of technologies has emerged to aid skin cancer diagnosis, both to ensure that malignancies (especially melanoma) are not missed, and at the same time minimising unnecessary surgical procedures. Dermoscopy using a hand‐held microscope has become the most widely used tool for clinicians to improve diagnostic accuracy of pigmented lesions, in particular for melanoma (<a href="./references#CD013186-bbs2-0229" title="ArgenzianoG , FabbrociniG , CarliP , DeGiorgiV , SammarcoE , DelfinoM . Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7‐point checklist based on pattern analysis. Archives of Dermatology1998;134(12):1563‐70. [PUBMED: 9875194] ">Argenziano 1998</a>; <a href="./references#CD013186-bbs2-0230" title="ArgenzianoG , AlbertiniG , CastagnettiF , DePaceB , DiLerniaV , LongoC , et al. Early diagnosis of melanoma: what is the impact of dermoscopy?. Dermatologic Therapy2012;25(5):403‐9. [PUBMED: 23046019] ">Argenziano 2012</a>; <a href="./references#CD013186-bbs2-0113" title="HaenssleHA , KorpasB , Hansen‐HaggeC , BuhlT , KauneKM , JohnsenS , et al. Selection of patients for long‐term surveillance with digital dermoscopy by assessment of melanoma risk factors. Archives of Dermatology2010;146(3):257‐64. ">Haenssle 2010</a>; <a href="./references#CD013186-bbs2-0291" title="KittlerH , PehambergerH , WolffK , BinderM . Diagnostic accuracy of dermoscopy (Review). Lancet Oncology2002;3(3):159‐65. [PUBMED: 11902502] ">Kittler 2002</a>), although it is less well established for the diagnosis of BCC or cSCC. Dermoscopy is frequently combined with visual inspection of a lesion in secondary‐care settings, and is also increasingly used in primary care, particularly in countries such as Australia (<a href="./references#CD013186-bbs2-0356" title="YoulPH , RaaschBA , JandaM , AitkenJF . The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions. Clinical and Experimental Dermatology2007;32(4):365‐70. [PUBMED: 17433042] ">Youl 2007</a>).The diagnostic accuracy, and comparative accuracy, of visual inspection and dermoscopy have been evaluated in a further three reviews in this series (<a href="./references#CD013186-bbs2-0254" title="DinnesJ , DeeksJJ , GraingeMJ , ChuchuN , Ferrante di RuffanoL , MatinRN , et al. Visual inspection for diagnosing cutaneous melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013194] ">Dinnes 2018a</a>; <a href="./references#CD013186-bbs2-0255" title="DinnesJ , DeeksJJ , ChuchuN , Ferrante di RuffanoL , MatinRN , ThomsonDR , et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD011902.pub2] ">Dinnes 2018b</a>; <a href="./references#CD013186-bbs2-0256" title="DinnesJ , DeeksJJ , ChuchuN , MatinRN , WongKY , AldridgeRB , et al. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD011901.pub2] ">Dinnes 2018c</a>). </p> <p>Consideration of the degree of prior testing that study participants have undergone is key to interpretation of test accuracy indices, as these are known to vary according to the disease spectrum (or case‐mix) of included participants (<a href="./references#CD013186-bbs2-0292" title="LachsMS , NachamkinI , EdelsteinPH , GoldmanJ , FeinsteinAR , SchwartzJS . Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Annals of Internal Medicine1992;117(2):135‐40. [PUBMED: 1605428] ">Lachs 1992</a>; <a href="./references#CD013186-bbs2-0298" title="LeeflangMM , RutjesAW , ReitsmaJB , HooftL , BossuytPM . Variation of a test's sensitivity and specificity with disease prevalence. CMAJ2013;185(11):E537‐44. [PUBMED: 23798453] ">Leeflang 2013</a>; <a href="./references#CD013186-bbs2-0317" title="MoonsKG , VanEsGA , DeckersJW , HabbemaJD , GrobbeeDE . Limitations of sensitivity, specificity, likelihood ratio, and Bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology1997;8(1):12‐7. [PUBMED: 9116087] ">Moons 1997</a>; <a href="./references#CD013186-bbs2-0348" title="Usher‐SmithJA , SharpSJ , GriffinSJ . The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ2016;353:i3139. [DOI: 10.1136/bmj.i3139; PUBMED: 27334281] ">Usher‐Smith 2016</a>). Spectrum effects are often observed when tests that are developed further down the referral pathway have lower sensitivity and higher specificity when applied in settings with participants with limited prior testing (<a href="./references#CD013186-bbs2-0348" title="Usher‐SmithJA , SharpSJ , GriffinSJ . The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ2016;353:i3139. [DOI: 10.1136/bmj.i3139; PUBMED: 27334281] ">Usher‐Smith 2016</a>). Studies of individuals with suspicious lesions at the initial clinical presentation stage ('test‐naïve') are likely to have a wider range of different diagnoses and include a higher proportion of people with benign diagnoses compared with studies of participants who have been referred for a specialist opinion on the basis of visual inspection (with or without dermoscopy) by a generalist practitioner. Furthermore, studies in more specialist settings may focus on equivocal or difficult‐to‐diagnose lesions rather than lesions with a more general level of clinical suspicion. However, this direction of effect is not consistent across tests and diseases, the mechanisms in action often being more complex than prevalence alone, and can be difficult to identify (<a href="./references#CD013186-bbs2-0298" title="LeeflangMM , RutjesAW , ReitsmaJB , HooftL , BossuytPM . Variation of a test's sensitivity and specificity with disease prevalence. CMAJ2013;185(11):E537‐44. [PUBMED: 23798453] ">Leeflang 2013</a>). A simple categorisation of studies according to primary, secondary or specialist setting therefore may not always adequately reflect these key differences in disease spectrum that can affect test performance. </p> </section> <section id="CD013186-sec-0053"> <h4 class="title">Role of index test(s)</h4> <p>Skin cancer diagnosis, whether by visual inspection alone or with the use of dermoscopy is undertaken iteratively, using both implicit pattern recognition (non‐analytical reasoning) and more explicit ‘rules’ based on conscious analytical reasoning (<a href="./references#CD013186-bbs2-0326" title="NormanG , BarracloughK , DolovichL , PriceD . Iterative diagnosis. BMJ2009;339:b3490. [DOI: 10.1136/bmj.b3490] ">Norman 2009</a>), the balance of which will vary according to experience and familiarity with the diagnostic question. In the hands of experienced dermatologists, dermoscopy has been shown to enhance the accuracy of skin cancer detection (especially melanoma) when compared to unaided visual examination (<a href="./references#CD013186-bbs2-0255" title="DinnesJ , DeeksJJ , ChuchuN , Ferrante di RuffanoL , MatinRN , ThomsonDR , et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD011902.pub2] ">Dinnes 2018b</a>; <a href="./references#CD013186-bbs2-0256" title="DinnesJ , DeeksJJ , ChuchuN , MatinRN , WongKY , AldridgeRB , et al. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD011901.pub2] ">Dinnes 2018c</a>). The subjectivity involved in interpreting lesion morphology is thought to underlie the decrease in accuracy that occurs when the dermatoscope is used by less experienced clinicians (<a href="./references#CD013186-bbs2-0240" title="BinderM , SchwarzM , WinklerA , SteinerA , KaiderA , WolffK , et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Archives of Dermatology1995;131(3):286‐91. [PUBMED: 7887657] ">Binder 1995</a>). </p> <p>The addition of computer–based diagnosis to these investigations has potential to increase the detection of melanomas by reducing the clinicians’ reliance on subjective information, which is necessarily interpreted using their experience of past cases. The additive value of CAD systems is also likely to vary with differences in setting, prior testing and selection of participants, as previously discussed (<a href="#CD013186-sec-0052">Prior test(s)</a>). CAD systems could therefore fulfil three different roles in clinical practice: (1) to help GPs, or other clinicians working in unreferred settings, to appropriately triage lesions for referral; (2) as part of a remote diagnostic service; or (3) as an expert–level second opinion to specialists in referral settings. All three roles would rely on CAD being as sensitive for the diagnosis of melanoma as experienced dermatologists. On the other hand, the specificity required for CAD to add value differs for each of these three situations, as discussed below. </p> <p>If sensitive enough, use of CAD in primary care could allow more appropriate triage of higher‐risk lesions to secondary care by increasing the early detection of potentially malignant lesions. However, although a relatively lower specificity (higher false‐positive rate) may be acceptable in a primary‐care setting, limiting false–positive diagnoses would create health service benefits by avoiding unnecessary referral, and alleviating patient anxiety more promptly. Similarly, the remote use of CAD could inform the need for referral, by sending images or other diagnostic data to specialist clinics, or even to commercial organisations, for remote interpretation, much as teledermatology is already used. In this circumstance, a relatively high specificity would be required in order to avoid unacceptable increases in rates of referral to specialist centres. </p> <p>Finally, when used in referral settings as a complement to in‐person diagnosis by a specialist, even if CAD could be shown to pick up difficult‐to‐diagnose melanomas that might be missed on visual inspection or dermoscopy, the specificity of the system would need to be very high so as not to inordinately increase the burden of skin surgery. False‐positive diagnoses not only cause unnecessary scarring from a biopsy or excision procedure, but also increase patient anxiety whilst they await the definitive histological results and increase healthcare costs as the number needed to remove to yield one melanoma diagnosis increases. Pigmented lesions are common, so the resource implication for even a small increase in the threshold to excise lesions in populations where melanoma rates are increasing, will avoid a considerable healthcare burden to both patient and healthcare provider, as long as lesions that are not excised turn out to be benign. The use of CAD to detect melanoma in specialist clinics would only be advantageous if it could be shown to detect skin cancers that would otherwise be missed, or to decrease unnecessary surgical intervention (i.e. removal of false–positive lesions) with no loss of sensitivity. </p> <p>Delay in diagnosis of a BCC as a result of a false‐negative test is not as serious as for melanoma, because BCCs are usually slow‐growing and very unlikely to metastasise. Nevertheless, delayed diagnosis can result in larger and more complex surgical procedures with consequent greater morbidity. Very sensitive diagnostic tests for BCC, however, may compromise on lower specificity, leading to a higher false‐positive rate and an increased burden of skin surgery such that a balance between sensitivity and specificity is needed. The greatest potential advantage of CAD in the management of BCC is likely to lie in its ability to perform rapid, non–invasive assessments of multiple lesions (common in BCC patients (<a href="./references#CD013186-bbs2-0295" title="LearJT , SmithAG , HeagertyAH , BowersB , JonesPW , GilfordJ , et al. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma. Carcinogenesis1997;18(8):1499‐503. [PUBMED: 9276622] ">Lear 1997</a>)). </p> <p>The situation for cSCC is more similar to melanoma, in that the consequences of falsely reassuring a person that they do not have skin cancer can be serious and potentially fatal, given that removal of an early cSCC is usually curative. Thus, a good diagnostic test for cSCC should demonstrate high sensitivity and a corresponding high negative predictive value. A test that can also reduce false‐positive clinical diagnoses without missing true cases of cSCC has patient and resource benefits. </p> </section> <section id="CD013186-sec-0054"> <h4 class="title">Alternative test(s)</h4> <p>A number of other tests which may have a role in the diagnosis of skin cancer in a specialist setting have been reviewed as part of our series of systematic reviews, including reflectance confocal microscopy (RCM) (<a href="./references#CD013186-bbs2-0257" title="DinnesJ , DeeksJJ , SalehD , ChuchuN , BaylissSE , PatelL , et al. Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013190] ">Dinnes 2018d</a><a href="./references#CD013186-bbs2-0258" title="DinnesJ , DeeksJJ , ChuchuN , SalehD , BaylissSE , TakwoingiY , et al. Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013191] ">Dinnes 2018e</a>), optical coherence tomography (OCT) (<a href="./references#CD013186-bbs2-0268" title="Ferrante di RuffanoL , DinnesJ , DeeksJJ , ChuchuN , BaylissSE , DavenportC , et al. Optical coherence tomography for diagnosing skin cancer in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013189] ">Ferrante di Ruffano 2018a</a>), high‐frequency ultrasound (<a href="./references#CD013186-bbs2-0259" title="DinnesJ , BamberJ , ChuchuN , BaylissSE , TakwoingiY , DavenportC , et al. High‐frequency ultrasound for diagnosing skin cancer in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013188] ">Dinnes 2018f</a>) and exfoliative cytology (<a href="./references#CD013186-bbs2-0269" title="Ferrante di RuffanoL , DinnesJ , ChuchuN , BaylissSE , TakwoingiY , DavenportC , et al. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013187] ">Ferrante di Ruffano 2018b</a>). Other tests with a role in earlier settings include teledermatology (<a href="./references#CD013186-bbs2-0249" title="ChuchuN , DinnesJ , TakwoingiY , MatinRN , BaylissSE , DavenportC , et al. Teledermatology for diagnosing skin cancer in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013193] ">Chuchu 2018a</a>) and smart–phone applications (<a href="./references#CD013186-bbs2-0250" title="ChuchuN , TakwoingiY , DinnesJ , MatinRN , BassettO , MoreauJF , et al. Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013192] ">Chuchu 2018b</a>). Reviews on the accuracy of gene expression testing and volatile organic compounds could not be performed as planned, due to an absence of relevant studies. Evidence permitting, we will compare the accuracy of available tests in an overview review, exploiting within‐study comparisons of tests and allowing the analysis and comparison of commonly used diagnostic strategies where tests may be used singly or in combination. </p> <p>We also considered and excluded a number of tests from this review, such as tests used for screening (e.g. total body photography of those with large numbers of typical or atypical naevi) or monitoring (e.g. CAD systems used to monitor the progression of suspicious skin lesions). </p> <p>Lastly, we did not assess the accuracy of histopathological confirmation following lesion excision, because it is the established reference standard for melanoma diagnosis and will be one of the standards against which the index tests are evaluated in these reviews. </p> </section> </section> <section id="CD013186-sec-0055"> <h3 class="title" id="CD013186-sec-0055">Rationale</h3> <p>Our series of reviews of diagnostic tests used to assist clinical diagnosis of skin cancer aims to identify the most accurate approaches to diagnosis and provide clinical and policy decision‐makers with the highest possible standard of evidence on which to base diagnostic and treatment decisions. With increasing rates of melanoma and basal cell carcinoma and a trend to adopt dermoscopy and other high‐resolution image analysis in primary care, the anxiety around missing early malignant lesions needs to be balanced against the risk of too many unnecessary referrals, and to avoid sending too many people with benign lesions for a specialist opinion. It is questionable whether all skin cancers identified by sophisticated techniques, even in specialist settings, help to reduce morbidity and mortality. It is also a concern that newer technologies incur the risk of increasing false‐positive diagnoses. It is also possible that the use of some technologies, e.g. widespread use of dermoscopy in primary care with little or no training, could actually result in harm by missing melanomas if they are used as replacement technologies for traditional history‐taking and clinical examination of the entire skin. Many branches of medicine have noted the danger of such "gizmo idolatry" amongst doctors (<a href="./references#CD013186-bbs2-0300" title="LeffB , FinucaneTE . Gizmo idolatry. JAMA2008;299(15):1830‐2. [PUBMED: 18413879] ">Leff 2008</a>). </p> <p>The central premise underlying CAD is that it uses quantitative, objective and expert–level assessments of lesion features, which lessen the need for specialist training and lengthy experience in test use. Given the reliance on specialist training and experience to make accurate skin cancer diagnosis using dermoscopy, CAD diagnosis has the potential to improve the health of patients by widening access to specialist diagnostic capabilities in primary and secondary care. If it is sensitive enough, introducing CAD could increase the early detection of skin cancers, which for melanoma and cSCC in particular, is critical to improving outcomes. As with any technology requiring significant investment, a full understanding should be acquired of the benefits including patient acceptability and cost effectiveness compared with usual practice before such an approach can be recommended; establishing the accuracy of diagnosis and referral accuracy is one of the key components. </p> <p>We identified four published systematic reviews focusing on the accuracy of CAD, two synthesising the performance of Derm–CAD systems (<a href="./references#CD013186-bbs2-0052" title="AliARA , DesernoTM . A systematic review of automated melanoma detection in dermatoscopic images and its ground truth data. SPIE. Medical Imaging 2012: Image Perception, Observer Performance, and Technology Assessment. 29 February 2012; Vol. 8318. [DOI: 10.1117/12.912389] ">Ali 2012</a>; <a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a>), and two reviewing both Derm–CAD and Spectro–CAD systems (<a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a>; <a href="./references#CD013186-bbs2-0205" title="VestergaardME , MenziesSW . Automated diagnostic instruments for cutaneous melanoma. Seminars in Cutaneous Medicine and Surgery2008;27(1):32‐6. ">Vestergaard 2008</a>). All are limited by out–of–date search periods (<a href="./references#CD013186-bbs2-0052" title="AliARA , DesernoTM . A systematic review of automated melanoma detection in dermatoscopic images and its ground truth data. SPIE. Medical Imaging 2012: Image Perception, Observer Performance, and Technology Assessment. 29 February 2012; Vol. 8318. [DOI: 10.1117/12.912389] ">Ali 2012</a> up to 2011, <a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a> and <a href="./references#CD013186-bbs2-0205" title="VestergaardME , MenziesSW . Automated diagnostic instruments for cutaneous melanoma. Seminars in Cutaneous Medicine and Surgery2008;27(1):32‐6. ">Vestergaard 2008</a> up to 2007, <a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a> up to 2002), which is a key concern in the rapidly advancing field of machine learning. Another concern for <a href="./references#CD013186-bbs2-0052" title="AliARA , DesernoTM . A systematic review of automated melanoma detection in dermatoscopic images and its ground truth data. SPIE. Medical Imaging 2012: Image Perception, Observer Performance, and Technology Assessment. 29 February 2012; Vol. 8318. [DOI: 10.1117/12.912389] ">Ali 2012</a>, <a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a> and <a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a> is their inclusion of studies which are ineligible for this Cochrane Review due to the absence of an independent validation set, a methodological feature likely to inflate the apparent accuracy of predictive models (<a href="./references#CD013186-bbs2-0228" title="AltmanDG , VergouweY , RoystonP , MoonsKG . Prognosis and prognostic research: validating a prognostic model. BMJ2009;338(7708):b605. [doi: 10.1136/bmj.b605; PUBMED: 19477892] ">Altman 2009</a>). <a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a> also selected datasets on the basis of highest performance, and pooled accuracy estimates for Derm–CAD with Spectro–CAD, which we consider to be two different diagnostic tests. There is therefore a need for an up‐to‐date and rigorous review of the accuracy of dermoscopy–based CAD and of spectroscopy–based CAD which explicitly considers the following key characteristics. </p> <p>Because CAD models are created by analysing patterns in archived datasets, the degree to which they are likely to make accurate classifications of new observations in real‐life clinical situations relies on the generalisability of the training sets used to develop them (<a href="./references#CD013186-bbs2-0284" title="HorschA . Melanoma diagnosis. In: TMDeserno editor(s). Biomedical Image Processing. Berlin: Springer‐Verlag, 2011:307‐26. ">Horsch 2011</a>). Training sets that contain few lesions, or a restricted range of the different diagnoses encountered in clinical practice, are likely to produce models that misclassify new observations due to inadequate learning. Other important attributes thought to influence diagnostic ability are the segmentation process (how the lesion’s border is detected by the computer), which features are selected for analysis (akin to the selection of features for analysis in the algorithms used in epiluminescence microscopy (ELM) dermoscopy, e.g. ABCD or seven–point), the algorithm used, and the type of information produced by the CAD system (e.g. binary outputs indicating presence of malignancy, or visual images of lesions such as macro– or microscopic photographs or graphical representations of highlighting suspect structures). </p> <p>This review follows a generic protocol which covers the full series of Cochrane DTA Reviews for the diagnosis of melanoma (<a href="./references#CD013186-bbs2-0358" title="DinnesJ , MatinRN , MoreauJF , PatelL , ChanSA , WongKY , et al. Tests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocol. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011902] ">Dinnes 2015a</a>) and for the diagnosis of keratinocyte cancers (<a href="./references#CD013186-bbs2-0359" title="DinnesJ , WongKY , GulatiA , ChuchuN , Leonardi‐BeeJ , BaylissSE , et al. Tests to assist in the diagnosis of keratinocyte skin cancers in adults: a generic protocol. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011901] ">Dinnes 2015b</a>). The <a href="#CD013186-sec-0044">Background</a> and <a href="#CD013186-sec-0059">Methods</a> sections of this review therefore use some text that was originally published in these protocols (<a href="./references#CD013186-bbs2-0358" title="DinnesJ , MatinRN , MoreauJF , PatelL , ChanSA , WongKY , et al. Tests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocol. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011902] ">Dinnes 2015a</a>; <a href="./references#CD013186-bbs2-0359" title="DinnesJ , WongKY , GulatiA , ChuchuN , Leonardi‐BeeJ , BaylissSE , et al. Tests to assist in the diagnosis of keratinocyte skin cancers in adults: a generic protocol. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011901] ">Dinnes 2015b</a>) and text that overlaps some of our other reviews (<a href="./references#CD013186-bbs2-0254" title="DinnesJ , DeeksJJ , GraingeMJ , ChuchuN , Ferrante di RuffanoL , MatinRN , et al. Visual inspection for diagnosing cutaneous melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013194] ">Dinnes 2018a</a>; <a href="./references#CD013186-bbs2-0255" title="DinnesJ , DeeksJJ , ChuchuN , Ferrante di RuffanoL , MatinRN , ThomsonDR , et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD011902.pub2] ">Dinnes 2018b</a>; <a href="./references#CD013186-bbs2-0268" title="Ferrante di RuffanoL , DinnesJ , DeeksJJ , ChuchuN , BaylissSE , DavenportC , et al. Optical coherence tomography for diagnosing skin cancer in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013189] ">Ferrante di Ruffano 2018a</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013186-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013186-sec-0056"></div> <p>To determine the accuracy of CAD systems for diagnosing cutaneous invasive melanoma and atypical intraepidermal melanocytic variants in adults, and to compare the accuracy of CAD systems with that of clinician diagnosis using dermoscopy. </p> <p>To determine the accuracy of CAD systems for diagnosing BCC in adults, and to compare the accuracy of CAD systems with that of clinician diagnosis using dermoscopy. </p> <p>To determine the accuracy of CAD systems for diagnosing cSCC in adults, and to compare the accuracy of CAD systems with that of clinician diagnosis using dermoscopy. </p> <section id="CD013186-sec-0057"> <h3 class="title" id="CD013186-sec-0057">Secondary objectives</h3> <p> <ul id="CD013186-list-0002"> <li> <p>To determine the accuracy of CAD systems for diagnosing invasive melanoma alone in adults, and to compare the accuracy of CAD systems with that of clinician diagnosis using dermoscopy </p> </li> <li> <p>To determine the accuracy of CAD systems for identifying any lesion requiring excision (due to any skin cancer or high–grade dysplasia) in adults, and to compare the accuracy of CAD systems with that of clinician diagnosis using dermoscopy </p> </li> </ul> </p> <p>For each of the primary target conditions:</p> <p> <ul id="CD013186-list-0003"> <li> <p>To compare the diagnostic accuracy of CAD systems to clinician diagnosis using dermoscopy, where both tests have been evaluated in the same studies (direct comparisons); </p> </li> <li> <p>To determine the diagnostic accuracy of individual CAD systems;</p> </li> <li> <p>To compare the accuracy of CAD–based diagnosis to CAD–assisted diagnosis (CAD results used by clinicians as a diagnostic aid) </p> </li> <li> <p>Where CAD systems are used as a diagnostic aid, to determine the effect of observer experience on diagnostic accuracy. </p> </li> </ul> </p> <section id="CD013186-sec-0058"> <h4 class="title">Investigation of sources of heterogeneity</h4> <p>We set out to investigate a range of potential sources of heterogeneity across our series of reviews, as outlined in our generic protocols (<a href="./references#CD013186-bbs2-0358" title="DinnesJ , MatinRN , MoreauJF , PatelL , ChanSA , WongKY , et al. Tests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocol. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011902] ">Dinnes 2015a</a>; <a href="./references#CD013186-bbs2-0359" title="DinnesJ , WongKY , GulatiA , ChuchuN , Leonardi‐BeeJ , BaylissSE , et al. Tests to assist in the diagnosis of keratinocyte skin cancers in adults: a generic protocol. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011901] ">Dinnes 2015b</a>) and described in <a href="./appendices#CD013186-sec-0118">Appendix 3</a>; however, we could not do this because of the available data on each individual test reviewed. </p> </section> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013186-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013186-sec-0059"></div> <section id="CD013186-sec-0060"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013186-sec-0061"> <h4 class="title">Types of studies</h4> <p>We included test accuracy studies that assessed the result of the index test against that of a reference standard, including the following: </p> <p> <ul id="CD013186-list-0004"> <li> <p>Studies where all participants received a single index test and a reference standard;</p> </li> <li> <p>Studies where all participants received more than one index test and reference standard;</p> </li> <li> <p>Studies where participants were allocated (by any method) to receive different index tests or combinations of index tests and all receive a reference standard (between‐person comparative studies (BPC)); </p> </li> <li> <p>Studies that recruited series of participants unselected by true disease status (referred to as case series for the purposes of this review); </p> </li> <li> <p>Diagnostic case‐control studies that separately recruited diseased and non‐diseased groups (see <a href="./references#CD013186-bbs2-0335" title="RutjesAW , ReitsmaJB , VandenbrouckeJP , GlasAS , BossuytPM . Case‐control and two‐gate designs in diagnostic accuracy studies. Clinical Chemistry2005;51(8):1335‐41. [PUBMED: 15961549] ">Rutjes 2005</a>); however, we did not include studies that compared results for malignant lesions to those for healthy skin (i.e. with no lesion present); </p> </li> <li> <p>Both prospective and retrospective studies;</p> </li> <li> <p>Studies where previously‐acquired clinical or dermoscopic images were retrieved and prospectively interpreted for study purposes. </p> </li> </ul> </p> <p>We excluded studies from which we could not extract or derive 2 x 2 contingency data of the number of true positives, false positives, false negatives and true negatives, or if studies included fewer than five skin cancer cases or fewer than five benign lesions. The size threshold of five is arbitrary, however such small studies are unlikely to add precision to estimate of accuracy. </p> <p>Studies available only as conference abstracts were excluded; however, attempts were made to identify full papers for potentially relevant conference abstracts (<a href="#CD013186-sec-0068">Searching other resources</a>). </p> </section> <section id="CD013186-sec-0062"> <h4 class="title">Participants</h4> <p>We included studies in adults with pigmented or non–pigmented skin lesions considered to be suspicious for melanoma or an atypical intraepidermal melanocytic variant or a keratinocyte skin cancer (BCC or cSCC). Studies examining adults at high risk of developing skin cancer, including those with a family history or previous history of skin cancer, atypical or dysplastic naevus syndrome, or genetic cancer syndromes were also eligible for inclusion. </p> <p>We excluded studies that recruited only participants with malignant diagnoses.</p> <p>We excluded studies conducted in children or which clearly reported inclusion of more than 50% of participants aged 16 and under. </p> </section> <section id="CD013186-sec-0063"> <h4 class="title">Index tests</h4> <p>Studies reporting accuracy data for tests using automated diagnosis were eligible for inclusion, whether diagnosis was produced independently by the CAD system (system–based diagnosis), or by a clinician using a CAD system as a diagnostic aid (computer–assisted diagnosis). CAD systems using any type of data capture were eligible, including imaging and non–imaging modalities. We included all machine learning algorithms. </p> <p>We <b>included</b> studies developing new algorithms or methods of diagnosis (i.e. derivation studies) if they evaluated the new approach using a separate 'test set' of participants or images. </p> <p>We <b>excluded</b> studies if they: </p> <p> <ul id="CD013186-list-0005"> <li> <p>Evaluated a new statistical model or algorithm in the same participants or images as those used to train the model (i.e. absence of an independent test set); </p> </li> <li> <p>Used cross‐validation approaches such as 'leave‐one‐out' cross‐validation (<a href="./references#CD013186-bbs2-0262" title="EfronB . Estimating the error rate of a prediction rule: improvement on cross‐validation. Journal of the American Statistical Association1983;78(382):316‐331. [DOI: 10.1080/01621459.1983.10477973] ">Efron 1983</a>); or </p> </li> <li> <p>Evaluated the accuracy of the presence or absence of individual lesion characteristics or morphological features, with no overall diagnosis of malignancy. </p> </li> </ul> </p> <p>Although primary‐care clinicians can in practice be specialists in skin cancer, we considered primary‐care physicians as generalist practitioners and dermatologists as specialists. Within each group, we extracted any reporting of special interest or accreditation in skin cancer. </p> </section> <section id="CD013186-sec-0064"> <h4 class="title">Target conditions</h4> <p>We defined the primary target conditions as the detection of:</p> <p> <ul id="CD013186-list-0006"> <li> <p>Any form of invasive cutaneous melanoma, or atypical intraepidermal melanocytic variants (i.e. including melanoma in situ, or lentigo maligna, which has a risk of progression to invasive melanoma) </p> </li> <li> <p>BCC</p> </li> <li> <p>cSCC</p> </li> </ul> </p> <p>We considered two additional target conditions in secondary analyses, namely the detection of: </p> <p> <ul id="CD013186-list-0007"> <li> <p>Any form of invasive cutaneous melanoma alone</p> </li> <li> <p>Any skin lesion requiring excision: all forms of skin cancer listed above, as well as melanoma in situ, lentigo maligna, and lesions with severe melanocytic dysplasia. </p> </li> </ul> </p> </section> <section id="CD013186-sec-0065"> <h4 class="title">Reference standards</h4> <p>The ideal reference standard is histopathological diagnosis in all eligible lesions. A qualified pathologist or dermatopathologist should perform histopathology. Ideally, reporting should be standardised, detailing a minimum dataset to include the histopathological features of melanoma to determine the American Joint Committee on Cancer (AJCC) Staging System (e.g. <a href="./references#CD013186-bbs2-0340" title="SlaterD , WalshM . Standards and datasets for reporting cancers: Dataset for the histological reporting of primary cutaneous malignant melanoma and regional lymph nodes, May 2014. www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/G125_DatasetMaligMelanoma_May14.pdf. London: Royal College of Pathologists, (accessed 29 July 2015). ">Slater 2014</a>). We did not apply this as a necessary inclusion criterion, but extracted any pertinent information. </p> <p>Partial verification (applying the reference test only to a subset of those undergoing the index test) was of concern, given that lesion excision or biopsy is unlikely to be carried out for all benign‐appearing lesions within a representative population sample. To reflect what happens in reality, we therefore accepted clinical follow‐up of benign‐appearing lesions as an eligible reference standard, whilst recognising the risk of variable verification bias (as misclassification rates of histopathology and follow‐up will differ). </p> <p>Additional eligible reference standards included cancer registry follow‐up and 'expert opinion' with no histology or clinical follow‐up. Cancer registry follow‐up is considered less desirable than active clinical follow‐up, as follow‐up is not carried out within the control of the study investigators. Furthermore, if participant‐based analyses as opposed to lesion‐based analyses are presented, it may be difficult to determine whether the detection of a malignant lesion during follow‐up is the same lesion that originally tested negative on the index test. </p> <p>We considered all of the above to be eligible reference standards, with the following caveats: </p> <p> <ul id="CD013186-list-0008"> <li> <p>All study participants with a final diagnosis of the target skin cancer disorder must have a histological diagnosis, either subsequent to the application of the index test or after a period of clinical follow‐up </p> </li> <li> <p>At least 50% of all participants with benign lesions must have either a histological diagnosis or clinical follow‐up to confirm benignity. </p> </li> </ul> </p> </section> </section> <section id="CD013186-sec-0066"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013186-sec-0067"> <h4 class="title">Electronic searches</h4> <p>The Information Specialist (SB) carried out a comprehensive search for published and unpublished studies. A single large literature search was conducted to cover all topics in the programme grant (see <a href="./appendices#CD013186-sec-0116">Appendix 1</a> for a summary of reviews included in the programme grant). This allowed for the screening of search results for potentially relevant papers for all reviews at the same time. A search combining disease related terms with terms related to the test names, using both text words and subject headings was formulated. The search strategy was designed to capture studies evaluating tests for the diagnosis or staging of skin cancer. As the majority of records were related to the searches for tests for staging of disease, a filter using terms related to cancer staging and to accuracy indices was applied to the staging test search, to try to eliminate irrelevant studies, for example, those using imaging tests to assess treatment effectiveness. A sample of 300 records that would be missed by applying this filter was screened and the filter adjusted to include potentially relevant studies. When piloted on MEDLINE, inclusion of the filter for the staging tests reduced the overall numbers by around 6000. The final search strategy, incorporating the filter, was subsequently applied to all bibliographic databases as listed below (<a href="./appendices#CD013186-sec-0123">Appendix 4</a>). The final search result was cross‐checked against the list of studies included in five systematic reviews; our search identified all but one of the studies, and this study was not indexed on MEDLINE. The Information Specialist (SB) devised the search strategy, with input from the Information Specialist from Cochrane Skin. No additional limits were used. </p> <p>We searched the following bibliographic databases to 29 August 2016 for relevant published studies: </p> <p> <ul id="CD013186-list-0009"> <li> <p>MEDLINE via OVID (from 1946);</p> </li> <li> <p>MEDLINE In‐Process &amp; Other Non‐Indexed Citations via OVID;</p> </li> <li> <p>Embase via OVID (from 1980).</p> </li> </ul> </p> <p>We searched the following bibliographic databases to 30 August 2016 for relevant published studies: </p> <p> <ul id="CD013186-list-0010"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) Issue 7, 2016, in the Cochrane Library; </p> </li> <li> <p>Cochrane Database of Systematic Reviews (CDSR) Issue 8, 2016 in the Cochrane Library;</p> </li> <li> <p>Cochrane Database of Abstracts of Reviews of Effects (DARE) Issue 2, 2015;</p> </li> <li> <p>CRD Health Technology Assessment (HTA) database Issue 3, 2016;</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) (via EBSCO from 1960). </p> </li> </ul> </p> <p>We searched the following databases for relevant unpublished studies using a strategy based on the MEDLINE search: </p> <p> <ul id="CD013186-list-0011"> <li> <p>CPCI (Conference Proceedings Citation Index), via Web of Science™ (from 1990; searched 28 August 2016); </p> </li> <li> <p>SCI Science Citation Index Expanded™ via Web of Science™ (from 1900, using the 'Proceedings and Meetings Abstracts' Limit function; searched 29 August 2016). </p> </li> </ul> </p> <p>We searched the following trials registers using search terms 'melanoma', 'squamous cell', 'basal cell' and 'skin cancer' combined with 'diagnosis': </p> <p> <ul id="CD013186-list-0012"> <li> <p>Zetoc (from 1993; searched 28 August 2016)</p> </li> <li> <p>The US National Institutes of Health Ongoing Trials Register (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>); searched 29 August 2016 </p> </li> <li> <p>NIHR Clinical Research Network Portfolio Database (<a href="http://www.nihr.ac.uk/research-and-impact/nihr-clinical-research-network-portfolio/" target="_blank">www.nihr.ac.uk/research‐and‐impact/nihr‐clinical‐research‐network‐portfolio/</a>); searched 29 August 2016; </p> </li> <li> <p>The World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>); searched 29 August 2016. </p> </li> </ul> </p> <p>We aimed to identify all relevant studies, regardless of language or publication status (published, unpublished, in press, or in progress). We applied no date limits. </p> </section> <section id="CD013186-sec-0068"> <h4 class="title">Searching other resources</h4> <p>We have screened relevant systematic reviews identified by the searches for their included primary studies, and included any missed by our searches. We have checked the reference lists of all included papers, and subject experts within the author team have reviewed the final list of included studies. We did not conduct any electronic citation searching. </p> </section> </section> <section id="CD013186-sec-0069"> <h3 class="title" id="CD013186-sec-0069">Data collection and analysis</h3> <section id="CD013186-sec-0070"> <h4 class="title">Selection of studies</h4> <p>At least one review author (JDi or NC) screened titles and abstracts, with any queries discussed and resolved by consensus. A pilot screen of 539 MEDLINE references showed good agreement (89% with a kappa of 0.77) between screeners. We included primary test accuracy studies and test accuracy reviews (for scanning of reference lists) of any test used to investigate suspected melanoma, BCC, or cSCC at initial screening. Inclusion criteria (<a href="./appendices#CD013186-sec-0124">Appendix 5</a>) were applied independently by both a clinical reviewer (from one of a team of 12 clinician reviewers) and a methodologist reviewer (JDi, NC or LFR) to all full‐text articles, resolving disagreements by consensus or by a third party (JDe, CD, HW, and RM). We contacted authors of eligible studies when insufficient data were presented to allow for the construction of 2 x 2 contingency tables. </p> </section> <section id="CD013186-sec-0071"> <h4 class="title">Data extraction and management</h4> <p>One clinical (as detailed above) and one methodologist reviewer (JDi, NC or LFR) independently extracted data for details of the study design, participants, index test(s) or test combinations and criteria for index test positivity, reference standards, and data required to populate a 2 x 2 diagnostic contingency table for each index test, using a piloted data extraction form. We extracted data at all available index test thresholds, resolving disagreements by consensus or by a third party (JDe, CD, HW, and RM). </p> <p>We contacted authors of included studies where information related to final lesion diagnoses or diagnostic threshold was missing. In particular, invasive cSCC (included as disease‐positive for one of our secondary objectives) is not always differentiated from in situ variants such as Bowens disease (which we did not consider as disease‐positive for any of our definitions of the target condition). </p> <p>We contacted authors of conference abstracts published from 2013 to 2015, to ask whether full data were available. We marked conference abstracts as 'pending', and will revisit them in a future review update. </p> <section id="CD013186-sec-0072"> <h5 class="title">Dealing with multiple publications and companion papers</h5> <p>Where we found multiple reports of a primary study, we maximised yield of information by collating all available data. Where there were inconsistencies in reporting or overlapping study populations, we contacted study authors for clarification in the first instance. If this contact with authors was unsuccessful, we used the most complete and up‐to‐date data source where possible. </p> </section> </section> <section id="CD013186-sec-0073"> <h4 class="title">Assessment of methodological quality</h4> <p>We assessed risks of bias and applicability of included studies using the QUADAS‐2 checklist (<a href="./references#CD013186-bbs2-0352" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529‐36. [PUBMED: 22007046] ">Whiting 2011</a>), tailored to the review topic (see <a href="./appendices#CD013186-sec-0125">Appendix 6</a>). We piloted the modified QUADAS‐2 tool on a small number of included full‐text articles. One clinical (as detailed above) and one methodologist reviewer (JDi, NC or LFR) independently assessed quality for the remaining studies, resolving any disagreement by consensus or by a third party where necessary (JDe, CD, HW, and RM). </p> </section> <section id="CD013186-sec-0074"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>Our unit of analysis was the lesion rather than the person. This is because (i) in skin cancer initial treatment is directed to the lesion rather than systemically (thus it is important to be able to correctly identify cancerous lesions for each person), and (ii) it is the most common way in which the primary studies reported data. Although there is a theoretical possibility of correlations of test errors when the same person contributes data for multiple lesions, most studies include very few people with multiple lesions and any potential impact on findings is likely to be very small, particularly in comparison with other concerns for risk of bias and applicability. For each analysis, we included only one dataset per study to avoid multiple counting of lesions. Where multiple CAD models or algorithms were assessed in an individual study, we selected one at random, using a random‐number generator. Where studies evaluated CAD as a diagnostic aid by clinicians with varying degrees of experience, we chose the dataset reporting the highest degree of clinical experience. We made these selections without reference to the corresponding accuracy data. </p> <p>We estimated accuracy of dermoscopy separately according to whether the diagnosis recorded was based on a face–to–face (in‐person) encounter or based on remote (image‐based) assessment. Where multiple algorithms were assessed in an individual study, we selected dermoscopy datasets on the following preferential basis: </p> <p> <ul id="CD013186-list-0013"> <li> <p>‘No algorithm’ reported; data presented for clinician’s overall diagnosis or management decision </p> </li> <li> <p>Pattern analysis or pattern recognition</p> </li> <li> <p>ABCD algorithm (or derivatives of)</p> </li> <li> <p>Seven‐point checklist (also referred to as Glasgow/Mackie checklist)</p> </li> <li> <p>Menzies algorithm</p> </li> <li> <p>Three‐point checklist</p> </li> </ul> </p> <p>As for CAD, we preferred dermoscopy datasets reporting the highest degree of clinical experience over studies reporting multiple results using clinicians of varying experience. </p> <p>We pooled CAD study data for systems using similar methods of data acquisition; thus we considered all studies using digital dermoscopy‐based CAD (Derm‐CAD) to be similar and pooled them. However, spectroscopy‐based CAD (Spectro‐CAD) systems analyse different data types and so were only pooled in these subgroups: multispectral imaging studies (MSI‐CAD), electrical impedance spectroscopy (EIS‐CAD), and diffuse reflectance spectroscopy (DRS‐CAD). For each index test, algorithm or checklist under consideration, we plotted estimates of sensitivity and specificity on coupled forest plots and in receiver operating characteristic (ROC) space. CAD thresholds are created by complex statistical algorithms, and a threshold is difficult to define. We therefore assumed results were binary for the purpose of pooling results across similar CAD systems. We estimated summary operating points (summary sensitivities and specificities) with 95% confidence and prediction regions using the bivariate model (<a href="./references#CD013186-bbs2-0248" title="ChuH , ColeSR . Bivariate meta‐analysis for sensitivity and specificity with sparse data: a generalized linear mixed model approach (comment). Journal of Clinical Epidemiology2006;59(12):1331‐2. [PUBMED: 17098577] ">Chu 2006</a>; <a href="./references#CD013186-bbs2-0331" title="ReitsmaJB , GlasAS , RutjesAW , ScholtenRJ , BossuytPM , ZwindermanAH . Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology2005;58(10):982‐90. [PUBMED: 16168343] ">Reitsma 2005</a>). Where inadequate data were available for the analysis to converge, we simplified the model, first by assuming no correlation between estimates of sensitivity and specificity and secondly by setting variance terms to zero if there was little or no heterogeneity on SROC plots (<a href="./references#CD013186-bbs2-0346" title="TakwoingiY , GuoB , RileyRD , DeeksJJ . Performance of methods for meta‐analysis of diagnostic test accuracy with few studies or sparse data. Statistical Methods in Medical Research2015;26(4):1896‐911. [DOI: 10.1177/0962280215592269; PUBMED: 26116616] ">Takwoingi 2015</a>). </p> <p>We extracted data on the accuracy of dermoscopy from all included studies that performed both CAD and dermoscopy in the same participants. We performed test comparisons using two analytic strategies. First, we performed indirect comparisons by using all studies of the two tests. Then we made direct comparisons of CAD and dermoscopy by including only comparative studies that assessed the accuracy of both tests in the same study population to enable a robust comparison (<a href="./references#CD013186-bbs2-0345" title="TakwoingiY , LeeflangMM , DeeksJJ . Empirical evidence of the importance of comparative studies of diagnostic test accuracy. Annals of Internal Medicine2013;158(7):544‐54. [PUBMED: 23546566] ">Takwoingi 2013</a>). To minimise the risk of bias in the direct comparison, we excluded studies that performed either CAD or dermoscopy on a subsample of the total analysed population. In the comparative meta‐analyses of indirect and direct comparisons, we compared summary points by using a bivariate meta‐regression model that included test type as a covariate. We included covariate terms for sensitivity and specificity. We assessed model fit using likelihood ratio tests to compare nested models. We computed estimates of absolute differences in sensitivity and specificity using the bivariate model parameters, and obtained 95% confidence intervals using the delta method. We obtained P values for the absolute differences using Wald tests. We fitted univariate random‐effects logistic regression models incorporating test type as a covariate when there were few studies or a bivariate meta‐regression analysis did not converge. When the number of studies was insufficient for meta‐analysis, we examined individual study results and calculated 95% CIs using the Newcombe‐Wilson method without continuity correction (<a href="./references#CD013186-bbs2-0322" title="NewcombeRG . Interval estimation for the difference between independent proportions: comparison of eleven methods. Statistics in Medicine1998;17(8):873‐90. ">Newcombe 1998</a>). </p> <p>For illustration of the meta‐analytic findings in the 'Summary of findings' table, we computed the numbers of true positives, false positives, false negatives and true negatives, using the summary estimates of sensitivity and specificity together with the lower quartile, median and upper quartile of the prevalence observed in the studies included in the meta‐analysis. </p> <p>We fitted bivariate models using the xtmelogit command in STATA 15.</p> </section> <section id="CD013186-sec-0075"> <h4 class="title">Investigations of heterogeneity</h4> <p>We examined heterogeneity between studies by visually inspecting the forest plots of sensitivity and specificity and summary ROC plots. Due to limited data availability, we were unable to formally investigate heterogeneity using meta‐regression. </p> </section> <section id="CD013186-sec-0076"> <h4 class="title">Sensitivity analyses</h4> <p>The primary analysis included both CAD–based diagnoses and CAD–aided diagnoses. We conducted sensitivity analyses excluding studies of CAD–aided diagnoses. </p> </section> <section id="CD013186-sec-0077"> <h4 class="title">Assessment of reporting bias</h4> <p>Because of uncertainty about the determinants of publication bias for diagnostic accuracy studies and the inadequacy of tests for detecting funnel plot asymmetry (<a href="./references#CD013186-bbs2-0253" title="DeeksJJ , MacaskillP , IrwigL . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology2005;58(9):882‐93. [PUBMED: 16085191] ">Deeks 2005</a>), we did not perform tests to detect publication bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013186-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013186-sec-0078"></div> <section id="CD013186-sec-0079"> <h3 class="title" id="CD013186-sec-0079">Results of the search</h3> <p>We identified 34,517 unique references, and screened them for inclusion. Of these, we reviewed 1051 full‐text papers for eligibility for any one of the suite of reviews of tests to assist in the diagnosis of melanoma or keratinocyte skin cancer. Of the 1051 full‐text papers assessed, we excluded 848 from all reviews in our series (see <a href="#CD013186-fig-0005">Figure 5</a> PRISMA flow diagram of search and eligibility results). </p> <div class="figure" id="CD013186-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="PRISMA flow diagram." data-id="CD013186-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> </div> <p>Of the 225 studies tagged as potentially eligible for this review of CAD (164 for Derm–CAD, 61 for Spectro–CAD), we include 42 publications (24 Derm–CAD and 18 Spectro–CAD). Exclusions were mainly due to the absence of a ‘test’ set of lesions used to evaluate CAD's performance independently of the computer algorithm’s development (Derm–CAD n = 76, Spectro‐CAD n = 17); inability to construct a 2 x 2 contingency table based on the data presented (Derm–CAD n = 24, Spectro‐CAD n = 8); the use of ineligible index tests (Derm–CAD n = 18, Spectro‐CAD n = 5) (for example: computers used to measure lesions but not to diagnose them, e.g. <a href="./references#CD013186-bbs2-0189" title="SeidenariS , FerrariC , BorsariS , BassoliS , CesinaroAM , GiustiF , et al. The dermoscopic variability of pigment network in melanoma in situ. Melanoma Research2012;22(2):151‐7. ">Seidenari 2012</a>); or not meeting our requirements for an eligible reference standard (Derm–CAD n = 13, Spectro‐CAD n = 9). Other reasons for exclusion included ineligible definition of the target condition (Derm–CAD n = 10, Spectro‐CAD n = 3) and CAD systems based on evaluating the presence of a single lesion characteristic (Derm–CAD n = 17) (for example, a CAD system analysing the colour balance of a lesion). We provide a list of the 183 publications excluded from this review, with reasons for exclusion in <a href="./references#CD013186-sec-0138" title="">Characteristics of excluded studies</a>, with a list of all studies excluded from the full series of reviews available as a separate pdf (please contact <a href="http://skin.cochrane.org" target="_blank">skin.cochrane.org</a> for a copy of the pdf). </p> <p>We contacted the authors of 10 publications to acquire additional detail on published 2 x 2 data for the accuracy of CAD, with responses for four publications received to date. These did not result in the inclusion of any additional studies, but did permit the inclusion of one additional dataset in an already–included study (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). One response highlighted an alternative publication that was independently ascertained by the project search, and was included (<a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>); two replies were unable to provide the information requested for two study publications, both of which we subsequently excluded due to incomplete 2 x 2 data. We failed to contact authors of six publications, resulting in the exclusion of those six studies from the review. In addition to these 10 attempted contacts, authors of one other publication (<a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>) were contacted as part of another review in this series, i.e. the accuracy of visual inspection for the diagnosis of melanoma (<a href="./references#CD013186-bbs2-0254" title="DinnesJ , DeeksJJ , GraingeMJ , ChuchuN , Ferrante di RuffanoL , MatinRN , et al. Visual inspection for diagnosing cutaneous melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD013194] ">Dinnes 2018a</a>), to provided clarification on methods used; the author response enabled us to include it. </p> <p>The 42 included studies reported on 39 cohorts of lesions, providing 63 datasets with 13,445 lesions and 2452 malignancies. Most of the studies (n = 24, 57%) contributed data on the diagnostic accuracy of digital dermoscopy–based CAD systems (Derm–CAD), of which seven also compared the diagnostic accuracy of Derm–CAD with dermoscopic diagnosis. The remaining 18 studies contributed data on the diagnostic accuracy of spectroscopy–based CAD (Spectro‐CAD), of which five provided comparative accuracy data with dermoscopy. A cross‐tabulation of studies by CAD type, reported comparisons and target conditions is available in <a href="#CD013186-tbl-0003">Table 2</a>. </p> <div class="table" id="CD013186-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">A cross‐tabulation of studies by CAD type, reported comparisons and target conditions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison with dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target conditions<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] "><b>Bauer 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] "><b>Wollina 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] "><b>Burroni 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] "><b>Rubegni 2002a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] "><b>Seidenari 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] "><b>Seidenari 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] "><b>Stanganelli 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] "><b>Piccolo 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DEM‐MIPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] "><b>Binder 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IBAS 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] "><b>Barzegari 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MicroDERM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] "><b>Boldrick 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MicroDERM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] "><b>Serrao 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MicroDERM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] "><b>Dreiseitl 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Image J (MoleMax II)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] "><b>Maglogiannis 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR (MoleMax II)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] "><b>Mollersen 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevus Doctor<br/> Mole Expert </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] "><b>Piccolo 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevuscreen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] "><b>Cascinelli 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skin View</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] "><b>Cristofolini 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skin View</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] "><b>Menzies 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SolarScan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] "><b>Binder 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] "><b>Blum 2004a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] "><b>Ferris 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,2,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] "><b>Gilmore 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] "><b>Menzies 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] "><b>Hauschild 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] "><b>Winkelmann 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] "><b>Friedman 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] "><b>Monheit 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] "><b>Wells 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] "><b>Sgouros 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope (version NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] "><b>Glud 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] "><b>Terstappen 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope V</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] "><b>Walter 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope V (MoleMate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] "><b>Tomatis 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectroshade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] "><b>Ascierto 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectroshade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] "><b>Gutkowicz Krusin 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] "><b>Tomatis 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telespectrophotometric system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] "><b>Bono 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telespectrophotometric System</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] "><b>Bono 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telespectrophotometric System</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] "><b>Garcia Uribe 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DRS–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OIDRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] "><b>Malvehy 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevisense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,2,3,4,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] "><b>Mohr 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevisense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,2,4,5</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Key: Derm‐CAD – Dermoscopy‐based computer–assisted diagnosis; DRS–CAD – diffuse reflectance spectroscopy computer–assisted diagnosis; EIS‐CAD ‐ Electrical impedance‐based computer‐assisted diagnosis; MSI‐CAD ‐ Multispectral imaging‐based computer–assisted diagnosis; NR – Not reported; OIDRS ‐ oblique incidence reflectance spectroscopy </p> <p><sup>a</sup>1 – Invasive melanoma and atypical intraepidermal melanocytic variants; 2 – Basal cell carcinoma; 3 – cutaneous Squamous cell carcinoma; 4 – Invasive melanoma alone; 5 – Any skin cancer or lesion requiring excision </p> </div> </div> <p>Studies were case series (n = 27, 64%), case‐control (n = 10, 24%), randomised controlled trial (n = 1, 2%), or of unclear design (n = 4, 10%). Lesion selection was most commonly retrospective (n = 22, 52%) or prospective (n = 15, 36%), and was unclear in five studies (12%). Studies included only pigmented (n = 29, 69%) or melanocytic lesions (n = 6, 14%), only suspected melanomas (n = 4, 10%), or any lesions suspected of malignancy (n = 2, 5%). Participant characteristics such as age and gender were reported by 15 of the 42 studies. </p> </section> <section id="CD013186-sec-0080"> <h3 class="title">Methodological quality of included studies</h3> <p>Most of the included studies were of methodological concern, primarily due to lack of applicability to the current review question, but also due to a high or unclear risk of bias in their design. Since there were no major differences in quality by CAD type, we provide an overview of the quality and applicability of all included studies regardless of CAD type. The methodological quality of studies according to CAD type (Derm–CAD or spectroscopy–based CAD) is summarised in <a href="#CD013186-fig-0006">Figure 6</a> and <a href="#CD013186-fig-0007">Figure 7</a>. </p> <div class="figure" id="CD013186-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies" data-id="CD013186-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies </p> </div> </div> </div> <div class="figure" id="CD013186-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD013186-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> </div> <p>We judged the risk of participant selection bias to be high in 17 studies (40%), due to the selection of lesions according to their final diagnosis (case–control studies: n = 10, 24%), and/or to the inappropriate exclusion of lesions with particular prognostic characteristics (n = 8, 19%), such as high‐grade dysplastic lesions (<a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>) or small/large lesions (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>). Study eligibility criteria and participant exclusions were not reported clearly enough to ascertain the risk of selection bias in 17 studies (40%); this meant that we could not determine whether consecutive or random samples of lesions were recruited (n = 22, 52%), whether participants had been selected according to their final diagnoses (use of 'case–control' selection, n = 5, 12%), or whether participant exclusions were appropriate (n = 22, 52%). </p> <p>A single study (<a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>) was of low concern for the applicability of its participant sample to the current review question: it included unexcised lesions and did not recruit participants with multiple lesions. All others (n = 41, 98%) were of high concern due to the use of restricted participant groups and settings (n = 40, 95%), with study populations limited to lesions selected for excision based on the clinical or dermoscopic diagnosis or selected retrospectively from histopathology databases (n = 36, 84%). Six studies did not restrict inclusion to excised lesions, but in three of these the non–excised lesions could not be extracted due to the absence of clinical follow–up in at least 50% of benign cases (<a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>; <a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] ">Bono 1996</a>; <a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>). Fourteen studies were also of concern due to their recruitment of participants with multiple lesions (including over 5% more lesions than participants). One of these (<a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>) provided participant–based 2 x 2 data as well as lesion–based data for the accuracy of a Derm–CAD system. These two analyses of the same population highlight the distortion that can occur in study populations that include multiple lesions per participant: lesion–based sensitivity was lower than participant‐based sensitivity (74% versus 89%), but lesion–based specificity was far higher (84% versus 48%) due to the inclusion of many disease‐negative lesions per participant. </p> <p>Twenty–two (52%) studies did not report the number of participants included (precluding assessment of the inclusion of multiple lesions). Of the 18 studies including model derivation, six (33%) used a wide range of skin conditions to train the classification algorithm. Two (11%) used an inadequately narrow range (absence of non–dysplastic benign conditions), while the remaining 10 (56%) provided inadequate detail of diagnoses included in the training set. </p> <p>Over half the studies were at high (n = 14, 33%) or unclear (n = 10, 24%) risk of bias due to the methods used to undertake the index test. Most studies (n = 40, 95%) blinded CAD results to the reference standard diagnosis, although almost half (n = 20, 48%) failed to clearly prespecify the diagnostic threshold, of which 13 (30%) were threshold–finding studies that provided accuracy data for the best threshold possible once index test results had been examined. Most studies (n = 35, 83%) evaluated CAD in an independent population from that used to train the classification algorithm, either by external validation (n = 23, 55%) or internal validation (randomised division of a single study group into training and test sets: n = 12, 29%). An additional six studies (14%) used internal validation, but failed to specify whether division of the study group was made randomly (i.e. not selected according to diagnosis), while one study was at risk of bias by selecting which diagnoses to place in the training and test sets (<a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>). </p> <p>Of the 18 studies that included CAD model derivation (training of the classification algorithm), eight (44%) accounted for model overfitting by using a Support Vector Machine algorithm (<a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a>; <a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>), performing a jack–knife calculation (<a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a>; <a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a>), or another method (<a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>; <a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a>). One study specified that model optimisation was not incorporated (<a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a>) and nine (50%) did not discuss overfitting. Most studies (n = 32, 76%) were of high concern for the applicability of the index test, due to their evaluation of an unestablished threshold (n = 23), lack of detail about the diagnostic threshold used (n = 16), and/or the use of non–expert clinicians (n = 2) in studies evaluating CAD as a diagnostic aid (n = 7). </p> <p>Almost all studies reported use of an acceptable reference standard (n = 37, 88%), and around half (n = 19, 45%) clearly reported blinding of the reference standard to the CAD result. For the applicability of the reference standard, four reported using expert diagnosis for some lesions (high concern) and 26 (62%) were unclear as to whether histopathology had been interpreted by an experienced histopathologist or dermatopathologist. </p> <p>Reporting of study flow and timing was generally poor, with an unclear risk of bias in 28 studies (67%), largely due to ambiguity about the interval between the application of the index test and reference standard (excision for histology or first follow–up visit) (n = 28). Thirteen studies (30%) were at a high risk of bias because they used different reference standards according to diagnosis (differential verification) (n = 6) and/or did not include all participants in the analysis (n = 10), primarily due to technical difficulties with the CAD system (n = 6). </p> <p>Eleven of the 15 studies comparing CAD with dermoscopy were at high (n = 2) or unclear (n = 9) risk of bias. Six reported blinding between tests, two reported no blinding and seven were unclear. Half (n = 8) did not clearly report the interval between tests. </p> </section> <section id="CD013186-sec-0081"> <h3 class="title" id="CD013186-sec-0081">Findings</h3> <p>The 24 studies evaluating a Derm–CAD system reported 23 cohorts of lesions providing 32 CAD datasets with 9602 lesions including 1313 malignancies of which 1220 were melanomas, at least 83 BCCs (number not specified in one study, <a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>), and nine cSCCs. We cannot estimate the total number of study participants with suspicious lesions, due to lack of reporting in study publications (reported in only 10 studies (with 2400 participants)). Two publications provided data for one cohort of lesions (<a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>); we included the larger of the two studies (<a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>) in the primary analysis with data from <a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a> contributing only to the direct comparison of Derm–CAD with dermoscopy. We evaluated a total of 16 different systems (listed in <a href="#CD013186-tbl-0004">Table 3</a>), three by multiple independent studies: Microderm (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>; <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>), DB–MIPS (also called DB–Dermo MIPS) (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a>; <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a>; <a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>), and Skin View (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992;</a><a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a>). The 16 systems differ in the type of dermoscopy used to acquire images, the storage devices used, features analysed and statistical classifier used (summarised in <a href="#CD013186-tbl-0004">Table 3</a>). The approach to computer–assisted support also differed, with 21 studies (88%) evaluating a stand–alone automated diagnosis (‘system–based diagnosis’), and three studies using Derm–CAD as a diagnostic aid to assist clinical decision–making. </p> <div class="table" id="CD013186-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of included digital dermoscopy‐based CAD (Derm–CAD) systems</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Derm‐CAD processing machine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Role of machine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Classifier</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD output</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MicroDERM (Visiomed AG, Germany)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dermoscopy unit with internal camera containing analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DANAOS software combines analytical system based on ABCD with database of 21,000 PSLs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DANAOS score indicating risk of malignancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>;<br/> <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>;<br/> <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>DB–Dermo MIPS (Biomips Engineering, Italy)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Dermoscopy unit, internal stereomicroscope, internal DB, pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system – integrated database stores the patient's data and the description of the lesion along with the image icons. 38 features analysed (grouped into geometries, colours and Burroni's islands of colours) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis suggested (e.g. melanoma, benign melanocytic naevus)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>;<br/> <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Automatic Data Analysis for Melanoma early detection (ADAM) software which analyses boundary shape, texture and colour distribution </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SVM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk, intermediate risk or high risk of melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multivariate discriminant analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graphical output and</p> <p>numerical output of features provided. Diagnosis suggested (e.g. melanoma, benign melanocytic naevus) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>; </p> <p><a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>KNN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis suggested (e.g. melanoma, benign melanocytic naevus)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discrimination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis suggested (e.g. melanoma, benign melanocytic naevus)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DDA software analysis – analyses 50 parameters subdivided into 3 categories, i.e. geometries, colours, and textures and islands of colours (Burroni islands) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Euclidian distances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>DEM–MIPS (Biomips SRL, Siena, Italy)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commercially available software coupled to stereomicroscope Wild M‐650 (Leica), video camera, computer, colour monitor. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DEM‐MIPS software (Digital Epi Microscopy Melanoma Image Processing Software; Biomips SRL, Siena, Italy). Evaluates colorimetric and geometric features (not reported). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] ">Piccolo 2002</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Skin View</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computerised image analysis system, digital television, videocamera. Connection with the computer is through a digitising board able to process colour images </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features of ABCD system plus clinical data (anatomic site, months of growth, size, shape, colour, ulceration or regression) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 2 of 8 binary (on/off) indicators indicates malignancy: 1. shape (asymmetry); 2. clinical data (changes through time, regression, ulceration); 3. size (mm); 4. colour (distribution of hue); 5. darkness (percent of black mixed with the hue); 6. saturation (percent of white mixed with the hue); 7. border (sharpness of transition between lesion and healthy skin; 8. texture. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; </p> <p><a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nevus Doctor</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computerised image analysis system coupled to digital dermatoscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ND takes a dermoscopic image from the Canon/DermLite device as input and classifies the lesion. </p> <p>Features not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probability of malignancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MoleExpert (DermoScan GmbH, Germany)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(micro Version 3.3.30.156). Computerised image analysis with output giving probability of malignancy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features of ABCD system plus other features (not listed), e.g. colour variation and grey veil </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number between −5.00 and 5.00, where high values indicate suspicion of melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image J (NIH, Bethesda,</b> </p> <p><b>USA)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Image segmentation, feature extraction, image analysis coupled with dermatoscope MoleMax II </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 features analysed from 38 extracted features describing shape, form and colour.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 outputs: 1) Visual rendering of analysis showing coloured areas 2) Excision vs no excision decision (system considers the green zone of the scale as benign (0 to 0.1), the yellow zone suspicious (0.1 to 0.4), and the red zone malignant (0.4 to 1)) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IBAS 2000 workstation (Zeiss, Oberkochen, Germany)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital image analysis workstation attached to Wild binocular stereomicroscope M 650 (Wild Heerbrugg AG, Switzerland) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of 16 morphometric parameters from the lesion and the border image: lesion area and perimeter: minimum polar distance, maximum polar distance, aspect ratio, circularity shape factor, variances of grey, number different colours, range different colours. Border features and area: maximum and minimum border width, ratio of border area to lesion area, ratio of border perimeter to lesion perimeter </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dichotomous decision: MM vs Benign (CN or DN)</p> <p>The network was trained to yield a value from 0 to 1 in the output nodes. The node yielding the greatest numerical output was then used as the classification result. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] ">Binder 1998</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nevuscreen ® (Arkè s.a.s., Avezzano, Italy)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital database containing image analysis software, coupled to digital dermatoscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevuscreen software automatically analyses ABCD features</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TDS score: &lt; 4.75 benign, 4.75 – 5.45 suspicious, &gt; 5.45 highly suggestive of melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SolarScan (Polartechnics Lts, Australia)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dermoscopy video unit with internal algorithm for image analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103 automated image analysis variables extracted: consisting of various properties of colour, pattern, and geometry. Number analysed not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probability of melanoma, with cut–off (not provided) for benign vs melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using different dermoscopy/camera combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54 features analysed, such as border irregularity, eccentricity, length of major and minor axes, and colour histogram properties </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital forest classifier</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severity score (the fraction of decision trees (n = 1000) in which the path ends in ‘‘malignant’’. Lesion classified as malignant if its image traced a path to a malignant node in at least 40% of the trees) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital stereomicroscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features analysed as present or absent (pattern analysis): Pigment network, brown globules, radial streaming, pseudopods, black dots, margin, pigmentation, depigmentation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of digital dermoscopy images (Molemax II)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features corresponding to the number, size and asymmetry of dots: (a) number of dots, (b) total number of pixels in dots, (c) mean number of pixels in dots, (d) variance of num. pixels in dots (e) fraction of lesion area occupied by dark dots. Asymmetry: radial, angular, primary axis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison of 5 classifiers:</p> <p>Multilayer perceptron</p> <p>KNN</p> <p>Random forest</p> <p>SVM polykernel c = 5*</p> <p>SVM PUK kernel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital microscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 features investigated: 4 asymmetry features, colour variance (red, green, blue), mean colour (red, green, blue, intensity), range colour (red, green, blue) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SVM (principal components analysis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital microscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Negative features: point and axial symmetry of pigmentation</p> <p>Presence of only a single colour.</p> <p>Positive features: blue‐white, veil, multiple brown dots, pseudopods, radial streaming, scarlike depigmentation, peripheral black dots/globules, multiple (5 ‐ 6) colours, multiple blue/grey dots, broadened network </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Classification and regression tree</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Presence of indicative features (Melanoma = 0/2 morphologically negative features AND at least 1/9 positive morphological features) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital microscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of 64 analytical parameters including: a large number of morphological parameters, such as </p> <p>margin, geometric parameters (surface area, extent, largest diameter and largest orthogonal diameter), invariant moments, symmetry, colours (red, green, blue and grey value), texture (energy, entropy, correlation, inverse difference moment and inertia), number of regions, focus and difference of the lesion and its convex cover </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vision algebra methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] ">Blum 2004a</a> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>*</b>(classifier selected at random for inclusion in review) </p> <p>Key: ANN – artificial neural network; CN – common naevus; DN – dysplastic naevus; KNN – K–nearest neighbour; NR – not reported; MM – malignant melanoma; SVM – support vector machine; TDS – total dermoscopic score </p> </div> </div> <p>The 18 publications evaluating a Spectro–CAD system reported 16 cohorts of lesions contributing 32 datasets with 6336 lesions including 1084 malignancies of which 934 were melanomas, 163 BCCs and 49 cSCCs. We cannot estimate the total number of study participants with suspicious lesions, due to lack of reporting in study publications (reported in only eight studies totaling 4484 participants). Four publications provided data for two patient cohorts (<a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002;</a><a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a> and <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>); we included the larger studies (<a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>) in the primary analysis, with data from <a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a> (same population as <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>) and <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a> (same population as <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>) contributing only to the direct comparison of Spectro–CAD with dermoscopy. These 18 studies reported on five different multispectral systems using DRSi: SpectroShade (<a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a>; <a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a>), Melafind (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a>; <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>; <a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>; <a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>), SIAscope (<a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009</a>; <a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a>), and ‘Telespectrophotometric System’ (<a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] ">Bono 1996</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>). One study evaluated a non–imaging diffuse reflectance spectroscopy system: OIDRS (<a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a>), which used analysis of data from incidentally‐reflected diffuse light. Nevisense was the only system to use electrical impedance spectroscopy (EIS), and was evaluated in two large prospective studies; these had overlapping recruitment periods and study centres, so we cannot rule out the possibility of overlap in analysed participants (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>; <a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a>). As for the Derm–CAD systems, the Spectro–CAD systems differ in terms of the image acquisition and storage devices used, features analysed, statistical classifier used, and the approach to computer–assisted support (i.e. whether used as a stand–alone automated diagnosis, or as information to assist a clinician’s diagnostic decision) (<a href="#CD013186-tbl-0005">Table 4</a>). </p> <div class="table" id="CD013186-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Characteristics of included Spectroscopy‐based CAD (Spectro‐CAD) systems</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Spectro–CAD system<br/> (spectroscopy type)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Role of machine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Classifier</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD Output</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>SpectroShade (MHT, Verona Italy)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Illumination assembly located inside a PC and an external detection device placed in a hand‐held probe, with integrated image analysis software </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Features analysed: (i) reflectance (R); (ii) variegation (V); (iii) area (A); (iv) dark area ratio (DAR); (v) dark island reflectance (DIR); (vi) dark distribution factor (DDF); (vii) dark permanence (D PER) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN (multilayer perceptron)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SpectroShade coupled with a MoleMax II dermatoscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnostic category: 1 no melanoma, 2 doubtful melanoma, 3 suspected melanoma, 4 probable melanoma </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MelaFind (early predecessor)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital camera and illumination assembly coupled to a computer, with separate image analysis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features analysed: Lesion asymmetry, border, gradient, centroid, texture, colour</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiparametric linear classifier</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p><b>MelaFind (STRATA Skin Sciences [formerly Mela Sciences Inc], Horsham, PA, USA)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Multispectral imaging system with integrated image analysis software; device takes images in vivo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>MelaFind image analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Binary output: (1) positive, (lesion should be considered for biopsy to rule out melanoma); and </p> <p>(2) negative (lesion should be considered for later evaluation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 constrained linear classifiers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Binary output: excise or follow–up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Logistic regression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Telespectrophotometric system (MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Digital camera coupled with an illumination system with interference filters and computer for storage and analysis of multispectral images </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>From each spectral image, 3 parameters, i.e. mean reflectance, variegation index and lesion area, were derived at the corresponding wavelength </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] ">Bono 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>For each spectral image, 5 parameters (lesion descriptors) based on ABCD and related to colour and shape of the imaged lesion were evaluated: mean reflectance, variegation index, compactness, roughness, and area </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant vs. ANN<b>*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>SIAscopy ™ (Astron Clinica, UK) (MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectrophotometric imaging system with hand–held skin probe (SIAscope II) and integrated software </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Analysis of dermal melanin, erythematous blush, lesion asymmetry, collagen 'holes', blood commas, or irregularities in the collagen </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs and Binary output (based on Australian Scoring System): ‘strong chance of melanoma' or 'low risk of melanoma' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectrophotometric imaging system with hand–held skin probe (SIAscope V) and integrated software (software Dermetrics Version 2.0, Astron Clinica Ltd., Great Britain) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs (no further information)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SIAscope (MedX Health Corp, Canada)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectrophotometric imaging system with hand–held skin probe (SIAscope, version NR) and integrated software </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs and lesion score using Primary Care Scoring Algorithm (6 or more points regarded as suspicious) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SIAscope (MedX Health Corp, Canada)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAscopy with MoleMate (software image management system) viewing platform and integrated Primary Care Scoring Algorithm </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs and lesion score using Primary Care Scoring Algorithm (6 or more points regarded as suspicious) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Oblique Incidence Diffuse Reflectance Spectroscopy (DRS‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Light probe coupled to imaging spectrograph, camera, and computer to store images.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnostic category (e.g. CN, MM, DN, BCC, cSCC)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nevisense (SciBase III, Sweden)</b> </p> <p><b>(EIS‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrical Impedance spectroscopy imaging system with integrated image analysis software</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The system measures the overall electrical resistance and reactance at 35 different frequencies </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SVM (non‐probabilistic binary linear classifier)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The system computes both a score (0 – 10) and a dichotomous output (EIS negative/positive) at a fixed cut‐off. The fixed threshold is set at 4, i.e. scores &lt; 4 are EIS‐negative and scores of ≥ 4 are EIS positive </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a> </p> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*Classifier excluded at random</p> <p>Key: ANN – artificial neural network; BCC – basal cell carcinoma; cSCC – cutaneous squamous cell carcinoma; CAD ‐ computer‐assisted diagnosis; CN – common naevus; DN – dysplastic naevus; EIS ‐ electrical impedance spectroscopy; KNN – K–nearest neighbour; NR – not reported; MM – malignant melanoma; MSI – multispectral imaging; SVM – support vector machine </p> </div> </div> <p>Study results are summarised below according to target condition, with forest plots of available study data provided in Figures 8 to 23. Results of meta–analysis are provided in <a href="#CD013186-tbl-0006">Table 5</a> and <a href="#CD013186-tbl-0007">Table 6</a>. </p> <div class="table" id="CD013186-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Summary estimates of sensitivity and specificity for CAD according to target condition</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index test, target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases/Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summary sensitivity (95% CI) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summary specificity (95% CI) %</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Main analyses: Invasive melanoma and</i> <i>atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1063/8992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.1 (84.0 to 94.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.3 (63.6 to 82.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286/2401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (83.7 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.6 (24.8 to 64.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>368/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.0 (94.7 to 98.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.6 (31.6 to 35.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Individual CAD systems: Invasive melanoma and</i> <i>atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS (Derm–CAD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>502/1903</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95.2 (89.5 to 97.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89.1 (78.7 to 94.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skin View (Derm–CAD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45/220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.0 (65.8 to 89.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.4 (40.1 to 54.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind (MSI–CAD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196/1798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.1 (91.9 to 98.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.8 (12.3 to 56.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Main analyses: Basal cell carcinoma</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (94.7 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3 (24.5 to 28.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Secondary target condition: invasive melanoma alone</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120/950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.8 (84.2 to 94.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.5 (60.2 to 66.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116/386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.5 (43.0 to 93.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.7 (38.5 to 79.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.2 (95.4 to 99.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.0 (36.0 to 40.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Secondary target condition: any skin cancer or lesions requiring excision</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>644/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.5 (91.3 to 95.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.6 (30.4 to 34.8)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*For EIS‐CAD the only evidence available was for one system</p> <p>Key: CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐based computer‐assisted diagnosis; EIS‐CAD ‐ electrical impedance spectroscopy‐based computer‐assisted diagnosis; MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis. </p> </div> </div> <div class="table" id="CD013186-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Comparisons of CAD with dermoscopy for detection of the primary target condition: invasive melanoma and atypical intraepidermal melanocytic variants</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Test</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cases</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pooled sensitivity (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pooled specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Derm‐CAD versus image‐based dermoscopy – indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Derm‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.1 (84.0 to 94.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.3 (63.6 to 82.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.3 (83.4 to 97.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.5 (57.3 to 97.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.21 (−11.2 to 4.79), P = 0.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−14.1 (−34.4 to 6.06), P = 0.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Derm‐CAD versus image‐based dermoscopy – direct comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Derm‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.1 (89.1 to 96.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.8 (68.2 to 89.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.9 (85.1 to 97.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.3 (56.5 to 97.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.17 (−6.61 to 6.95), P = 0.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−7.44 (−28.4 to 13.6), P = 0.49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>MSI‐CAD versus image‐based dermoscopy – indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MSI‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (83.7 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.6 (24.8 to 64.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.0 (66.5 to 80.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.7 (43.5 to 72.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.9 (9.58 to 28.2), P = 0.003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−15.0 (−40.7 to 10.6), P = 0.26</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>MSI‐CAD versus image‐based dermoscopy – direct comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MSI‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.8 (92.4 to 98.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.8 (12.4 to 56.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.0 (66.5 to 80.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.7 (43.5 to 72.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.7 (15.2 to 30.2), P &lt; 0.001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−28.9 (−56.3 to −1.48), P = 0.039</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Melafind (MSI–CAD) versus Image‐based dermoscopy – indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MelaFind</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.4 (94.0 to 98.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.3 (12.1 to 55.6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.5 (64.6 to 79.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.7 (42.6 to 58.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.5 (16.5 to 32.4), P &lt; 0.001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−20.9 (−45.5 to 3.75), P = 0.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Melafind (MSI‐CAD) versus Image‐based dermoscopy – direct comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MelaFind</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.5 (91.8 to 98.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.8 (8.38 to 48.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.5 (64.6 to 79.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.7 (42.6 to 58.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.9 (16.0 to 31.9), P &lt; 0.001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−27.9 (−50.1 to ‐5.66), P = 0.014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b><i>Derm‐CAD versus MSI‐CAD ‐ indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Derm‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90.1 (84.0 to 94.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.3 (63.6 to 82.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MSI‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.9 (83.7 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.6 (24.8 to 64.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.83 (−5.04 to 10.7),</p> <p>P = 0.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>−30.7 (−53.8 to −7.64), P = 0.009</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Key: CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐ based computer‐assisted diagnosis; MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis; P ‐ probability. </p> </div> </div> <section id="CD013186-sec-0082"> <h4 class="title">Target condition: invasive melanoma and atypical intraepidermal melanocytic variants</h4> <p>The diagnostic accuracy of CAD assessment for the detection of invasive cutaneous melanoma or atypical intraepidermal variants was reported by 36 studies with a total of 14,451 lesions including 1889 melanomas. Of these, 23 studies evaluated a Derm–CAD system (total 9082 lesions with 1094 melanomas) and 13 studies evaluated a Spectro‐CAD system (total 5369 lesions with 795 melanomas). </p> <section id="CD013186-sec-0083"> <h5 class="title">Derm‐CAD</h5> <p>Twenty–two studies were included in a meta–analysis to estimate the accuracy of dermoscopy–based CAD systems in referral settings, regardless of the system manufacturer, algorithm used, or whether CAD was used as a stand–alone automated diagnosis or as a diagnostic aid (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a>; <a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] ">Binder 1998</a>; <a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] ">Blum 2004a</a>; <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>; <a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a>; <a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a>; <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a>; <a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>; <a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] ">Piccolo 2002</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>). We excluded one additional study from this analysis (<a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>), due to suspected population overlap with an included study (<a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>). These 22 studies provided 23 datasets for meta–analysis (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> evaluated two CAD systems, Nevus Doctor and MoleExpert, in the same lesion population). Eleven studies were model derivation studies, eight evaluating the resulting classification algorithm in an independent population (random division of one study group into training and test sets: <a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a>; <a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] ">Binder 1998</a>; <a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] ">Blum 2004a</a>; <a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>), and three providing insufficient details to determine the independence of the test population (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a>; <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a>). The remaining 11 studies were external validation studies with prospective (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a>; <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>), retrospective (<a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] ">Piccolo 2002</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>), or unclear (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>) recruitment designs. Only one study did not use excision as an eligibility criterion (<a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>). </p> <p>Across the 23 datasets, sensitivity ranged from 17% to 100% and specificity from 20% to 98%. We pooled a total of 8992 lesions including 1063 melanomas, giving summary sensitivity of 90.1% (95% confidence interval (CI) 84.0% to 94.0%) and summary specificity of 74.3% (95% CI 63.6% to 82.7%) (<a href="#CD013186-tbl-0006">Table 5</a>; <a href="#CD013186-fig-0008">Figure 8</a>; <a href="#CD013186-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD013186-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of different types of digital dermoscopy CAD systems (DermCAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of different types of digital dermoscopy CAD systems (DermCAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <div class="figure" id="CD013186-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Summary plot of digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>The prevalence of melanoma ranged from 1% (<a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>) to 52% (<a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a>; <a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a>), and the number of melanomas missed ranged from 0 (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>) to 16 (<a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a>) (not reported in four studies). Ten of the 22 studies did not provide clear identification of the target condition (<a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a>; <a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] ">Blum 2004a</a>; <a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a>; <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>; <a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a>; <a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a>; <a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] ">Piccolo 2002</a>; <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>), and the inclusion of melanoma in situ lesions as disease‐positive was assumed on the basis that the disease‐positive group was described as ‘melanoma’ and not as ‘invasive melanoma’ or ‘malignant melanoma’. Of the 12 studies that clearly reported including in situ lesions (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] ">Binder 1998</a>; <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>; <a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>), the percentage of the disease‐positive group (invasive melanoma and atypical intraepidermal melanocytic variants) described as being in situ ranged from 12% to 50%. The number of missed in situ lesions was reported in seven studies, with no missed lesions in three studies (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>) and between 7% (1 of 14, <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>) and 100% (3 of 3, <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>) of in situ lesions misdiagnosed by the remaining studies. </p> <p>Some studies reported difficulties in excluding a malignancy from clinically benign lesions, particularly non‐melanocytic pigmented lesions such as seborrhoeic keratoses which were reported as an included lesion by five studies (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). Four of these provided lesion diagnoses by CAD result, finding 41 of 61 seborrhoeic keratoses (67%) to have been falsely identified as malignant, while a fifth study highlighted their problematic misclassification of this lesion by both Derm–CAD systems (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). Other notable false‐positive diagnoses include dysplastic melanocytic naevi (<a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a>; <a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] ">Binder 1998</a>; <a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>), actinic keratosis (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>), dermatofibroma (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>) and haemangioma (<a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>). </p> <p>One dataset from one study contributed data for the accuracy of a Derm–CAD system in self–referring patients seeking advice for pigmented naevi (<a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>) (<a href="#CD013186-tbl-0008">Table 7</a>). This prospective study evaluated the DB–MIPS system, a fully‐integrated dermoscopy unit with internal stereomicroscope, storage database and pattern analysis software, giving it to clinicians to use as a diagnostic aid. Although 3541 lesions (1308 participants) were examined, only the excised lesions (n = 466) were analysed by the authors, of which 357 were recruited in primary‐care clinics. These included 19 melanomas, and 283 dysplastic melanocytic naevi. The authors reported a sensitivity of 89.5% (95% CI 68.6% to 97.1%) and specificity of 84.0% (95% CI 79.7% to 87.5%). </p> <div class="table" id="CD013186-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Sensitivity and Specificity of CAD systems in Unreferred Populations</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>Derm‐CAD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD System</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DB‐MIPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89.5 (68.6 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84.0 (79.7 to 87.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign="top"> <p><b>MSI‐CAD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD System</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MoleMate SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 (82.4 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.1 (68.7 to 75.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MoleMate SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 (78.5 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.7 (68.4 to 74.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MoleMate SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.0 (75.0 to 97.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.5 (69.1 to 75.6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83.9 (67.4 to 92.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.2 (23.2 to 70.9)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Any ‐ any skin cancer or lesion requiring excision (secondary objective); CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐based computer‐assisted diagnosis; FN ‐ false negative; FP ‐ false positive; MEL ‐ invasive melanoma and atypical intraepidermal melanocytic variants (primary objective); MM ‐ malignant (invasive) melanoma only (secondary objective); MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis; TN ‐ true negative; TP ‐ true positive </p> </div> </div> </section> <section id="CD013186-sec-0084"> <h5 class="title">Derm‐CAD versus Dermoscopy</h5> <p>Seven studies (32%) reported accuracy data comparing Derm–CAD with dermoscopy for the detection of invasive melanoma and atypical intraepidermal melanocytic variants, providing seven datasets (4104 lesions including 226 melanomas and no other malignancies). A further four studies reported accuracy data for dermoscopy in a subsample of the total study population, and so we excluded them from analysis (<a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] ">Blum 2004a</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>). </p> <p>Five of the seven studies compared Derm–CAD to diagnosis by expert dermoscopists using dermoscopic images alone (<a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a>; <a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>) or alongside clinical images (<a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] ">Piccolo 2002</a>) in 765 lesions (153 melanomas). Two studies compared face‐to‐face dermoscopic diagnosis by an expert dermatologist with Derm–CAD systems DB–MIPS (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>) and Image J (<a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>). </p> <p>The accuracy of Derm‐CAD was compared with the accuracy of dermoscopy in:</p> <p>(a) all 22 Derm‐CAD studies (8992 lesions and 1063 melanomas) and the five image‐based dermoscopy studies (765 lesions and 153 melanomas) in an indirect comparison (<a href="#CD013186-fig-0010">Figure 10</a>; <a href="#CD013186-fig-0011">Figure 11</a>), and </p> <div class="figure" id="CD013186-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot of data for image‐based dermoscopy diagnosis and digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of data for image‐based dermoscopy diagnosis and digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <div class="figure" id="CD013186-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Summary plot of image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>(b) direct comparisons in the subset of five studies that evaluated both Derm‐CAD and image‐based dermoscopy (765 lesions and 153 melanomas; <a href="#CD013186-fig-0012">Figure 12</a>; <a href="./appendices#CD013186-sec-0126">Appendix 7</a>). </p> <div class="figure" id="CD013186-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>In both comparisons similar sensitivities were observed but with lower specificity for CAD compared to dermoscopy, but none of the observed differences were statistically significant (<a href="#CD013186-tbl-0007">Table 6</a>). For the indirect comparison, the difference (95% CI) in summary sensitivities (Derm‐CAD 90.1% versus dermoscopy 93.3%) was −3.21% (<b>−</b>11.2% to 4.79%), P = 0.43; the difference (95% CI) in summary specificities (Derm CAD 74.3% versus dermoscopy 88.5%) was −14.1% (−34.4% to 6.06%), P = 0.17. For the direct comparison the difference (95% CI) in summary sensitivities (Derm–CAD 94.1% versus dermoscopy 93.9%) was 0.17% (−6.61% to 6.95%), P = 0.96; the difference (95% CI) in summary specificities (CAD‐Derm 80.8% versus dermoscopy 88.3%) was −7.44% (−28.4% to 13.6%), P = 0.49. </p> <p>Contrasting differences in accuracy were produced by the two studies comparing Derm–CAD with face–to–face dermoscopic diagnosis by an expert (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>; <a href="#CD013186-tbl-0009">Table 8</a>), but these differences were imprecise. </p> <div class="table" id="CD013186-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Direct comparisons of single CAD studies with dermoscopy for diagnosis of melanoma and other types of skin cancer</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Sensitivity (true positives/cases) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Specificity (true negatives/non cases) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>MSI–CAD study comparisons: invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>MSI–CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In–person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>MSI–CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In–person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3 (53/66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.9 (60/66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−10.6 (−22.8 to 1.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49.0 (121/247)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.5 (184/247)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−25.5 (−33.5 to −17.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>MSI–CAD study comparisons:</i> Invasive melanoma</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>MSI‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>MSI‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.7 (8/12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (12/12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−33.3 (−60.9 to −2.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.2 (32/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45.2 (19/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.0 (10.1 to 48.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>MelaFind</i> <br/> <i>(MSI‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Melafind</i> <br/> <i>(MSI‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (21/21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81.0 (17/21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.1 (−0.15 to 40.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.5 (23/78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44.9 (35/78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−15.4 (−29.6 to −0.23)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Derm–CAD comparisons: invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>Derm‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>Derm‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (39/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.6 (33/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3 (−1.06 to 29.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.8 (267/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3 (263/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47 (−1.55 to 4.64)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a><b>*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.9 (24/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3 (26/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−7.41 (−24.6 to 8.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48.0 (207/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71.9 (310/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−23.9 (−30.1 to −17.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Unnamed system</i> <br/> <i>Derm‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Unnamed system</i> <br/> <i>Derm–CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.9 (40/45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91.1 (41/45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−2.22 (−15.7 to 11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.6 (90/119)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70.6 (84/119)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.04 (−6.21 to 16.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> <br/> <i>(Derm‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> <br/> <i>(Derm‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (39/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.6 (33/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3 (−1.06 to 29.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.8 (267/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3 (263/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47 (−1.55 to 4.64)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> </b> </p> <p><b><i>(Derm–CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> </b> </p> <p><b><i>(Derm–CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.5 (29/31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.6 (25/31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.9 (−4.62 to 30.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.9 (56/59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.9 (56/59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−9.44 to 9.44)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>CAD‐based diagnosis vs CAD‐aided diagnosis: invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐based diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐aided diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐based<br/> diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐aided<br/> diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a><b>*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.9 (24/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.1 (20/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.8 (−6.4 to 34.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48.0 (207/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81.9 (353/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−33.9 (39.6 to −27.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.9 (63/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.5 (51/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.5 (7.3 to 30.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.2 (6/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46.2 (30/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−36.9 (−49.9 to −22.0)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>*</b>Patient‐based analysis, unlike other studies in the table which were lesion‐based. The <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a> study did report lesion‐based for the accuracy of CAD‐only Derm‐CAD, used in the meta‐analysis for Derm‐CAD accuracy to detect invasive melanoma or atypical intraepidermal melanocytic variants (data presented in <a href="#CD013186-fig-0010">Figure 10</a>). </p> <p>Key: CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐based computer‐assisted diagnosis; MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis. </p> </div> </div> </section> <section id="CD013186-sec-0085"> <h5 class="title">Spectro‐CAD</h5> <p>We meta‐analysed eight datasets to estimate the accuracy of MSI‐CAD systems in referral settings, regardless of the system make, algorithm used, or whether CAD was used as a stand–alone automated diagnosis or as a diagnostic aid (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009</a>; <a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>; <a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a>; <a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>; <a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>). We excluded one other dataset (<a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>) from this analysis as it was a subgroup of <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>. Four were model derivation studies (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>; <a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a>), two of which validated the resulting classification algorithm in an independent population (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008;</a><a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a>), and the remaining four were prospective (<a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009;</a><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>) or retrospective (<a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012;</a><a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>) external validation studies. Melanoma prevalence ranged from 7% (<a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>) to 49% (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008;</a><a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>). These eight datasets evaluated 2537 excised lesions with 296 melanomas, with sensitivities ranging from 76% (<a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>) to 100% (<a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009;</a><a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a>), and specificities ranging from 8% (<a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>) to 77% (<a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a>). The pooled sensitivity was 92.9% (95% CI 83.7% to 97.1%) and specificity was 43.6% (95% CI 24.8% to 64.5%) (<a href="#CD013186-tbl-0006">Table 5</a>; <a href="#CD013186-fig-0013">Figure 13</a>; <a href="#CD013186-fig-0014">Figure 14</a>). The number of melanomas missed ranged from 0 (<a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009;</a><a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a>) to 9 (<a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a>), although the reporting of false‐positive diagnoses was poor so we could not analyse the data. </p> <div class="figure" id="CD013186-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Forest plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <div class="figure" id="CD013186-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Summary plot of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>One study evaluated a Spectro–CAD system based on the analysis of diffuse reflectance spectroscopy data, a non–imaging CAD system called OIDRS (<a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a>). This model derivation study prospectively recruited 136 pigmented skin lesions with a melanoma prevalence of 7% (final diagnosis determined by histology following biopsy). OIDRS was found to operate with a sensitivity of 90.0% (95% CI 59.6% to 98.2%) and specificity of 89.7% (95% CI 83.2% to 93.9%) (<a href="#CD013186-tbl-0010">Table 9</a>). </p> <div class="table" id="CD013186-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Sensitivity and specificity of oblique incidence diffuse reflectance spectrometry CAD (OIDRS–CAD) studies for primary target condition: invasive melanoma and atypical intraepidermal melanocytic variants</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index test, target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI) %</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.0 (59.6 to 98.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89.7 (83.2 to 93.9)</p> </td> </tr> </tbody> </table> </div> <p>The two studies evaluating Nevisense, a CAD system using electrical impedance spectroscopy (EIS), included one internal validation study (<a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a>) and one external validation study (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>) (<a href="#CD013186-tbl-0011">Table 10</a>). Pooling 2389 lesions with 368 melanomas, the summary sensitivity was 97% (95% CI 94.7% to 98.3%) and specificity was 33.6% (95% CI 31.6% to 35.7%) (<a href="#CD013186-tbl-0006">Table 5</a>). Both studies reported considerable difficulties in the ability of Nevisense to identify seborrhoeic keratoses, with 69/73 (95%) such lesions falsely identified as malignant. Other notable false‐positive diagnoses included dysplastic melanocytic naevi, actinic keratoses and dermatofibroma. </p> <div class="table" id="CD013186-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Sensitivity and specificity of electrical impedance spectroscopy CAD (EIS–CAD) studies for each primary target condition</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index test, target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI) %</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.1 (93.2 to 99.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.3 (23.8 to 33.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.6 (93.7 to 98.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.7 (32.5 to 37.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Basal cell carcinoma</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (84.5 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.4 (14.1 to 21.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (92.6 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.3 (26.3 to 30.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Cutaneous Squamous cell carcinoma</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>841</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (64.6 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.4 (41.3 to 45.7)</p> </td> </tr> </tbody> </table> </div> <p>One study evaluated the accuracy of an MSI–CAD system in an unreferred population (<a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>). A series of participants with pigmented skin lesions who were presenting for a first clinical assessment were prospectively recruited and imaged by GPs, using a SIAscope™ coupled with MoleMate, a multispectral imaging device with viewing platform and integrated Primary Care Scoring Algorithm (developed by <a href="./references#CD013186-bbs2-0086" title="EmeryJD , HunterJ , HallPN , WatsonAJ , MoncrieffM , WalterFM . Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm. BMC Dermatology2010;10:9. ">Emery 2010</a>). This was originally an RCT comparing patient referrals by GPs using MSI–CAD (experimental arm) with GP clinical assessment only (control arm), and we extracted the experimental arm data as a prospective case series evaluating MSI–CAD against histology or clinical follow‐up of at least three months for lesions considered benign, as well as expert diagnosis without follow‐up for some benign lesions. Overall 36 melanomas were identified and an additional 209 false diagnoses made amongst 766 included lesions; MSI–CAD sensitivity was 100% (95% CI 82.4% to 100%) and specificity was 72.1% (95% CI 68.7% to 75.2%) (<a href="#CD013186-tbl-0008">Table 7</a>). </p> </section> <section id="CD013186-sec-0086"> <h5 class="title">Spectro–CAD versus Dermoscopy</h5> <p>Six MSI–CAD studies (67%) also evaluated the accuracy of dermoscopy, providing six datasets (684 lesions and 229 malignancies comprising 220 melanomas, 8 BCCs and no cSCCs). One of these compared Derm–CAD to in–person dermoscopic diagnosis (<a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a>), and five studies evaluated dermoscopy using expert dermoscopists (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009</a>; <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>) or dermatologists of unreported expertise (<a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012;</a><a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>) to interpret stored dermoscopic images of 371 lesions, including 154 melanomas. Four studies also provided additional diagnostic information to clinicians in the form of clinical examination notes (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>; <a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>) or clinical images (<a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>). </p> <p>The accuracy of MSI‐CAD was compared with the accuracy of dermoscopy in:</p> <p>(a) all eight MSI‐CAD studies (2401 lesions and 286 melanomas) and the five image‐based dermoscopy studies (371 lesions and 154 melanomas) in an indirect comparison (<a href="#CD013186-fig-0015">Figure 15</a>; <a href="#CD013186-fig-0016">Figure 16</a>), and </p> <div class="figure" id="CD013186-fig-0015"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 15</div> </div> <hr class="top"/><img alt="Forest plot of data for image‐based dermoscopy diagnosis and multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG15.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of data for image‐based dermoscopy diagnosis and multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <div class="figure" id="CD013186-fig-0016"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 16</div> </div> <hr class="top"/><img alt="Summary plot of image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG16.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>(b) direct comparisons in the subset of five studies that evaluated both MSI‐CAD and image‐based dermoscopy (371 lesions and 154 melanomas; <a href="#CD013186-fig-0017">Figure 17</a>; <a href="./appendices#CD013186-sec-0126">Appendix 7</a>). </p> <div class="figure" id="CD013186-fig-0017"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 17</div> </div> <hr class="top"/><img alt="Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG17.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>In both comparisons MSI–CAD was significantly more sensitive with lower specificity, although differences in specificity were only significant for (b), the direct comparison (<a href="#CD013186-tbl-0007">Table 6</a>). For the indirect comparison (a), the difference (95% CI) in summary sensitivities (MSI–CAD 92.9% versus dermoscopy 74.0%) was 18.9% (9.58% to 28.2%), P = 0.003; the difference (95% CI) in summary specificities (MSI–CAD 43.6% versus dermoscopy 58.7%) was −15.0% (−40.7% to 10.6%), P = 0.26. For the direct comparison (b), the difference (95% CI) in summary sensitivities (MSI–CAD 96.8% versus dermoscopy 74.0%) was 22.7% (15.2% to 30.2%), P &lt; 0.001; the difference (95% CI) in summary specificities (MSI–CAD 29.8% versus dermoscopy 58.7%) was −28.9% (−56.3% to −1.48%), P = 0.039. </p> <p>Four of the five image–based dermoscopy studies used the MelaFind system (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>; <a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>; <a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>), with the same impact on sensitivity (MelaFind 96.5% versus dermoscopy 72.5%; difference (95% CI) of 23.9% (16.0% to 31.9%), P &lt; 0.001) and specificity (MelaFind 22.8% versus dermoscopy 50.7%; difference (95% CI) −27.9% (−50.1% to −5.66%), P = 0.014) (<a href="#CD013186-tbl-0007">Table 6</a>). </p> <p>One study compared the accuracy of MSI–CAD to in–person diagnosis by an expert dermatologist (<a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a>), and we present the results in <a href="#CD013186-tbl-0009">Table 8</a>. </p> </section> <section id="CD013186-sec-0087"> <h5 class="title">Derm–CAD versus Spectro–CAD</h5> <p>None of the studies directly compared the accuracy of Derm‐CAD and MSI‐CAD. An indirect comparison of MSI–CAD (8 studies) and Derm–CAD (22 studies) demonstrated similar sensitivities (Derm–CAD 90.1% versus MSI–CAD 92.9%) with a difference (95% CI) of 2.83% (−5.04% to 10.7%), P = 0.48. However, specificity was lower for MSI–CAD (43.6%) compared to Derm‐CAD (74.3%) with a difference of −30.7% (−53.8% to −7.64%), P = 0.009 (<a href="#CD013186-tbl-0007">Table 6</a>). </p> </section> <section id="CD013186-sec-0088"> <h5 class="title">Secondary analyses for the detection of invasive melanoma and atypical intraepidermal melanocytic variants </h5> <section id="CD013186-sec-0089"> <h6 class="title">Accuracy of individual Derm‐CAD systems</h6> <p>Our ability to compare the accuracy of individual CAD systems was limited by lack of data. A sufficient number of datasets to allow separate pooling were available only for the DB‐MIPS system. Six studies evaluated the DB–MIPS system, using varying classification algorithms, in a total of 1903 lesions including 502 melanomas (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a>; <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>; we dropped a seventh study (<a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>) from this analysis due to population overlap with <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>). Three were external validation studies (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>), and all six included only excised lesions. Summary estimates of sensitivity were 95.2% (95% CI 89.5% to 97.9%) and specificity 89.1% (95% CI 78.7% to 94.8%) (<a href="#CD013186-tbl-0006">Table 5</a>; <a href="#CD013186-fig-0008">Figure 8</a>; <a href="#CD013186-fig-0018">Figure 18</a>). </p> <div class="figure" id="CD013186-fig-0018"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 18</div> </div> <hr class="top"/><img alt="Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) DBMIPS for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG18.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) DBMIPS for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>Three external validation studies evaluated the MicroDERM system in a total of 793 lesions with 54 melanomas. However, due to the limited number of studies and substantial variability between studies, we did not perform meta‐analysis. Sensitivities ranged from 17% (95% CI 0% to 64%) to 86% (95% CI 42% to 100%) and specificities from 50% (95% CI 46% to 54%) to 90% (95% CI 83% to 95%) (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>; <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>; <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>). These represent accuracy for thresholds using DANAOS scores of ≥ 6.5 (<a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>), ≥ 7 (<a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a>) and ≥ 7.34 (<a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>). The outlying sensitivity of 17% observed in <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a> is likely due to a skewed sample of lesions, since of the 1000 pigmented skin lesions assessed in the study, only 18 received an eligible reference standard (histology, clinical follow–up was not reported) and so could be included. The vast majority of the original sample (982/1000) were clinically diagnosed as benign lesions not requiring excision. </p> <p>Two studies evaluated the Skin View system in 220 excised lesions with 45 melanomas (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992;</a><a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a>). The earlier publication included a model validation phase using internal validation (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>), while <a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a> performed an external validation only. Summary estimates of sensitivity were 80.0% (95% CI 65.8% to 89.3%) and specificity 47.4% (95% CI 40.1% to 54.8%) (<a href="#CD013186-tbl-0006">Table 5</a>; <a href="#CD013186-fig-0008">Figure 8</a>). </p> </section> <section id="CD013186-sec-0090"> <h6 class="title">Accuracy of individual Spectro‐CAD systems</h6> <p>Five MSI–CAD studies evaluated the MelaFind system in a total of 1798 lesions including 196 melanomas (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a>; <a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a>; <a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>). Summary estimates of sensitivity were 97.1% (95% CI 91.9% to 98.9%) and specificity 29.8% (95% CI 12.3% to 56.3%) (<a href="#CD013186-tbl-0006">Table 5</a>; <a href="#CD013186-fig-0011">Figure 11</a>; <a href="#CD013186-fig-0019">Figure 19</a>). </p> <div class="figure" id="CD013186-fig-0019"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 19</div> </div> <hr class="top"/><img alt="Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) MelaFind for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG19.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) MelaFind for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> </div> <p>Both EIS–CAD studies reported above evaluated the Nevisense system, in a total of 2389 lesions with 368 melanomas, giving a summary sensitivity of 97.0% (95% CI 94.7% to 98.3%) and specificity of 33.6% (95% CI 31.6% to 35.7%). </p> </section> <section id="CD013186-sec-0091"> <h6 class="title">CAD‐only performance versus CAD‐aided performance</h6> <p>In sensitivity analyses, we excluded studies that used CAD as a diagnostic aid. Three of the 22 Derm–CAD studies evaluated the Derm–CAD system as a diagnostic aid in referral settings (<a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>; <a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a>; <a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a>). Two of the six DB–MIPS studies (both prospective external validation studies) assessed the system as a diagnostic aid. For MSI–CAD, one of the eight studies used CAD as a diagnostic aid in a referral setting (MelaFind, <a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a>). The results of the sensitivity analyses are shown in <a href="./appendices#CD013186-sec-0127">Appendix 8</a>. The results indicate very similar findings to the main analyses. </p> <p>Direct evidence was available from one study (<a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a>) which compared Derm–CAD computer diagnoses (CAD only) with diagnoses produced by clinicians using Derm–CAD as a diagnostic aid (CAD–aided). In an external validation study, <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a> compared CAD–only performance of MoleMax II analysed with the Image J software programme (using a neural network classifier), with CAD–aided diagnosis performed by dermatologists with high experience, low experience, and a third cohort with mixed experience. In this prospective study, 458 consecutive participants were included who were referred to a secondary‐care centre for further investigation of 3021 suspicious pigmented skin lesions. While lesion–based results were reported for the CAD–only diagnosis (pooled for the primary objective Derm‐CAD accuracy estimates in <a href="#CD013186-fig-0010">Figure 10</a>), only participant–based results were provided for its comparison to CAD–aided diagnoses; it is notable that the lesion–based sensitivity and specificity for CAD‐only diagnosis differ substantially from the participant–based estimates for CAD‐only diagnosis (74% versus 89% sensitivity, 84% versus 48% specificity), which is to be expected when many more lesions were free of disease (true negatives n = 2512) than were participants (n = 207). The within–study results for the comparison to CAD‐aided diagnosis are reported in <a href="#CD013186-tbl-0009">Table 8</a>. </p> <p>A case–control reader study (<a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>), undertaken in a referred setting, was the only direct comparison of an MSI CAD–only diagnosis with MSI CAD–aided diagnosis. The study included 65 melanomas and 65 benign pigmented skin lesions that had been excised to evaluate the ability of MelaFind to accurately recommend biopsy in pigmented skin lesions. The study sample was a randomly‐selected subset of the consecutively‐recruited, prospective <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> population. Differences (95% CI) are reported in <a href="#CD013186-tbl-0009">Table 8</a>. </p> </section> </section> </section> <section id="CD013186-sec-0092"> <h4 class="title">Target Condition: Basal Cell Carcinoma (BCC)</h4> <section id="CD013186-sec-0093"> <h5 class="title">Derm‐CAD</h5> <p>Four study populations from referred settings included BCC lesions (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>); however two did not provide adequate data to derive 2 x 2 data (<a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>) and one included fewer than the minimum of five lesions to meet our inclusion criteria for this question (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>). The remaining study evaluated 11 BCCs amongst 173 dermoscopically atypical lesions using the output of an unnamed CAD system (CAD–based diagnosis), in a retrospective case series. Three BCCs were missed, giving a sensitivity of 73% (95% CI 43.4% to 90.3%) with 108 false positives, giving a specificity of 33% (95% CI 26.5% to 40.9%) for the detection of BCC (<a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>). The study used dermoscopic images of skin lesions excised on the basis of clinical suspicion of malignancy, and also included melanomas, cSCCs, seborrhoeic keratosis and benign melanocytic lesions. The very low specificity was as a result of misclassification of seborrhoeic keratoses (7/11), low–grade dysplastic naevi (27/47) and lentigo (8/10) as malignant lesions. </p> </section> <section id="CD013186-sec-0094"> <h5 class="title">Spectro‐CAD</h5> <p>Two studies evaluated the ability of a Spectro–CAD system to detect BCC lesions, both using the EIS–CAD Nevisense system in participants with suspected melanoma referred for excision (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>; <a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a>) (<a href="#CD013186-tbl-0011">Table 10</a>). Of 2389 analysed lesions, all 69 BCCs were identified, giving a summary sensitivity of 100% (95% CI 94.7% to 100%) and very low specificity of 26.3% (95% CI 24.5% to 28.1%). Since both populations were recruited to rule out melanoma, few benign keratotic lesions were included (including lichenoid keratosis (n = 4), seborrhoeic keratosis (n = 73) and actinic keratosis (n = 8)), a factor which may have contributed to the very low specificity. </p> </section> </section> <section id="CD013186-sec-0095"> <h4 class="title">Target condition: cutaneous squamous cell carcinoma (cSCC)</h4> <p>The only study to evaluate the performance of a CAD system to detect cSCC used the EIS–based Nevisense system in referred patients, identifying all seven cSCCs amongst 1943 lesions to give a sensitivity of 100% (95% CI 64.6% to 100%) and specificity of 43.4% (95% CI 41.3% to 45.7%) (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>) (<a href="#CD013186-tbl-0011">Table 10</a>). The high sensitivity could have been influenced by the study's melanoma–focused recruitment selection which resulted in very few benign different diagnoses being included (lichenoid keratosis (n = 4), seborrhoeic keratosis (n = 51) and actinic keratosis (n = 8)). </p> </section> <section id="CD013186-sec-0096"> <h4 class="title">Secondary target conditions: invasive melanoma alone</h4> <p>The diagnostic accuracy of CAD assessment for the detection of invasive cutaneous melanoma alone was reported by seven studies for a total of 1336 lesions with 236 invasive melanomas. </p> <p>Of these, two studies evaluated Derm–CAD systems (total 950 lesions with 120 invasive melanomas): SolarScan (<a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>) and an unnamed system (<a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>), both of which included model derivation within the same population (<a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a> did not report the method of dividing lesions into training and test sets). Both also included pigmented skin lesions referred for excision (<a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>; <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>), of which one may have included BCCs amongst the target disease‐negative group (<a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a> included 18 BCCs in the full study population but did not report how many were included in the independent test set). Melanoma prevalence was 10% in <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a> and 27% in <a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>. Meta–analysis of these studies provided a summary sensitivity estimate of 90.8% (95% CI 84.2% to 94.9%) and summary specificity of 63.5% (95% CI 60.2% to 66.7%) (<a href="#CD013186-tbl-0006">Table 5</a>). <a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a> also reported data for the primary target condition, invasive melanoma and atypical intraepidermal melanocytic variants, with little difference in sensitivity (92.0% invasive melanoma only versus 91.0%, 1.0% difference (95% CI −8.7% to 8.2%)) or specificity (61.5% invasive melanoma only versus 65.1%, −3.6% difference (95% CI −8.7% to 1.5%)). Despite in situ lesions making up 39% (47/122) of disease positives, similar proportions of in situ (5/47) and invasive lesions (6/75) were missed by the SolarScan. </p> <p>One Derm–CAD study, retrospective and of uncertain design, also allowed a comparison with image–based dermoscopy in 164 lesions containing 45 invasive melanomas (<a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a>). Observer experience was not reported. Accuracy estimates were similar and are reported in <a href="#CD013186-tbl-0009">Table 8</a>. </p> <p>Five studies evaluated an MSI‐CAD system (total 386 lesions with 116 invasive melanomas), regardless of the system make, algorithm used, or whether CAD was used as a stand–alone automate diagnosis or as a diagnostic aid. All were conducted in lesions referred for excision, four solely in pigmented skin lesions (<a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a>; <a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] ">Bono 1996</a>; <a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>; <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>) and the fifth in any lesion clinically suspected of being a melanoma (<a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a>). Systems evaluated were MelaFind (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008;</a><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>), SpectroShade (<a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a>), Telespectrophotometric System (<a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] ">Bono 1996</a>) and SIAscope, version V (<a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a>). </p> <p>Sensitivities ranged from 24% (<a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a>) to 100% (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>), and specificities from 29% (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>) to 84% (<a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a>). The study producing the highest sensitivity and lowest specificity (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>) excluded all high‐grade dysplastic lesions and therefore included only melanomas, BCCs (n = 2), low‐grade dysplastic naevi (n = 32) and other benign melanocytic lesions (n = 14). The lowest sensitivity and highest specificity were produced by <a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a>, who further selected their population of clinically suspicious lesions to include only lesions with a positive CAD result (SIAscope). Both datasets that evaluated the MelaFind system (<a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014;</a><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>) generated high sensitivities (81% and 100%) and low specificities (39% and 29%). These five studies (386 lesions including 116 invasive melanomas) gave a summary sensitivity estimate of 76.5% (95% CI 43.0% to 93.3%) and summary specificity of 60.7% (95% CI 38.5% to 79.2%) (<a href="#CD013186-fig-0020">Figure 20</a>; <a href="#CD013186-fig-0021">Figure 21</a>; <a href="#CD013186-tbl-0006">Table 5</a>). </p> <div class="figure" id="CD013186-fig-0020"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 20</div> </div> <hr class="top"/><img alt="Forest plot of different types of multi‐spectral imaging CAD system (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma)" data-id="CD013186-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG20.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of different types of multi‐spectral imaging CAD system (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma) </p> </div> </div> </div> <div class="figure" id="CD013186-fig-0021"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 21</div> </div> <hr class="top"/><img alt="Summary plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma)" data-id="CD013186-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG21.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma) </p> </div> </div> </div> <p>In sensitivity analyses, we excluded one study that used CAD as a diagnostic aid, in a referral setting (<a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>). The results of the sensitivity analysis are shown in <a href="./appendices#CD013186-sec-0127">Appendix 8</a>. The results indicate very similar findings to the main analysis. </p> <p>One study compared MSI–CAD (MelaFind) to diagnosis by expert dermoscopists using dermoscopic images in 99 lesions including 21 invasive melanomas, finding Melafind’s sensitivity to be higher (100% versus 81%) and specificity lower (29% versus 45%) than dermoscopy (<a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a>) (<a href="#CD013186-tbl-0009">Table 8</a>). </p> <p>One other study compared MSI–CAD (SpectroShade) to face–to–face diagnosis by expert dermatologists in 54 lesions with 12 invasive melanomas, finding SpectroShade’s sensitivity to be lower (67% versus 100%) and specificity higher (76% versus 45%) than dermoscopy (<a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a>) (<a href="#CD013186-tbl-0009">Table 8</a>). </p> <p>The two studies evaluating the EIS–based Nevisense system produced accuracy data for 2389 lesions with 226 invasive melanomas, giving a summary sensitivity of 98.2% (95% CI 95.4% to 99.3%) and specificity of 38.0% (95% CI 36.0% to 40.1%) (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>; <a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a>) (<a href="#CD013186-tbl-0006">Table 5</a>). </p> <p>A single study contributed data for the accuracy of detecting invasive melanoma in an unreferred setting, reporting the use of MoleMate with SIAscope by GPs in 766 lesions with 14 invasive melanomas (<a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>). No melanomas were missed: sensitivity 100% (95% CI 78.5% to 100%); although false‐positive findings were high, giving a specificity of 71.7% (95% CI 68.4% to 74.8%) (<a href="#CD013186-tbl-0008">Table 7</a>). </p> </section> <section id="CD013186-sec-0097"> <h4 class="title">Secondary target conditions: any lesion requiring excision</h4> <section id="CD013186-sec-0098"> <h5 class="title">Derm‐CAD</h5> <p>Four datasets from three studies (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; <a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>) provided data to evaluate the accuracy of Derm–CAD to detect any skin cancer or other atypical lesion requiring excision in referred settings. Two were retrospective derivation studies using stored dermoscopic images to train either the Skin View system in clinically suspect pigmented skin lesions referred for excision (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>), or an unnamed system in lesions suspected of malignancy also referred for excision (<a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a>). The third study conducted a head–to–head external validation comparison of two systems, in a case series of pigmented and nonpigmented (if melanoma, BCC, or SCC was a potentially different diagnosis) skin lesions scheduled for excision (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). The Nevus Doctor system was the subject of evaluation as a system still in development, being compared against the commercially available Mole Expert. The three studies provided a total of 1087 lesions, with the 186 malignancies including 83 BCCs, 9 cSCCs and 1 adnexal carcinoma (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). Sensitivities were high, ranging from 83% (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>) to 98% (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>, Nevus Doctor), while specificities were low and more varied ranging from 12% (<a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> Nevus Doctor) to 59% (<a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>). The lowest specificities (Nevus Doctor 12%, Mole Expert 13%) were produced by the study with the lowest disease prevalence (14%, <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> also produced the highest sensitivity and was the only study to include clinically obvious melanomas amongst its lesions. </p> <p>These accuracy estimates did not differ substantially from those for the detection of the individual target conditions reported above. </p> <p>No data were available to compare these results with the use of standard dermoscopy to detect any skin cancer. </p> </section> <section id="CD013186-sec-0099"> <h5 class="title">Spectro‐CAD</h5> <p>Two datasets evaluated the performance of DRS–CAD systems in referred settings, both from one study (<a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a>) evaluating the performance of the Oblique Incidence Diffuse Reflectance Spectrometry (OIDRS) system in two cohorts of lesions (i.e. CAD algorithms trained separately in each cohort). Amongst 136 pigmented skin lesions including 25 lesions to be excised (10 melanoma, 15 severe dysplastic lesions) OIDRS gave a sensitivity of 92% (95% CI 74.0% to 98.8%) and specificity of 86% (95% CI 78.9% to 91.6%). Amongst 89 non–pigmented skin lesions including 64 lesions to be excised (39 BCC, 25 cSCC) OIDRS gave a sensitivity of 92% (95% CI 83.0% to 96.6%) and specificity of 92% (95% CI 74.0% to 98.8%). However, caution must be used to interpret these estimates, as the spread of disease was different from that intended by our target condition definition of all malignancies: no malignancies other than melanoma were included in the pigmented population, and no melanomas were included in the non–pigmented population. </p> <p>The two EIS–CAD studies conducted in referred settings produced accuracy data for 2389 lesions with 644 malignancies or highly dysplastic lesions, giving a summary sensitivity of 93.5% (95% CI 91.3% to 95.1%) and specificity of 32.6% (95% CI 30.4% to 34.8%) (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>; <a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a>) (<a href="#CD013186-tbl-0006">Table 5</a>). In addition to the malignancies described above, one Merkel cell carcinoma was included (<a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a>) and detected by Nevisense. </p> <p>Two datasets provided data for the use of MSI–CAD in unreferred settings (<a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>; <a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>) (<a href="#CD013186-tbl-0008">Table 7</a>). While both used a SIAscope™ device, <a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> used the MoleMate analysis system incorporating the Primary Care Scoring Algorithm to analyse lesion images and arrive at a diagnosis (<a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>), while <a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a> also used the Primary Care Scoring Algorithm but did not report how images were interpreted. Sensitivity was slightly higher in <a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> (92.0% versus 83.9% in <a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>) and specificity substantially so (72.5% versus 46.2% <a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>). In addition to the probable use of different analysis software, this difference is likely explained by two factors: firstly CAD test results were used in different ways, as a diagnostic aid to GPs (after a period of training) by <a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>, and as the diagnostic output for a CAD–based diagnosis in <a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>. Second, our exclusion of 144 benign cases with no reference standard diagnosis from <a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a> has created a highly selected (excised only) and unrepresentative study population in this study (low sample size, n = 44, and high prevalence of malignancy, 70%). Of the 153 lesions considered benign after clinico‐dermoscopic assessment (of which nine were later excised), 122 were diagnosed as naevi, 23 as seborrhoeic keratoses, seven as dermatofibroma and one as cherry angioma. SIAscopy gave a negative score (&lt; 6) in 100 of these 153 lesions. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013186-sec-0100" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013186-sec-0100"></div> <section id="CD013186-sec-0101"> <h3 class="title" id="CD013186-sec-0101">Summary of main results</h3> <p>Computer–assisted diagnosis has been evaluated using a wide range of computer systems that analyse lesion images obtained by digital dermoscopy, lesion images obtained by multispectral imaging, or that analyse non–visual data from electrical impedance or diffuse reflectance spectroscopy. These computer systems have used a variety of classification algorithms to scrutinise a diverse selection of features. CAD sensitivity estimates were generally high, although with highly variable specificity. </p> <p>We present six main findings from our review:</p> <section id="CD013186-sec-0102"> <h4 class="title">1) Included studies inadequately address the review question due to an abundance of low‐quality studies, poor reporting, and recruitment of highly selected groups of participants </h4> <p>This review aimed to assess the accuracy of computer–assisted diagnosis for detecting melanoma, BCC or cSCC in adults. Most included studies focused on its use for detecting or ruling out melanoma in lesions scheduled for excision. These studies therefore do not reveal CAD’s ability to detect clinically missed melanomas, since most have excluded lesions clinically diagnosed as benign. Only three studies, all of Derm–CAD systems, examined lesions not recommended for excision (and thus potentially missed melanomas) using an adequate reference standard in clinically benign lesions. </p> <p>Studies were poorly reported and generally at unclear to high risk of bias across all domains, particularly for the selection of study participants, the timing of CAD diagnosis in relation to the reference standard diagnosis, and prespecification of CAD thresholds. Most studies used restricted groups of participants and failed to provide details of diagnostic thresholds sufficient for their reproducibility, leading to an almost universally poor clinical applicability of studies. </p> <p>Poor reporting in the primary studies also hindered attempts to assess sources of heterogeneity, particularly for the lack of reporting CAD results according to the final diagnosis. A substantial number of included studies (half of Derm–CAD studies and a third of Spectro–CAD studies) evaluated experimental versions of CAD systems, in which classification algorithms were trained alongside preliminary assessments of test performance within the same source population. The frequency of these internal validation studies causes high concern for the reliability of accuracy estimates, chiefly because models are likely to give overly optimistic results when training and testing datasets are very similar in the spread of lesion types and severity, as is the case when the same source population is used (<a href="./references#CD013186-bbs2-0228" title="AltmanDG , VergouweY , RoystonP , MoonsKG . Prognosis and prognostic research: validating a prognostic model. BMJ2009;338(7708):b605. [doi: 10.1136/bmj.b605; PUBMED: 19477892] ">Altman 2009</a>). In addition, great caution should be used when considering the applicability of these results to current clinical practice, since the generalisability of a new model can only be estimated in <i>external validation</i> studies that recruit new groups of patients from entirely new source populations. </p> <p>Most study populations were restricted to excised lesions. Since lesions which are not excised are more likely to be benign, and without an atypical morphological pattern that could be mistaken for a malignancy, their absence from datasets may have reduced CAD specificity estimates from their likely performance in populations where CAD tests would be used in clinical practice, namely those being referred for specialist assessment. Including the appropriate spectrum of benign conditions is key to establishing the accuracy of any test (<a href="./references#CD013186-bbs2-0301" title="LijmerJG , MolBW , HeisterkampS , BonselGJ , PrinsMH , Van derMeulenJH , et al. Empirical evidence of design‐related bias in studies of diagnostic tests. JAMA1999;282(11):1061‐6. [PUBMED: 10493205] ">Lijmer 1999</a>). Spectrum effects are often observed when tests that are developed further down the referral pathway have lower sensitivity and higher specificity when applied in settings with participants with limited prior testing (<a href="./references#CD013186-bbs2-0348" title="Usher‐SmithJA , SharpSJ , GriffinSJ . The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ2016;353:i3139. [DOI: 10.1136/bmj.i3139; PUBMED: 27334281] ">Usher‐Smith 2016</a>). However, this direction of effect is not consistent across tests and diseases, as <a href="./references#CD013186-bbs2-0298" title="LeeflangMM , RutjesAW , ReitsmaJB , HooftL , BossuytPM . Variation of a test's sensitivity and specificity with disease prevalence. CMAJ2013;185(11):E537‐44. [PUBMED: 23798453] ">Leeflang 2013</a> clearly demonstrates; the mechanisms in action are often more complex than prevalence alone and can be difficult to identify. It is therefore crucial that tests are evaluated in lesions that are representative of those in which the test will be used in practice. For tests such as CAD that use machine learning, a representative patient population is vital both for training the algorithm and for testing its validity. If a narrow range of benign conditions is used to train a computer algorithm, the resulting CAD system is likely to struggle in discriminating new, previously unseen benign lesions at the validation stage. Unfortunately, very poor reporting of the spectrum of conditions included in studies prevents any assessment of whether mismatches have occurred between training and validation populations. </p> <p>Limited data about the use of CAD as a diagnostic aid further limits the applicability of study results. Although CAD systems are designed to be used as diagnostic aids, most studies did not evaluate how CAD outputs were interpreted and acted upon by clinicians in their diagnostic decision–making, but instead evaluated the accuracy of the CAD system outputs as stand–alone tests. </p> </section> <section id="CD013186-sec-0103"> <h4 class="title">2) CAD systems correctly identify melanoma in highly selected populations, but their low and very variable specificity suggest they are unreliable as stand‐alone diagnostic tests, especially in less selected populations </h4> <p>Reflecting the design aims of system developers, almost all the studies sought to evaluate the ability of CAD to identify melanomas. <a href="./full#CD013186-tbl-0001">summary of findings Table</a> presents key results for the primary target condition of cutaneous invasive melanoma or atypical intraepidermal melanocytic variants. For digital dermoscopy CAD systems, pooled results from 22 studies (8992 lesions, 1063 melanomas) provided a sensitivity of 90.1% (95% CI 84.0% to 94.0%) and specificity of 74.3% (95% CI 63.6% to 82.7%). <a href="./full#CD013186-tbl-0001">summary of findings Table</a> illustrates how these estimates would affect diagnoses in a hypothetical cohort of 1000 lesions clinically suspected of being melanomas. At the median melanoma prevalence of 20% that might occur in a highly specialised melanoma referral clinic, digital dermoscopy CAD systems would on average miss 20 out of 200 melanomas and would result in 206 false‐positive diagnoses. At the lower and upper quartile melanoma prevalence of 7% and 40%, 7 and 40 melanomas would be missed, with 239 and 154 false‐positive diagnoses respectively. </p> <p>For multispectral imaging CAD systems, pooled results from eight studies (2401 lesions, 286 melanomas) provided a sensitivity of 92.9% (95% CI 83.7% to 97.1%) and specificity of 43.6% (95% CI 24.8% to 64.5%). In a hypothetical cohort of 1000 lesions clinically suspected of being melanomas with melanoma prevalence of 20%, MSI–CAD systems would on average miss 14 out of 200 melanomas and would result in 451 false‐positive diagnoses (<a href="./full#CD013186-tbl-0001">summary of findings Table</a>). At the lower and upper quartile melanoma prevalence of 7% and 40%, 5 and 28 melanomas would be missed, with 525 and 338 false‐positive diagnoses respectively. </p> <p>These results demonstrate a consistently high sensitivity for the detection of invasive melanoma and atypical intraepidermal melanocytic variants by CAD, regardless of type (Derm–CAD versus Spectro–CAD). However, specificity tends to be low and varies considerably between studies, particularly for MSI–based systems. The evidence certainly indicates that some benign lesions are more difficult to distinguish from malignancy using both Derm–CAD and Spectro–CAD systems, particularly seborrhoeic keratoses which proved problematic for Derm–CAD and EIS–CAD systems. However the reporting of benign diagnoses by CAD result was very poor, and omitted in 29 of the 42 included studies. As a result, the performance of MSI–CAD systems for these lesions remains uncertain. This difficulty in ruling melanoma out from seborrhoeic keratoses is also encountered when visual examination and dermoscopy are employed, and for CAD systems is equally likely to be due to similarities in the morphological appearance of these non‐melanocytic pigmented lesions and melanomas (<a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a>; <a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a>). </p> <p>Poor reporting of other aspects of study conduct also limit our interpretation of the heterogeneity in specificity, but likely causes include a wide variation in the spread of disease‐negative conditions included in study populations (both for training algorithms and for validating them), as well as considerable variation in CAD system characteristics. </p> </section> <section id="CD013186-sec-0104"> <h4 class="title">3) There is insufficient evidence to assess the accuracy of CAD systems in primary‐care settings </h4> <p>Insufficient data were available from primary‐care populations to draw firm conclusions, particularly for Derm–CAD, with only one included study which restricted inclusion to excised lesions only. For MSI–CAD, we found some suggestion of high sensitivity, although the evidence base was limited to two studies evaluating differing target conditions and with differing approaches to the use of CAD results (CAD–based versus CAD–aided diagnosis). Limiting study populations to excised lesions is particularly problematic in such settings, since the frequency and distribution of disease is far removed from the range one would expect to see in patients who have received limited prior testing, such as those self–referring to specialist pigmented lesion clinics. Only one study examined all individuals presenting to generalist settings that had lesions which could not immediately be diagnosed as benign (<a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a>). A second study also included all such lesions (<a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a>), but failed to provide non–excised lesions with any clinical follow–up and so these lesions had to be excluded from our analysis. </p> </section> <section id="CD013186-sec-0105"> <h4 class="title">4) Preliminary findings suggest CAD systems are at least as sensitive as assessment of dermoscopic images for the diagnosis of invasive melanoma and atypical intraepidermal melanocytic variants </h4> <p>MSI–CAD was significantly more sensitive than image‐based dermoscopy (92.9% versus 74%, P = 0.003), while direct comparisons indicate that it is also significantly less able to rule out truly benign lesions (29.8% versus 58.7%, P = 0.039). However indirect comparisons did not confirm this difference (43.6% versus 58.7%, P = 0.26) (<a href="#CD013186-tbl-0007">Table 6</a>). Conversely, our evidence suggests Derm–CAD may not differ significantly from dermoscopy in its ability to identify melanomas. However, we caution against drawing firm conclusions from these comparisons in the absence of sufficient data from studies evaluating face–to–face dermoscopy, on the basis that another review in this series has found such studies to demonstrate significantly higher accuracy for dermoscopy than those relying on review of dermoscopic images (<a href="./references#CD013186-bbs2-0255" title="DinnesJ , DeeksJJ , ChuchuN , Ferrante di RuffanoL , MatinRN , ThomsonDR , et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database of Systematic Reviews2018, Issue 12. [DOI: 10.1002/14651858.CD011902.pub2] ">Dinnes 2018b</a>). </p> </section> <section id="CD013186-sec-0106"> <h4 class="title">5) The evidence base for individual systems is too limited to draw conclusions on which might be preferred for practice </h4> <p>Despite the large number of included studies, the evidence base for the accuracy of individual systems to detect the primary target condition of the detection (invasive melanoma and atypical intraepidermal melanocytic variants) remains low, with meta–analysis possible for only two Derm–CAD systems (DB–MIPS and Skin View), one MSI–CAD system (MelaFind) and one EIS–CAD system (Nevisense). Only one of these, DB–MIPS, demonstrated a high specificity (89.1%) alongside high sensitivity (95.2%). Even though they evaluated the same CAD system, the six studies that we pooled for this estimate of DB‐MIPS were very varied in the classification algorithm used (ANN, SVM, K–NN, discriminant analysis, Euclidean distances), disease prevalence (5% to 45%), use of CAD results (two studies evaluated DB–MIPS as a diagnostic aid and four evaluated the DB–MIPS computer output) and range of disease‐negative conditions included (poorly reported, with a mixture of common naevus, dysplastic naevus, and only one study including seborrhoeic keratoses). The clinical settings to which this estimate applies therefore remain unclear. </p> <p>We observed considerable variation in test characteristics across all CAD systems, such as hardware and software technologies used, the types of classification algorithm employed, methods used to train the algorithms, and which lesion morphological features were extracted and analysed. Wide variations in technology specifications were observed even within the same CAD systems; for example, the four studies evaluating the SIAscope (a commercially available MSI–CAD system) captured between four and eight optical reflectance images at varying wavelengths to inform the final image (not reported in two studies), using different SIAscopes (versions II and V, not reported in two studies) coupled to different software programmes (the MoleMate™ in two studies, and not reported in two studies) using two different thresholds (the <a href="./references#CD013186-bbs2-0152" title="MoncrieffM , CottonS , ClaridgeE , HallP . Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. British Journal of Dermatology2002;146(3):448‐57. ">Moncrieff 2002</a> and <a href="./references#CD013186-bbs2-0086" title="EmeryJD , HunterJ , HallPN , WatsonAJ , MoncrieffM , WalterFM . Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm. BMC Dermatology2010;10:9. ">Emery 2010</a> methods). We noted this variation in CAD method, alongside limited reporting of important technological variables, in all CAD systems evaluated in this review. </p> </section> <section id="CD013186-sec-0107"> <h4 class="title">6) Evidence of the ability of CAD to detect keratinocyte cancers is very limited and studies are confined to specialist settings </h4> <p>Only three studies included sufficient numbers of BCC cases for analysis; the one small retrospective study evaluating Derm–CAD is insufficient to draw any conclusions. For EIS–CAD, the two large prospective studies were designed to evaluate Nevisense’s ability to detect melanoma, so that neither recruited populations clinically applicable for keratinocyte cancer detection, casting doubt on the generalisability of pooled estimates to clinical practice. Similarly, evidence for the accuracy of cSCC detection is limited to one Nevisense study, of unlikely clinical applicability to the target condition. </p> </section> </section> <section id="CD013186-sec-0108"> <h3 class="title" id="CD013186-sec-0108">Strengths and weaknesses of the review</h3> <p>The strengths of this review include an in‐depth and comprehensive electronic literature search, systematic review methods including double extraction of papers by both clinicians and methodologists, and contact with authors to allow study inclusion or clarify data. We adopted a clear analysis structure focusing on estimating incremental gains in accuracy, and undertook a detailed and replicable analysis of methodologic quality. </p> <p>In comparison with the four main existing systematic reviews, our review extends the time period searched for eligible studies (from 2002 in <a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a>, from 2007 in <a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a> and <a href="./references#CD013186-bbs2-0205" title="VestergaardME , MenziesSW . Automated diagnostic instruments for cutaneous melanoma. Seminars in Cutaneous Medicine and Surgery2008;27(1):32‐6. ">Vestergaard 2008</a>, and from 2011 in <a href="./references#CD013186-bbs2-0052" title="AliARA , DesernoTM . A systematic review of automated melanoma detection in dermatoscopic images and its ground truth data. SPIE. Medical Imaging 2012: Image Perception, Observer Performance, and Technology Assessment. 29 February 2012; Vol. 8318. [DOI: 10.1117/12.912389] ">Ali 2012</a>), includes all eligible studies regardless of language (<a href="./references#CD013186-bbs2-0052" title="AliARA , DesernoTM . A systematic review of automated melanoma detection in dermatoscopic images and its ground truth data. SPIE. Medical Imaging 2012: Image Perception, Observer Performance, and Technology Assessment. 29 February 2012; Vol. 8318. [DOI: 10.1117/12.912389] ">Ali 2012</a>; <a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a>), the presence of melanocytic lesions (<a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a>), or use of a histological reference standard (<a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a>). Although <a href="./references#CD013186-bbs2-0205" title="VestergaardME , MenziesSW . Automated diagnostic instruments for cutaneous melanoma. Seminars in Cutaneous Medicine and Surgery2008;27(1):32‐6. ">Vestergaard 2008</a> reviewed studies evaluating multispectral imaging CAD, electrical impedance spectroscopy CAD, and digital dermoscopy–based CAD systems, ours is the first review to meta‐analyse data and provide pooled accuracy estimates for each of these three types of CAD system. Ours is also the first review to include keratinocyte cancers as a target condition. </p> <p>Our stringent application of review inclusion criteria meant that we excluded some studies included in previous reviews. For example, we did not include those developing CAD systems and training new algorithms (‘derivation studies’) without assessing their performance in an independent population. Of the 30 studies included in <a href="./references#CD013186-bbs2-0169" title="RosadoB , MenziesS , HarbauerA , PehambergerH , WolffK , BinderM , et al. Accuracy of computer diagnosis of melanoma: a quantitative meta‐analysis. Archives of Dermatology2003;139(3):361‐7; discussion 366. ">Rosado 2003</a>, we excluded 23, including 17 derivation studies without independent test sets (16 Derm–CAD studies (<a href="./references#CD013186-bbs2-0054" title="AndreassiL , PerottiR , RubegniP , BurroniM , CeveniniG , BiagioliM , et al. Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma: a new quantitative semiology. Archives of Dermatology1999;135(12):1459‐65. ">Andreassi 1999</a>; <a href="./references#CD013186-bbs2-0064" title="BinderM , KittlerH , DreiseitlS , GansterH , WolffK , PehambergerH . Computer‐aided epiluminescence microscopy of pigmented skin lesions: the value of clinical data for the classification process. Melanoma Research2000;10(6):556‐61. ">Binder 2000</a>; <a href="./references#CD013186-bbs2-0085" title="ElbaumM , KopfAW , RabinovitzHS , LangleyRG , KaminoH , MihmMCJr , et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. Journal of the American Academy of Dermatology2001;44(2):207‐18. ">Elbaum 2001</a>; <a href="./references#CD013186-bbs2-0088" title="ErcalF , ChawlaA , StoeckerWV , LeeHC , MossRH . Neural network diagnosis of malignant melanoma from color images. IEEE Transactions on Biomedical Engineering1994;41(9):837‐45. ">Ercal 1994</a>; <a href="./references#CD013186-bbs2-0097" title="GansterH , PinzP , RohrerR , WildlingE , BinderM , KittlerH . Automated melanoma recognition. IEEE Transactions on Medical Imaging2001;20(3):233‐9. ">Ganster 2001</a>; <a href="./references#CD013186-bbs2-0106" title="GreenA , MartinN , McKenzieG , PfitznerJ , QuintarelliF , ThomasBW , et al. Computer image analysis of pigmented skin lesions. Melanoma Research1991;1(4):231‐236. [PUBMED: 1823631] ">Green 1991</a>; <a href="./references#CD013186-bbs2-0107" title="GreenA , MartinN , PfitznerJ , O'RourkeM , KnightN . Computer image analysis in the diagnosis of melanoma. Journal of the American Academy of Dermatology1994;31(6):958‐64. ">Green 1994</a>; <a href="./references#CD013186-bbs2-0115" title="Hintz‐MadsenM , HansenLK , LarsenJ , DrzewieckiKT . A probabilistic neural network framework for detection of malignant melanoma. In: NaguibRNG , SherbetGV editor(s). Artificial Neural Networks in Cancer Diagnosis, Prognosis and Patient Management. CRC Press, 2001:141‐83. ">Hintz‐Madsen 2001</a>; <a href="./references#CD013186-bbs2-0117" title="HorschA , StolzW , NeissA , AbmayrW , PomplR , BernklauA , et al. Improving early recognition of malignant melanomas by digital image analysis in dermatoscopy. Studies in Health Technology and Informatics1997;43(Pt B):531‐5. ">Horsch 1997</a>; <a href="./references#CD013186-bbs2-0134" title="KahoferP , Hofmann‐WellenhofR , SmolleJ . Tissue counter analysis of dermatoscopic images of melanocytic skin tumours: preliminary findings. Melanoma Research2002;12(1):71‐5. ">Kahofer 2002</a>; <a href="./references#CD013186-bbs2-0165" title="PomplR , BunkW , HorschA , StolzW , AbmayrW , BrauerW , et al. MELDOQ: A system to support the early detection of malignant melanoma through digital image processing [MELDOQ: Ein System zur Unterstützung der Früherkennung des malignen Melanoms durch digitale Bildverarbeitung]. In: HorschA , LehmannT editor(s). Bildverarbeitung für die Medizin 2000. Springer, Berlin, Heidelberg, 2000:234‐8. [DOI: 10.1007/978‐3‐642‐59757‐2_44] ">Pompl 2000</a>; <a href="./references#CD013186-bbs2-0170" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EuaG , AndreassiL . Digital dermoscopy analysis of pigmented skin lesions: An important auxiliary for clinical decision and not for automatic diagnosis. Archives of Dermatology2001;137(3):378. ">Rubegni 2001a</a>; <a href="./references#CD013186-bbs2-0179" title="SbonerA , BlanzieriE , EccherC , BauerP , CristofoliniM , ZumianiG , et al. A knowledge based system for early melanoma diagnosis support. pdfs.semanticscholar.org/9e12/21c5904bbd310c932414de841d3b126e5579.pdf (accessed prior to 1 May 2018). ">Sboner 2001</a>; <a href="./references#CD013186-bbs2-0183" title="SchindewolfT , SchiffnerR , StolzW , AlbertR , AbmayrW , HarmsH . Evaluation of different image acquisition techniques for a computer vision system in the diagnosis of malignant melanoma. Journal of the American Academy of Dermatology1994;31(1):33‐41. ">Schindewolf 1994</a>; <a href="./references#CD013186-bbs2-0184" title="Schmid‐SaugeonP , GuillodJ , ThiranJP . Towards a computer‐assisted diagnosis system for pigmented skin lesions. Computerized Medical Imaging and Graphics2003;27(1):65‐78. ">Schmid‐Saugeon 2003</a>; <a href="./references#CD013186-bbs2-0195" title="SmithY , WeinbergA , KlaussS , SofferD , IngberA . Improving screening for melanoma by measuring similarity to pre‐classified images. Melanoma Research2000;10(3):265‐72. ">Smith 2000</a>) and one MSI–CAD study, <a href="./references#CD013186-bbs2-0090" title="FarinaB , BartoliC , BonoA , ColomboA , LualdiM , TragniG , et al. Multispectral imaging approach in the diagnosis of cutaneous melanoma: potentiality and limits. Physics in Medicine and Biology2000;45(5):1243‐54. ">Farina 2000</a>). We excluded three others for lack of clarity on the 2 x 2 contingency table (<a href="./references#CD013186-bbs2-0182" title="SchindewolfT , StolzW , AlbertR , AbmayerW , HarmsH . Comparison of classification rates for conventional and dermatoscopic images of malignant and benign melanocytic lesions using computerized colour image analysis. European Journal of Dermatology1993;3(4):299‐303. ">Schindewolf 1993</a>), evaluating the diagnostic ability of a single feature (shape, <a href="./references#CD013186-bbs2-0077" title="ClaridgeE , HallPN , KeefeM , AllenJP . Shape analysis for classification of malignant melanoma. Journal of Biomedical Engineering1992;14(3):229‐34. ">Claridge 1992</a>), and unclear reporting on CAD type and eligibility of the reference standard (<a href="./references#CD013186-bbs2-0140" title="LefevreE , ColotO , VannoorenbergheP , DeBrucqD . Knowledge modeling methods in the framework of evidence theory: an experimental comparison for melanoma detection. IEEE International Conference on Systems, Man, and Cybernetics. 2000; Vol. 4:2806‐11. [DOI: 10.1109/ICSMC.2000.884422] ">Lefevre 2000</a>). Two others were conference abstracts, and so were not eligible for analysis. Of the 12 Derm–CAD studies included in <a href="./references#CD013186-bbs2-0166" title="RajparaSM , BotelloAP , TownendJ , OrmerodAD . Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. British Journal of Dermatology2009;161(3):591‐604. ">Rajpara 2009</a>, we excluded four derivation studies without independent test sets (<a href="./references#CD013186-bbs2-0107" title="GreenA , MartinN , PfitznerJ , O'RourkeM , KnightN . Computer image analysis in the diagnosis of melanoma. Journal of the American Academy of Dermatology1994;31(6):958‐64. ">Green 1994</a>; <a href="./references#CD013186-bbs2-0146" title="ManousakiAG , ManiosAG , EITsompanaki , PanayiotidesJG , TsiftsisDD , KostakiAK , et al. A simple digital image processing system to aid in melanoma diagnosis in an everyday melanocytic skin lesion unit. A preliminary report. International Journal of Dermatology2006;45(4):8. [DOI: 10.1111/j.1365‐4632.2006.02726.x] ">Manousaki 2006</a>; <a href="./references#CD013186-bbs2-0172" title="RubegniP , BurroniM , CeveniniG , PerottiR , Dell'EvaG , BarbiniP , et al. Digital dermoscopy analysis and artificial neural network for the differentiation of clinically atypical pigmented skin lesions: a retrospective study. Journal of Investigative Dermatology2002;119(2):471‐4. ">Rubegni 2002b</a>; <a href="./references#CD013186-bbs2-0179" title="SbonerA , BlanzieriE , EccherC , BauerP , CristofoliniM , ZumianiG , et al. A knowledge based system for early melanoma diagnosis support. pdfs.semanticscholar.org/9e12/21c5904bbd310c932414de841d3b126e5579.pdf (accessed prior to 1 May 2018). ">Sboner 2001</a>). Similarly, we excluded four of the nine Derm‐CAD studies in <a href="./references#CD013186-bbs2-0052" title="AliARA , DesernoTM . A systematic review of automated melanoma detection in dermatoscopic images and its ground truth data. SPIE. Medical Imaging 2012: Image Perception, Observer Performance, and Technology Assessment. 29 February 2012; Vol. 8318. [DOI: 10.1117/12.912389] ">Ali 2012</a>, due to the absence of independent test sets in derivation studies (<a href="./references#CD013186-bbs2-0121" title="IyatomiH , OkaH , SaitoM , MiyakeA , KimotoM , YamagamiJ , et al. Quantitative assessment of tumour extraction from dermoscopy images and evaluation of computer‐based extraction methods for an automatic melanoma diagnostic system. Melanoma Research2006;16(2):183‐90. ">Iyatomi 2006</a>; <a href="./references#CD013186-bbs2-0122" title="IyatomiH , CelebiME , OkaH , TanakaM . An Internet‐based melanoma screening system with acral volar lesion support. Engineering in Medicine and Biology Society (EMBC), 30th Annual International Conference of the IEEE. 2008:5156‐9. [DOI: 10.1109/IEMBS.2008.4650375] ">Iyatomi 2008a</a>; <a href="./references#CD013186-bbs2-0123" title="IyatomiH , OkaH , CelebiME , HashimotoM , HagiwaraM , TanakaM , et al. An improved Internet‐based melanoma screening system with dermatologist‐like tumor area extraction algorithm. Computerized Medical Imaging and Graphics2008;32(7):566‐79. ">Iyatomi 2008b</a>; <a href="./references#CD013186-bbs2-0125" title="IyatomiH , CelebiME , SchaeferG , TanakaM . Automated color normalization for dermoscopy images. 17th IEEE International Conference on Image Processing (ICIP). 2010:4357‐60. [DOI: 10.1109/ICIP.2010.5652370] ">Iyatomi 2010a</a>), and another that did not evaluate diagnosis of the presence of skin cancer (<a href="./references#CD013186-bbs2-0044" title="AbbasQ , CelebiME , Fondon GarciaI , RashidM . Lesion border detection in dermoscopy images using dynamic programming. Skin Research and Technology2011;17(1):91‐100. [PUBMED: 21226876] ">Abbas 2011a</a>). <a href="./references#CD013186-bbs2-0205" title="VestergaardME , MenziesSW . Automated diagnostic instruments for cutaneous melanoma. Seminars in Cutaneous Medicine and Surgery2008;27(1):32‐6. ">Vestergaard 2008</a> also required studies to evaluate CAD systems in an independent test set, and we consequently excluded only one of the nine studies included in <a href="./references#CD013186-bbs2-0205" title="VestergaardME , MenziesSW . Automated diagnostic instruments for cutaneous melanoma. Seminars in Cutaneous Medicine and Surgery2008;27(1):32‐6. ">Vestergaard 2008</a>, due to the absence of a reference standard test in selected participants (<a href="./references#CD013186-bbs2-0130" title="JamoraMJ , WainwrightBD , MeehanSA , BystrynJC . Improved identification of potentially dangerous pigmented skin lesions by computerized image analysis. Archives of Dermatology2003;139(2):195‐8. ">Jamora 2003</a>). </p> <p>Our stringent exclusion of studies without an independent test population has resulted in the exclusion of all studies evaluating non–imaging diffuse reflectance spectroscopy (DRS) systems (e.g. <a href="./references#CD013186-bbs2-0208" title="WallaceVP , BamberJC , OttRJ , CrawfordDC , MortimerPS . Monitoring pigmented skin lesions. SPIE. International Symposium on Biomedical Optics. Functional Monitoring and Drug‐Tissue Interaction. 2002; Vol. 4623. [DOI: 10.1117/12.469443] ">Wallace 2002</a>). This class of technologies used high spectral sampling to achieve a much higher resolution of spectral information from pigmented skin lesions than is found in the included DRSi (multispectral imaging) studies, giving an apparently strong performance for the detection of melanoma (<a href="./references#CD013186-bbs2-0206" title="WallaceVP , BamberJC , CrawfordDC , OttRJ , MortimerPS . Classification of reflectance spectra from pigmented skin lesions, a comparison of multivariate discriminant analysis and artificial neural networks. Physics in Medicine and Biology2000;45(10):2859‐71. ">Wallace 2000a</a>; <a href="./references#CD013186-bbs2-0207" title="WallaceVP , CrawfordDC , MortimerPS , OttRJ , BamberJC . Spectrophotometric assessment of pigmented skin lesions: methods and feature selection for evaluation of diagnostic performance. Physics in Medicine and Biology2000;45(3):735. ">Wallace 2000b</a>). We cannot assess in this review whether these promising results were overoptimistic due to their study design, or are genuine indicators of diagnostic capability. However, as technology improves we are likely to see systems with both imaging capability and high spectral sampling, making further carefully planned evaluation worthwhile. </p> <p>The main concerns for the review are a result of the poor reporting of primary studies, limiting our assessment of methodological quality, and in particular limiting an understanding of which malignant and benign conditions were correctly and incorrectly identified by the CAD systems. The poor reporting is of particular concern, given the clear heterogeneity in all aspects of study design, and consequently the clinical applicability of results is difficult to determine. Poor reporting also precludes identification of those studies that may have been well designed, but did not document their design and conduct adequately. </p> <p>Clear identification of the target condition was not provided in nine of the 22 Derm–CAD datasets or in four of the eight MSI–CAD datasets included in our primary analyses for detection of invasive melanoma or atypical intraepidermal melanocytic variants. These studies may or may not have included melanoma in situ lesions. Where studies included other invasive skin cancers in the study population, we tried to class any that were correctly identified as true negative results as opposed to false positives, on the basis that removal of any skin cancer in the attempt to identify melanomas would not be a negative consequence of the test. This relied on studies providing a disaggregation of test results according to final lesion classification and was not always possible. </p> <p>Our review is limited to studies published up to August 2016, and since computer–assisted diagnosis is a rapidly developing field of technology, the review will have missed some important and more recent developments in the field of machine learning with an application to the detection of skin cancer. Deep learning algorithms (<a href="./references#CD013186-bbs2-0264" title="EstevaA , KuprelB , NovoaRA , KoJ , SwetterSM , BlauHM , et al. Dermatologist‐level classification of skin cancer with deep neural networks. Nature2017;542(7639):115‐8. [doi: 10.1038/nature21056; PUBMED: 28117445] ">Esteva 2017</a>; <a href="./references#CD013186-bbs2-0281" title="HanSS , KimMS , LimW , ParkGH , ParkI , ChangSE . Classification of the clinical images for benign and malignant cutaneous tumors using a deep learning algorithm. Journal of Investigative Dermatology2018;138(7):1529‐38. [DOI: 10.1016/j.jid.2018.01.028; PUBMED: 29428356] ">Han 2018</a>) are one example where recent advances in computation have been applied to the development of new CAD systems for the detection of skin cancer. In future, it is also probable that CAD systems using continuous machine learning algorithms (where the CAD model continues to refine itself with exposure to clinical cases) will be developed. </p> </section> <section id="CD013186-sec-0109"> <h3 class="title" id="CD013186-sec-0109">Applicability of findings to the review question</h3> <p>Most of the data included in this review are unlikely to be applicable to the current clinical settings of primary care and dermatology clinics that exist in many high‐income countries. The predominance of highly selected lesion groups, scarce documentation of prior testing and frequency of internally validated derivation studies are likely to restrict the applicability of accuracy estimates to clinical practice. Poor documentation of the final diagnoses used to train CAD systems prevents any conclusion about the ideal target patient group, while very limited reporting of CAD results by final diagnosis does not allow us to make clear statements regarding the expected accuracy of different CAD systems, further restricting the transferability of results in practice. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013186-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Sample photographs of superficial spreading melanoma (left) and nodular melanoma (right). Copyright © 2010 Dr Rubeta Matin: reproduced with permission." data-id="CD013186-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Sample photographs of superficial spreading melanoma (left) and nodular melanoma (right). Copyright © 2010 Dr Rubeta Matin: reproduced with permission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Sample photographs of BCC (left) and cSCC (right). Copyright © 2012 Dr Rubeta Matin: reproduced with permission." data-id="CD013186-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Sample photographs of BCC (left) and cSCC (right). Copyright © 2012 Dr Rubeta Matin: reproduced with permission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Examples of commercially available CAD systems using digital dermoscopy (A), electrical impedance spectroscopy (B) and multispectral imaging (C and D). Reproduced with permission of the manufacturers. Copyright © 2018 MedX Corp, Canada; DermoScanGmbH, Germany; SciBase III, Sweden: reproduced with permission." data-id="CD013186-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Examples of commercially available CAD systems using digital dermoscopy (A), electrical impedance spectroscopy (B) and multispectral imaging (C and D). Reproduced with permission of the manufacturers. Copyright © 2018 MedX Corp, Canada; DermoScanGmbH, Germany; SciBase III, Sweden: reproduced with permission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Current clinical pathway for people with skin lesions." data-id="CD013186-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Current clinical pathway for people with skin lesions.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram." data-id="CD013186-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies" data-id="CD013186-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD013186-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of different types of digital dermoscopy CAD systems (DermCAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of different types of digital dermoscopy CAD systems (DermCAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Summary plot of digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of data for image‐based dermoscopy diagnosis and digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot of data for image‐based dermoscopy diagnosis and digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Summary plot of image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG13.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Forest plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG14.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Summary plot of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG15.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of data for image‐based dermoscopy diagnosis and multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 15</div> <div class="figure-caption"> <p>Forest plot of data for image‐based dermoscopy diagnosis and multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG16.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 16</div> <div class="figure-caption"> <p>Summary plot of image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG17.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 17</div> <div class="figure-caption"> <p>Summary plot of direct comparisons between image‐based dermoscopy diagnosis versus multi‐spectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG18.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) DBMIPS for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 18</div> <div class="figure-caption"> <p>Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) DBMIPS for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG19.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) MelaFind for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 19</div> <div class="figure-caption"> <p>Summary plot for the multi‐spectral imaging CAD system (MSI‐CAD) MelaFind for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG20.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of different types of multi‐spectral imaging CAD system (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma)" data-id="CD013186-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 20</div> <div class="figure-caption"> <p>Forest plot of different types of multi‐spectral imaging CAD system (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG21.png" target="_blank"><b></b></a></p> </div><img alt="Summary plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma)" data-id="CD013186-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 21</div> <div class="figure-caption"> <p>Summary plot of different types of multi‐spectral imaging CAD (MSI‐CAD) for the detection of invasive melanoma alone (invasive melanoma) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG22.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of direct comparisons between image‐based dermoscopy diagnosis versus multispectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0089" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 22</div> <div class="figure-caption"> <p>Forest plot of direct comparisons between image‐based dermoscopy diagnosis versus multispectral imaging CAD systems (MSI‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/appendices#CD013186-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-AFig-FIG23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-AFig-FIG23.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of direct comparisons between image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants)" data-id="CD013186-fig-0090" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 23</div> <div class="figure-caption"> <p>Forest plot of direct comparisons between image‐based dermoscopy diagnosis versus digital dermoscopy CAD systems (Derm‐CAD) for the detection of invasive melanoma or atypical intraepidermal melanocytic variants (invasive melanoma or atypical intraepidermal melanocytic variants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/appendices#CD013186-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-AFig-FIG23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-001" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-001.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD Microderm (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-001.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>Derm‐CAD Microderm (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-001.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-002" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-002.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD DBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-002.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 2</div> <div class="figure-caption"> <p>Derm‐CAD DBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-002.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-003" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-003.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD DBMIPS vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-003.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 3</div> <div class="figure-caption"> <p>Derm‐CAD DBMIPS vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-003.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-004" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-004.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD DEMMIPS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-004.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 4</div> <div class="figure-caption"> <p>Derm‐CAD DEMMIPS (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-004.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-006" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-006.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD SkinView (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-006.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 6</div> <div class="figure-caption"> <p>Derm‐CAD SkinView (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-006.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-007" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-007.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD SkinView (Any lesion requiring excision)." data-id="CD013186-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-007.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 7</div> <div class="figure-caption"> <p>Derm‐CAD SkinView (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-007.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-008" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-008.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD NevusDr (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-008.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 8</div> <div class="figure-caption"> <p>Derm‐CAD NevusDr (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-008.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-009" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-009.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD NevusDr (Any lesion requiring excision)." data-id="CD013186-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-009.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 9</div> <div class="figure-caption"> <p>Derm‐CAD NevusDr (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-009.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-010" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-010.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD ImageJ (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-010.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 10</div> <div class="figure-caption"> <p>Derm‐CAD ImageJ (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-010.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-011" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-011.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD IBAS2000 (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-011.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 11</div> <div class="figure-caption"> <p>Derm‐CAD IBAS2000 (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-011.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-012" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-012.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD Nevuscreen (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0032" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-012.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 12</div> <div class="figure-caption"> <p>Derm‐CAD Nevuscreen (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-012.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-013" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-013.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD SolarScan (invasive melanoma)." data-id="CD013186-fig-0033" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-013.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 13</div> <div class="figure-caption"> <p>Derm‐CAD SolarScan (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-013.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-014" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-014.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD SolarScan (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0034" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-014.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 14</div> <div class="figure-caption"> <p>Derm‐CAD SolarScan (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-014.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-015" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-015.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD No name (invasive melanoma)." data-id="CD013186-fig-0035" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-015.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 15</div> <div class="figure-caption"> <p>Derm‐CAD No name (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-015.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-016" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-016.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD No name (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0036" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-016.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 16</div> <div class="figure-caption"> <p>Derm‐CAD No name (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-016.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-017" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-017.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD No name (Any lesion requiring excision)." data-id="CD013186-fig-0037" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-017.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 17</div> <div class="figure-caption"> <p>Derm‐CAD No name (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-017.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-018" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-018.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD No name (BCC)." data-id="CD013186-fig-0038" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-018.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 18</div> <div class="figure-caption"> <p>Derm‐CAD No name (BCC).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-018.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-019" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-019.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD DBMIPS_UNREF (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0039" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-019.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 19</div> <div class="figure-caption"> <p>Derm‐CAD DBMIPS_UNREF (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-019.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-020" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-020.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SIAscope_UNREF (invasive melanoma)." data-id="CD013186-fig-0040" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-020.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 20</div> <div class="figure-caption"> <p>MSI‐CAD SIAscope_UNREF (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-020.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-021" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-021.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SIAscope_UNREF (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0041" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-021.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 21</div> <div class="figure-caption"> <p>MSI‐CAD SIAscope_UNREF (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-021.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-022" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-022.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SIAscope_UNREF (Any lesion requiring excision)." data-id="CD013186-fig-0042" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-022.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 22</div> <div class="figure-caption"> <p>MSI‐CAD SIAscope_UNREF (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-022.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-023" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-023.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SpectroShade (invasive melanoma)." data-id="CD013186-fig-0043" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-023.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 23</div> <div class="figure-caption"> <p>MSI‐CAD SpectroShade (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-023.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-024" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-024.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SpectroShade (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0044" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-024.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 24</div> <div class="figure-caption"> <p>MSI‐CAD SpectroShade (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-024.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-025" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-025.xxx" target="_blank"><b></b></a></p> </div><img alt="EIS‐CAD‐Nevisense (invasive melanoma)." data-id="CD013186-fig-0045" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-025.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 25</div> <div class="figure-caption"> <p>EIS‐CAD‐Nevisense (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-025.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-026" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-026.xxx" target="_blank"><b></b></a></p> </div><img alt="EIS‐CAD‐Nevisense (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0046" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-026.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 26</div> <div class="figure-caption"> <p>EIS‐CAD‐Nevisense (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-026.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-027" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-027.xxx" target="_blank"><b></b></a></p> </div><img alt="EIS‐CAD‐Nevisense (Any lesion requiring excision)." data-id="CD013186-fig-0047" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-027.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 27</div> <div class="figure-caption"> <p>EIS‐CAD‐Nevisense (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-027.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-028" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-028.xxx" target="_blank"><b></b></a></p> </div><img alt="EIS‐CAD‐Nevisense (BCC)." data-id="CD013186-fig-0048" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-028.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 28</div> <div class="figure-caption"> <p>EIS‐CAD‐Nevisense (BCC).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-028.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-029" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-029.xxx" target="_blank"><b></b></a></p> </div><img alt="EIS‐CAD‐Nevisense (cSCC)." data-id="CD013186-fig-0049" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-029.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 29</div> <div class="figure-caption"> <p>EIS‐CAD‐Nevisense (cSCC).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-029.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-030" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-030.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD Melafind (invasive melanoma)." data-id="CD013186-fig-0050" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-030.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 30</div> <div class="figure-caption"> <p>MSI‐CAD Melafind (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-030.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-031" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-031.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD Melafind (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0051" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-031.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 31</div> <div class="figure-caption"> <p>MSI‐CAD Melafind (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-031.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-032" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-032.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD Melafind_vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0052" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-032.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 32</div> <div class="figure-caption"> <p>MSI‐CAD Melafind_vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-032.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-034" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-034.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SIAscopy (invasive melanoma)." data-id="CD013186-fig-0053" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-034.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 34</div> <div class="figure-caption"> <p>MSI‐CAD SIAscopy (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-034.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-035" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-035.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SIAscopy (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0054" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-035.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 35</div> <div class="figure-caption"> <p>MSI‐CAD SIAscopy (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-035.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-036" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-036.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD SIAscope Only_UNREF (Any lesion requiring excision)." data-id="CD013186-fig-0055" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-036.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 36</div> <div class="figure-caption"> <p>MSI‐CAD SIAscope Only_UNREF (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-036.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-037" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-037.xxx" target="_blank"><b></b></a></p> </div><img alt="DRS‐CAD OIDRS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0056" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-037.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 37</div> <div class="figure-caption"> <p>DRS‐CAD OIDRS (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-037.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-038" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-038.xxx" target="_blank"><b></b></a></p> </div><img alt="DRS‐CAD OIDRS (Any + dysplastic)." data-id="CD013186-fig-0057" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-038.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 38</div> <div class="figure-caption"> <p>DRS‐CAD OIDRS (Any + dysplastic).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-038.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-039" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-039.xxx" target="_blank"><b></b></a></p> </div><img alt="DRS‐CAD OIDRS (Any lesion requiring excision)." data-id="CD013186-fig-0058" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-039.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 39</div> <div class="figure-caption"> <p>DRS‐CAD OIDRS (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-039.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-040" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-040.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD TS (invasive melanoma)." data-id="CD013186-fig-0059" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-040.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 40</div> <div class="figure-caption"> <p>MSI‐CAD TS (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-040.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-041" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-041.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD TS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0060" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-041.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 41</div> <div class="figure-caption"> <p>MSI‐CAD TS (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-041.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-042" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-042.xxx" target="_blank"><b></b></a></p> </div><img alt="CAD–DRS–TS vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0061" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-042.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 42</div> <div class="figure-caption"> <p>CAD–DRS–TS vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-042.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-046" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-046.xxx" target="_blank"><b></b></a></p> </div><img alt="PersonDERM‐DigidermDBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0062" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-046.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 46</div> <div class="figure-caption"> <p>PersonDERM‐DigidermDBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-046.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-047" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-047.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDERM‐DigidermDBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0063" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-047.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 47</div> <div class="figure-caption"> <p>ImageDERM‐DigidermDBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-047.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-048" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-048.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDERM‐DigidermDEMMIPS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0064" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-048.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 48</div> <div class="figure-caption"> <p>ImageDERM‐DigidermDEMMIPS (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-048.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-049" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-049.xxx" target="_blank"><b></b></a></p> </div><img alt="PersonDerm‐DigidermImageJ (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0065" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-049.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 49</div> <div class="figure-caption"> <p>PersonDerm‐DigidermImageJ (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-049.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-050" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-050.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDerm‐DigidermNevuscreen (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0066" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-050.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 50</div> <div class="figure-caption"> <p>ImageDerm‐DigidermNevuscreen (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-050.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-051" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-051.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDerm‐DigidermNR (invasive melanoma)." data-id="CD013186-fig-0067" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-051.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 51</div> <div class="figure-caption"> <p>ImageDerm‐DigidermNR (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-051.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-052" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-052.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDerm‐DigidermNR (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0068" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-052.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 52</div> <div class="figure-caption"> <p>ImageDerm‐DigidermNR (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-052.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-053" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-053.xxx" target="_blank"><b></b></a></p> </div><img alt="PersonDERM‐DRS‐SpectroShade (invasive melanoma)." data-id="CD013186-fig-0069" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-053.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 53</div> <div class="figure-caption"> <p>PersonDERM‐DRS‐SpectroShade (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-053.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-054" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-054.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDERM‐DRSMelafind (invasive melanoma)." data-id="CD013186-fig-0070" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-054.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 54</div> <div class="figure-caption"> <p>ImageDERM‐DRSMelafind (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-054.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-055" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-055.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDERM‐DRSMelafind (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0071" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-055.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 55</div> <div class="figure-caption"> <p>ImageDERM‐DRSMelafind (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-055.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-056" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-056.xxx" target="_blank"><b></b></a></p> </div><img alt="ImageDERM‐DRSSIA (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0072" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-056.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 56</div> <div class="figure-caption"> <p>ImageDERM‐DRSSIA (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-056.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-057" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-057.xxx" target="_blank"><b></b></a></p> </div><img alt="PersonDERM‐DRSTS (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0073" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-057.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 57</div> <div class="figure-caption"> <p>PersonDERM‐DRSTS (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-057.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-058" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-058.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD (direct comparison only) (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0074" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-058.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 58</div> <div class="figure-caption"> <p>Derm‐CAD (direct comparison only) (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-058.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-059" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-059.xxx" target="_blank"><b></b></a></p> </div><img alt="Image‐based Dermoscopy (for Derm‐CAD comparison) (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0075" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-059.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 59</div> <div class="figure-caption"> <p>Image‐based Dermoscopy (for Derm‐CAD comparison) (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-059.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-060" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-060.xxx" target="_blank"><b></b></a></p> </div><img alt="In‐person based Dermoscopy ‐ Derm‐CAD studies (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0076" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-060.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 60</div> <div class="figure-caption"> <p>In‐person based Dermoscopy ‐ Derm‐CAD studies (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-060.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-061" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-061.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD (direct comparison only) (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0077" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-061.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 61</div> <div class="figure-caption"> <p>MSI‐CAD (direct comparison only) (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-061.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-062" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-062.xxx" target="_blank"><b></b></a></p> </div><img alt="Image‐based Dermoscopy (for MSI‐CAD comparison) (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0078" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-062.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 62</div> <div class="figure-caption"> <p>Image‐based Dermoscopy (for MSI‐CAD comparison) (invasive melanoma or atypical intraepidermal melanocytic variants). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-062.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-063" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-063.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD All systems (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0079" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-063.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 63</div> <div class="figure-caption"> <p>MSI‐CAD All systems (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-063.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-064" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-064.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD All systems (invasive melanoma or atypical intraepidermal melanocytic variants)." data-id="CD013186-fig-0080" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-064.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 64</div> <div class="figure-caption"> <p>Derm‐CAD All systems (invasive melanoma or atypical intraepidermal melanocytic variants).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-064.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-065" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-065.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD MoleExpert (Any lesion requiring excision)." data-id="CD013186-fig-0081" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-065.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 65</div> <div class="figure-caption"> <p>Derm‐CAD MoleExpert (Any lesion requiring excision).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-065.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-066" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-066.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD All systems (invasive melanoma)." data-id="CD013186-fig-0082" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-066.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 66</div> <div class="figure-caption"> <p>Derm‐CAD All systems (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-066.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-067" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-067.xxx" target="_blank"><b></b></a></p> </div><img alt="Image‐based Dermoscopy ‐ Derm‐CAD studies (invasive melanoma)." data-id="CD013186-fig-0083" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-067.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 67</div> <div class="figure-caption"> <p>Image‐based Dermoscopy ‐ Derm‐CAD studies (invasive melanoma).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-067.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-068" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-068.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD All (Melafind) (invasive melanoma or atypical intraepidermal melanocytic variants), CAD + Clinician (diagnostic aid) only." data-id="CD013186-fig-0084" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-068.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 68</div> <div class="figure-caption"> <p>MSI‐CAD All (Melafind) (invasive melanoma or atypical intraepidermal melanocytic variants), CAD + Clinician (diagnostic aid) only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-068.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-069" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-069.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only." data-id="CD013186-fig-0085" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-069.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 69</div> <div class="figure-caption"> <p>MSI‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-069.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-070" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-070.xxx" target="_blank"><b></b></a></p> </div><img alt="MSI‐CAD Melafind (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only." data-id="CD013186-fig-0086" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-070.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 70</div> <div class="figure-caption"> <p>MSI‐CAD Melafind (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-070.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-071" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-071.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD + Clinician (diagnostic aid) only." data-id="CD013186-fig-0087" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-071.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 71</div> <div class="figure-caption"> <p>Derm‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD + Clinician (diagnostic aid) only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-071.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013186-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/urn:x-wiley:14651858:media:CD013186:CD013186-TST-072" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_t/tCD013186-TST-072.xxx" target="_blank"><b></b></a></p> </div><img alt="Derm‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only." data-id="CD013186-fig-0088" src="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-072.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 72</div> <div class="figure-caption"> <p>Derm‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013186/media/CDSR/CD013186/image_n/nCD013186-TST-072.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013186-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Question: </b> </p> </td> <td align="" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b>What is the diagnostic accuracy of computer‐assisted diagnosis for the detection of: i) cutaneous invasive melanoma and atypical intraepidermal melanocyticvariants, ii) BCC, or iii) cSCC in adults?</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Adults with lesions suspicious for skin cancer, including:</p> <p> <ul id="CD013186-list-0001"> <li> <p>Any lesion referred for specialist investigation due to suspicion of skin cancer, and </p> </li> <li> <p>Any lesion excised due to suspicion of skin cancer</p> </li> </ul> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Index test:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Computer‐assisted diagnosis (CAD)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparator test:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Dermoscopy</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Target condition:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Cutaneous invasive melanoma and atypical intraepidermal melanocytic variants, or basal cell carcinoma (BCC), or cutaneous squamous cell carcinoma (cSCC) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference standard:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Histology with or without long‐term follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Action:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>If accurate, positive results of CAD will identify skin cancers that could otherwise be missed, while negative results will stop patients having unnecessary excision of skin lesions </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quantity of evidence</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>42<sup>a</sup> </b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Total lesions with test results</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>13,445</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Total with target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>2452</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>Limitations </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk of bias:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Patient selection methods were poorly reported, with some concern (34/42) due to use of case‐control designs, exclusion of difficult‐to‐diagnose types of lesion, and inadequate reporting to assess risks of bias. CAD was generally evaluated in independent populations (35/42). Some concern as it was not clear that the reference standard was interpreted blind to the CAD results in 19/42 studies. Differential verification was used in 6/42 studies, participants were excluded in 10/42, primarily due to technical difficulties with CAD. Timing of tests was not mentioned in 28/42. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Applicability of evidence to question:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>High concern for poor clinical applicability of included studies. Almost all studies recruited narrowly‐defined populations (41/42) or multiple lesions per participant (14/42) or both, and may not be representative of populations eligible for CAD. Studies provided little information regarding the thresholds used for presence of malignancy (16/42) and often evaluated unestablished thresholds (23/42). Studies performing training of algorithms provided scarce information on the range of conditions included in training sets. Little information was given about the expertise of the histopathologist. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>FINDINGS: All analyses are undertaken on subgroups of the studies</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>All included studies considered the detection of melanoma, three of which also looked at the detection of BCC and one at the detection of cSCC. There are therefore insufficient data to make summary statements about the accuracy of CAD for the detection of BCC or cSCC. All results below consider the detection of the primary target condition: cutaneous invasive melanoma and atypical intraepidermal melanocytic variants.</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>Test: Digital dermoscopy‐based CAD (all systems)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quantity of evidence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total lesions with test results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8992</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total with melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1063</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI):</b> </p> <p><b>Specificity (95% CI):</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.1% (84.0% to 94.0%)</p> <p>74.3% (63.6% to 82.7%)</p> </td> <td align="" class="table-header" colspan="2" rowspan="1" valign="top"></td> <td align="" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Numbers observed in a cohort of 1000 people being tested<sup>b</sup> </b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><b>Consistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>Sensitivity estimates consistent. Some heterogeneity in specificity between studies</p> </td> <td align="center" class="table-header" colspan="2" rowspan="2" valign="top"> <p><b>Consequences</b> </p> </td> <td align="center" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Prevalence</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>7%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>20%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>40%</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive necessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>360</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive unnecessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Do not receive required excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Appropriately do not receive excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>446</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>PPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70%</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>NPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="7" rowspan="1" valign=""> <p><b>Test: Multispectral imaging‐based CAD (all systems)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quantity of evidence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>8</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total lesions with test results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2401</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total with melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>286</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI):</b> </p> <p><b>Specificity (95% CI):</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.9% (83.7% to 97.1%)</p> <p>43.6% (24.8% to 64.5%)</p> </td> <td align="" class="table-header" colspan="2" rowspan="1" valign=""></td> <td align="" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Numbers observed in a cohort of 1000 people being tested</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><b>Consistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>Sensitivity estimates consistent. High heterogeneity in specificity between studies</p> </td> <td align="center" class="table-header" colspan="2" rowspan="2" valign=""> <p><b>Consequences </b> </p> </td> <td align="center" class="table-header" colspan="3" rowspan="1" valign="top"> <p><b>Prevalence </b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>7%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>20%</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>40%</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive necessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>372</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Receive unnecessary excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Do not receive required excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Appropriately do not receive excision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>262</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>PPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52%</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>NPV</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Six studies with overlapping lesions (<a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a> and <a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a>; <a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a> and <a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a>; <a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> and <a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a>).<br/> <sup>b</sup>Numbers estimated at 25th, 50th (median) and 75% percentiles of invasive melanoma and atypical intraepidermal melanocytic variants prevalence, observed across 42 studies reporting evaluations of CAD.<br/> BCC ‐ Basal cell carcinoma; CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; cSCC ‐ cutaneous squamous cell carcinoma; NPV ‐ negative predictive value; PPV ‐ positive predictive value </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Artificial intelligence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Computer systems undertaking tasks that normally require human intelligence, such as decision–making or visual perception </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Atypical intraepidermal melanocytic variant</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unusual area of darker pigmentation contained within the epidermis that may progress to an invasive melanoma; includes melanoma <i>in situ</i> and lentigo maligna </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Atypical naevi</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unusual looking but noncancerous mole or area of darker pigmentation of the skin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Basaloid cells</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cells in the skin that look like those in epidermal basal layer</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>BRAF V600 mutation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>BRAF is a human gene that makes a protein called B‐Raf which is involved in the control of cell growth. BRAF mutations (damaged DNA) occur in around 40% of melanomas, which can then be treated with particular drugs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>BRAF inhibitors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapeutic agents which inhibit the serine‐threonine protein kinase BRAF mutated metastatic melanoma. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Breslow thickness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A scale for measuring the thickness of melanomas by the pathologist using a microscope, measured in mm from the top layer of skin to the bottom of the tumour. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Congenital naevi</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A type of mole found on infants at birth</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Whereby a handheld microscope is used to allow more detailed, magnified, examination of the skin compared to examination by the naked eye alone </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dermo‐epidermal junction</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The area where the lower part of the epidermis and top layer of the dermis meet</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dermis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Layer of skin below the epidermis, composed of living tissue and containing blood capillaries, nerve endings, sweat glands, hair follicles and other structures </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Desmoplastic subtypes of SCC</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An aggressive squamous cell carcinoma variant characterised by a proliferation of fibroblasts and formation of fibrous connective tissue </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Electrodesiccation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The use of high‐frequency electric currents to cut, destroy or cauterise tissue. It is performed with the use of a fine needle‐shaped instrument </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Electrical impedance spectroscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of electrical current properties as they pass through skin tissues, to retrieve information on cellular structures </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Epidermis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outer layer of the skin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negative</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An individual who is truly positive for a disease, but whom a diagnostic test classifies them as disease‐free. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positive</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An individual who is truly disease‐free, but whom a diagnostic test classifies them as having the disease. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histopathology/Histology</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study of tissue, usually obtained by biopsy or excision, for example under a microscope.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Incidence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The number of new cases of a disease in a given time period.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Index test</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A diagnostic test under evaluation in a primary study</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interferometry</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of waves of light or sound after interference in order to extract information </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lentigo maligna</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unusual area of darker pigmentation contained within the epidermis which includes malignant cells but with no invasive growth. May progress to an invasive melanoma </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lymph node</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymph nodes filter the lymphatic fluid (clear fluid containing white blood cells) that travels around the body to help fight disease; they are located throughout the body often in clusters (nodal basins). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Melanocytic naevus</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An area of skin with darker pigmentation (or melanocytes) also referred to as ‘moles’</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A form of statistical analysis used to synthesise results from a collection of individual studies. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metastases/metastatic disease</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spread of cancer away from the primary site to somewhere else through the bloodstream or the lymphatic system. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Morbidity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detrimental effects on health.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either (1) the condition of being subject to death; or (2) the death rate, which reflects the number of deaths per unit of population in relation to any specific region, age group, disease, treatment or other classification, usually expressed as deaths per 100, 1000, 10,000 or 100,000 people. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Multidisciplinary team</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A team with members from different healthcare professions and specialties (e.g. urology, oncology, pathology, radiology, and nursing). Cancer care in the National Health Service (NHS) uses this system to ensure that all relevant health professionals are engaged to discuss the best possible care for that patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Naevus</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A mole or collection of pigment cells (plural: naevi or nevi)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Optical coherence tomography (OCT)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Based on the same principle as ultrasound, OCT uses a handheld probe to measure the optical scattering of near‐infrared (1310 nm) light waves (rather than sound waves) from under the surface of the skin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prevalence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The proportion of a population found to have a condition.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prognostic factors/indicators</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specific characteristics of a cancer or the person who has it which might affect the patient’s prognosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Receiver operating characteristic (ROC) plot</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A plot of the sensitivity and 1 minus the specificity of a test at the different possible thresholds for test positivity; represents the diagnostic capability of a test with a range of binary test results </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Receiver operating characteristic (ROC) analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The analysis of a ROC plot of a test to select an optimal threshold for test positivity</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Recurrence is when new cancer cells are detected following treatment. This can occur either at the site of the original tumour or at other sites in the body. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference Standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A test or combination of tests used to establish the final or ‘true’ diagnosis of a patient in an evaluation of a diagnostic test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reflectance confocal microscopy (RCM)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A microscopic technique using infrared light (either in a handheld device or a static unit) that can create images of the deeper layers of the skin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Resolution in an imaging system refers to its ability to distinguish two points in space as being separate points; resolution is measured in two directions: axial and lateral. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In this context the term is used to mean the proportion of individuals with a disease who have that disease correctly identified by the study test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The proportion of individuals without the disease of interest (in this case with benign skin lesions) who have that absence of disease correctly identified by the study test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spectroscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study of the interaction between matter and electromagnetic radiation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Spindle subtypes of SCC</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A squamous cell carcinoma variant characterised by poorly differentiated spindle cells surrounded by collagenous stroma </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Staging</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinical description of the size and spread of a patient’s tumour, fitting into internationally agreed categories. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stratum corneum</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The outermost layer of the epidermis. This layer is the most superficial layer of skin, which is composed of flattened skin cells organised like a brick wall. In normal conditions cells are not nucleated at this layer </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Subclinical (disease)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disease that is usually asymptomatic and not easily observable, e.g. by clinical or physical examination. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">A cross‐tabulation of studies by CAD type, reported comparisons and target conditions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison with dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target conditions<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] "><b>Bauer 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] "><b>Wollina 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] "><b>Burroni 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] "><b>Rubegni 2002a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] "><b>Seidenari 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] "><b>Seidenari 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] "><b>Stanganelli 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB‐MIPs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] "><b>Piccolo 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DEM‐MIPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] "><b>Binder 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IBAS 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] "><b>Barzegari 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MicroDERM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] "><b>Boldrick 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MicroDERM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] "><b>Serrao 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MicroDERM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] "><b>Dreiseitl 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Image J (MoleMax II)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] "><b>Maglogiannis 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR (MoleMax II)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] "><b>Mollersen 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevus Doctor<br/> Mole Expert </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] "><b>Piccolo 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevuscreen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] "><b>Cascinelli 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skin View</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] "><b>Cristofolini 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skin View</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] "><b>Menzies 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SolarScan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] "><b>Binder 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] "><b>Blum 2004a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] "><b>Ferris 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,2,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] "><b>Gilmore 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] "><b>Menzies 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] "><b>Hauschild 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] "><b>Winkelmann 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] "><b>Friedman 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] "><b>Monheit 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] "><b>Wells 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] "><b>Sgouros 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope (version NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] "><b>Glud 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>image–based assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] "><b>Terstappen 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope V</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] "><b>Walter 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Siascope V (MoleMate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD diagnostic aid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,4,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] "><b>Tomatis 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectroshade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] "><b>Ascierto 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectroshade</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] "><b>Gutkowicz Krusin 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>System name NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] "><b>Tomatis 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telespectrophotometric system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] "><b>Bono 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telespectrophotometric System</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] "><b>Bono 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Telespectrophotometric System</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>in–person dermoscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] "><b>Garcia Uribe 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DRS–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OIDRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] "><b>Malvehy 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevisense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded (different sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,2,3,4,5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] "><b>Mohr 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevisense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAD only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1,2,4,5</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Key: Derm‐CAD – Dermoscopy‐based computer–assisted diagnosis; DRS–CAD – diffuse reflectance spectroscopy computer–assisted diagnosis; EIS‐CAD ‐ Electrical impedance‐based computer‐assisted diagnosis; MSI‐CAD ‐ Multispectral imaging‐based computer–assisted diagnosis; NR – Not reported; OIDRS ‐ oblique incidence reflectance spectroscopy </p> <p><sup>a</sup>1 – Invasive melanoma and atypical intraepidermal melanocytic variants; 2 – Basal cell carcinoma; 3 – cutaneous Squamous cell carcinoma; 4 – Invasive melanoma alone; 5 – Any skin cancer or lesion requiring excision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">A cross‐tabulation of studies by CAD type, reported comparisons and target conditions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of included digital dermoscopy‐based CAD (Derm–CAD) systems</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Derm‐CAD processing machine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Role of machine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Classifier</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD output</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MicroDERM (Visiomed AG, Germany)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dermoscopy unit with internal camera containing analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DANAOS software combines analytical system based on ABCD with database of 21,000 PSLs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DANAOS score indicating risk of malignancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0002" title="BarzegariM , GhaninezhadH , MansooriP , TaheriA , NaraghiZS , AsgariM . Computer‐aided dermoscopy for diagnosis of melanoma. BMC Dermatology2005;5:8. [ER4:15465860; PUBMED: 16000171] ">Barzegari 2005</a>;<br/> <a href="./references#CD013186-bbs2-0033" title="SerraoVV , BaptistaJ , ParisF , LopesLC , FidalgoA , FerreiraA . Digital dermoscopy. Review of 652 lesions analysed by the DANAOS system. Skin Cancer2006;21(4):185‐98. [ER4:18375096] ">Serrao 2006</a>;<br/> <a href="./references#CD013186-bbs2-0007" title="BoldrickJC , LaytonCJ , NguyenJ , SwetterSM . Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Journal of the American Academy of Dermatology2007;56(3):417‐21. [ER4:19728338; PUBMED: 17109995] ">Boldrick 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>DB–Dermo MIPS (Biomips Engineering, Italy)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Dermoscopy unit, internal stereomicroscope, internal DB, pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system – integrated database stores the patient's data and the description of the lesion along with the image icons. 38 features analysed (grouped into geometries, colours and Burroni's islands of colours) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis suggested (e.g. melanoma, benign melanocytic naevus)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a>;<br/> <a href="./references#CD013186-bbs2-0030" title="RubegniP , CeveniniG , BurroniM , PerottiR , Dell'EvaG , SbanoP , et al. Automated diagnosis of pigmented skin lesions. International Journal of Cancer2002;101(6):576‐80. [ER4:20569489; PUBMED: 12237900] ">Rubegni 2002a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Automatic Data Analysis for Melanoma early detection (ADAM) software which analyses boundary shape, texture and colour distribution </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SVM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk, intermediate risk or high risk of melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0035" title="StanganelliI , BrucaleA , CaloriL , GoriR , LovatoA , MagiS , et al. Computer‐aided diagnosis of melanocytic lesions. Anticancer Research2005;25(6C):4577‐82. [ER4:15466126; PUBMED: 16334145] ">Stanganelli 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multivariate discriminant analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graphical output and</p> <p>numerical output of features provided. Diagnosis suggested (e.g. melanoma, benign melanocytic naevus) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a>; </p> <p><a href="./references#CD013186-bbs2-0032" title="SeidenariS , PellacaniG , GiannettiA . Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Research1999;9(2):163‐71. [ER4:17940983; PUBMED: 10380939] ">Seidenari 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>KNN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis suggested (e.g. melanoma, benign melanocytic naevus)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS pattern analysis system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discrimination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis suggested (e.g. melanoma, benign melanocytic naevus)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0010" title="BurroniM , CoronaR , Dell'EvaG , SeraF , BonoR , PudduP , et al. Melanoma computer‐assisted diagnosis: reliability and feasibility study. Clinical Cancer Research2004;10(6):1881‐6. [ER4:15465878; PUBMED: 15041702] ">Burroni 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DDA software analysis – analyses 50 parameters subdivided into 3 categories, i.e. geometries, colours, and textures and islands of colours (Burroni islands) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Euclidian distances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>DEM–MIPS (Biomips SRL, Siena, Italy)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commercially available software coupled to stereomicroscope Wild M‐650 (Leica), video camera, computer, colour monitor. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DEM‐MIPS software (Digital Epi Microscopy Melanoma Image Processing Software; Biomips SRL, Siena, Italy). Evaluates colorimetric and geometric features (not reported). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0028" title="PiccoloD , FerrariA , PerisK , DiadoneR , RuggeriB , ChimentiS . Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐assisted diagnosis of 341 pigmented skin lesions: a comparative study. British Journal of Dermatology2002;147(3):481‐6. [ER4:15466057; PUBMED: 12207587] ">Piccolo 2002</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Skin View</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computerised image analysis system, digital television, videocamera. Connection with the computer is through a digitising board able to process colour images </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features of ABCD system plus clinical data (anatomic site, months of growth, size, shape, colour, ulceration or regression) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 2 of 8 binary (on/off) indicators indicates malignancy: 1. shape (asymmetry); 2. clinical data (changes through time, regression, ulceration); 3. size (mm); 4. colour (distribution of hue); 5. darkness (percent of black mixed with the hue); 6. saturation (percent of white mixed with the hue); 7. border (sharpness of transition between lesion and healthy skin; 8. texture. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0011" title="CascinelliN , FerrarioM , BufalinoR , ZurridaS , GalimbertiV , MascheroniL , et al. Results obtained by using a computerized image analysis system designed as an aid to diagnosis of cutaneous melanoma. Melanoma Research1992;2(3):163‐70. [ER4:15465891; PUBMED: 1450670] ">Cascinelli 1992</a>; </p> <p><a href="./references#CD013186-bbs2-0012" title="CristofoliniM , BauerP , BoiS , CristofoliniP , MiccioloR , SicherMC . Diagnosis of cutaneous melanoma: Accuracy of a computerized image analysis system (Skin View). Skin Research and Technology1997;3(1):23‐7. [ER4:17941039; PUBMED: 27333169] ">Cristofolini 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nevus Doctor</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computerised image analysis system coupled to digital dermatoscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ND takes a dermoscopic image from the Canon/DermLite device as input and classifies the lesion. </p> <p>Features not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probability of malignancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MoleExpert (DermoScan GmbH, Germany)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(micro Version 3.3.30.156). Computerised image analysis with output giving probability of malignancy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features of ABCD system plus other features (not listed), e.g. colour variation and grey veil </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number between −5.00 and 5.00, where high values indicate suspicion of melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0026" title="MollersenK , KircheschH , ZorteaM , SchopfTR , HindbergK , GodtliebsenF . Computer‐aided decision support for melanoma detection applied on melanocytic and nonmelanocytic skin lesions: A comparison of two systems based on automatic analysis of dermoscopic images. BioMed Research International2015;2015:579282. [ER4:25012302; PUBMED: 26693486] ">Mollersen 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image J (NIH, Bethesda,</b> </p> <p><b>USA)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Image segmentation, feature extraction, image analysis coupled with dermatoscope MoleMax II </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 features analysed from 38 extracted features describing shape, form and colour.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 outputs: 1) Visual rendering of analysis showing coloured areas 2) Excision vs no excision decision (system considers the green zone of the scale as benign (0 to 0.1), the yellow zone suspicious (0.1 to 0.4), and the red zone malignant (0.4 to 1)) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IBAS 2000 workstation (Zeiss, Oberkochen, Germany)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital image analysis workstation attached to Wild binocular stereomicroscope M 650 (Wild Heerbrugg AG, Switzerland) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of 16 morphometric parameters from the lesion and the border image: lesion area and perimeter: minimum polar distance, maximum polar distance, aspect ratio, circularity shape factor, variances of grey, number different colours, range different colours. Border features and area: maximum and minimum border width, ratio of border area to lesion area, ratio of border perimeter to lesion perimeter </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dichotomous decision: MM vs Benign (CN or DN)</p> <p>The network was trained to yield a value from 0 to 1 in the output nodes. The node yielding the greatest numerical output was then used as the classification result. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0005" title="BinderM , KittlerH , SeeberA , SteinerA , PehambergerH , WolffK . Epiluminescence microscopy‐based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Research1998;8(3):261‐6. [ER4:15465863; PUBMED: 9664148] ">Binder 1998</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nevuscreen ® (Arkè s.a.s., Avezzano, Italy)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital database containing image analysis software, coupled to digital dermatoscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nevuscreen software automatically analyses ABCD features</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TDS score: &lt; 4.75 benign, 4.75 – 5.45 suspicious, &gt; 5.45 highly suggestive of melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0029" title="PiccoloD , CrismanG , SchoinasS , AltamuraD , PerisK . Computer‐automated ABCD versus dermatologists with different degrees of experience in dermoscopy. European Journal of Dermatology2014;24(4):477‐81. [ER4:17941089; PUBMED: 24721784] ">Piccolo 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SolarScan (Polartechnics Lts, Australia)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dermoscopy video unit with internal algorithm for image analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103 automated image analysis variables extracted: consisting of various properties of colour, pattern, and geometry. Number analysed not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probability of melanoma, with cut–off (not provided) for benign vs melanoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0024" title="MenziesSW , BischofL , TalbotH , GutenevA , AvramidisM , WongL , et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.[Erratum appears in Arch Dermatol. 2006 May;142(5):558]. Archives of Dermatology2005;141(11):1388‐96. [ER4:20569478; PUBMED: 16301386] ">Menzies 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using different dermoscopy/camera combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54 features analysed, such as border irregularity, eccentricity, length of major and minor axes, and colour histogram properties </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital forest classifier</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severity score (the fraction of decision trees (n = 1000) in which the path ends in ‘‘malignant’’. Lesion classified as malignant if its image traced a path to a malignant node in at least 40% of the trees) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0014" title="FerrisLK , HarkesJA , GilbertB , WingerDG , GolubetsK , AkilovO , et al. Computer‐aided classification of melanocytic lesions using dermoscopic images. Journal of the American Academy of Dermatology2015;73(5):769‐76. [ER4:25012337; PUBMED: 26386631] ">Ferris 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital stereomicroscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features analysed as present or absent (pattern analysis): Pigment network, brown globules, radial streaming, pseudopods, black dots, margin, pigmentation, depigmentation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0004" title="BinderM , SteinerA , SchwarzM , KnollmayerS , WolffK , PehambergerH . Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. British Journal of Dermatology1994;130(4):460‐5. [ER4:18375032; PUBMED: 8186110] ">Binder 1994</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of digital dermoscopy images (Molemax II)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features corresponding to the number, size and asymmetry of dots: (a) number of dots, (b) total number of pixels in dots, (c) mean number of pixels in dots, (d) variance of num. pixels in dots (e) fraction of lesion area occupied by dark dots. Asymmetry: radial, angular, primary axis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison of 5 classifiers:</p> <p>Multilayer perceptron</p> <p>KNN</p> <p>Random forest</p> <p>SVM polykernel c = 5*</p> <p>SVM PUK kernel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0021" title="MaglogiannisI , DelibasisKK . Enhancing classification accuracy utilizing globules and dots features in digital dermoscopy. Computer Methods and Programs in Biomedicine2015;118(2):124‐33. [ER4:25012309; PUBMED: 25540998] ">Maglogiannis 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital microscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 features investigated: 4 asymmetry features, colour variance (red, green, blue), mean colour (red, green, blue, intensity), range colour (red, green, blue) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SVM (principal components analysis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0017" title="GilmoreS , Hofmann‐WellenhofR , SoyerHP . A support vector machine for decision support in melanoma recognition. Experimental Dermatology2010;19(9):830‐5. [ER4:15465935; PUBMED: 20629732] ">Gilmore 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital microscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Negative features: point and axial symmetry of pigmentation</p> <p>Presence of only a single colour.</p> <p>Positive features: blue‐white, veil, multiple brown dots, pseudopods, radial streaming, scarlike depigmentation, peripheral black dots/globules, multiple (5 ‐ 6) colours, multiple blue/grey dots, broadened network </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Classification and regression tree</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Presence of indicative features (Melanoma = 0/2 morphologically negative features AND at least 1/9 positive morphological features) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name not reported</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer analysis of stored images captured using digital microscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of 64 analytical parameters including: a large number of morphological parameters, such as </p> <p>margin, geometric parameters (surface area, extent, largest diameter and largest orthogonal diameter), invariant moments, symmetry, colours (red, green, blue and grey value), texture (energy, entropy, correlation, inverse difference moment and inertia), number of regions, focus and difference of the lesion and its convex cover </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vision algebra methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0006" title="BlumA , LuedtkeH , EllwangerU , SchwabeR , RassnerG , GarbeC . Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. British Journal of Dermatology2004;151(5):1029‐38. [ER4:15465866; PUBMED: 15541081] ">Blum 2004a</a> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><b>*</b>(classifier selected at random for inclusion in review) </p> <p>Key: ANN – artificial neural network; CN – common naevus; DN – dysplastic naevus; KNN – K–nearest neighbour; NR – not reported; MM – malignant melanoma; SVM – support vector machine; TDS – total dermoscopic score </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of included digital dermoscopy‐based CAD (Derm–CAD) systems</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Characteristics of included Spectroscopy‐based CAD (Spectro‐CAD) systems</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Spectro–CAD system<br/> (spectroscopy type)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Role of machine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Classifier</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD Output</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>SpectroShade (MHT, Verona Italy)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Illumination assembly located inside a PC and an external detection device placed in a hand‐held probe, with integrated image analysis software </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Features analysed: (i) reflectance (R); (ii) variegation (V); (iii) area (A); (iv) dark area ratio (DAR); (v) dark island reflectance (DIR); (vi) dark distribution factor (DDF); (vii) dark permanence (D PER) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN (multilayer perceptron)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0038" title="TomatisS , CarraraM , BonoA , BartoliC , LualdiM , TragniG , et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Physics in Medicine and Biology2005;50(8):1675‐87. [ER4:17941003; PUBMED: 15815089] ">Tomatis 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SpectroShade coupled with a MoleMax II dermatoscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnostic category: 1 no melanoma, 2 doubtful melanoma, 3 suspected melanoma, 4 probable melanoma </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MelaFind (early predecessor)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital camera and illumination assembly coupled to a computer, with separate image analysis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Features analysed: Lesion asymmetry, border, gradient, centroid, texture, colour</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiparametric linear classifier</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0019" title="Gutkowicz‐KrusinD , ElbaumM , SzwaykowskiP , KopfAW . Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques? Part II. Automatic machine vision classification. Skin Research and Technology1997;3(1):15‐22. [ER4:20569466; PUBMED: 27333168] ">Gutkowicz Krusin 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p><b>MelaFind (STRATA Skin Sciences [formerly Mela Sciences Inc], Horsham, PA, USA)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>Multispectral imaging system with integrated image analysis software; device takes images in vivo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>MelaFind image analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Binary output: (1) positive, (lesion should be considered for biopsy to rule out melanoma); and </p> <p>(2) negative (lesion should be considered for later evaluation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 constrained linear classifiers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Binary output: excise or follow–up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0040" title="WellsR , Gutkowicz‐KrusinD , VeledarE , ToledanoA , ChenSC . Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. Archives of Dermatology2012;148(9):1083‐4. [ER4:15466163; PUBMED: 22986873] ">Wells 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Logistic regression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0041" title="WinkelmannRR , FarbergAS , TuckerN , WhiteR , RigelDS . Enhancement of international dermatologists' pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multispectral digital skin lesion analysis. Journal of Clinical and Aesthetic Dermatology2016;9(7):53‐5. [ER4:25701735; PUBMED: 27672411] ">Winkelmann 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0027" title="MonheitG , CognettaAB , FerrisL , RabinovitzH , GrossK , MartiniM , et al. The performance of MelaFind: a prospective multicenter study. Archives of Dermatology2011;147(2):188‐94. [ER4:15466015; PUBMED: 20956633] ">Monheit 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Telespectrophotometric system (MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Digital camera coupled with an illumination system with interference filters and computer for storage and analysis of multispectral images </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>From each spectral image, 3 parameters, i.e. mean reflectance, variegation index and lesion area, were derived at the corresponding wavelength </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0008" title="BonoA , TomatisS , BartoliC , CascinelliN , ClementeC , CupetaC , et al. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions. European Journal of Cancer1996;32(4):727‐9. [DOI: http://dx.doi.org/10.1016/0959‐8049(95)00649‐4; ER4:20569437] ">Bono 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>For each spectral image, 5 parameters (lesion descriptors) based on ABCD and related to colour and shape of the imaged lesion were evaluated: mean reflectance, variegation index, compactness, roughness, and area </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant vs. ANN<b>*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0037" title="TomatisS , BonoA , BartoliC , CarraraM , LualdiM , TragniG , et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Medical Physics2003;30(2):212‐21. [ER4:18375057; PUBMED: 12607839] ">Tomatis 2003</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linear discriminant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>SIAscopy ™ (Astron Clinica, UK) (MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectrophotometric imaging system with hand–held skin probe (SIAscope II) and integrated software </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Analysis of dermal melanin, erythematous blush, lesion asymmetry, collagen 'holes', blood commas, or irregularities in the collagen </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs and Binary output (based on Australian Scoring System): ‘strong chance of melanoma' or 'low risk of melanoma' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0018" title="GludM , GniadeckiR , DrzewieckiKT . Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double‐blind study in a secondary reference centre. Melanoma Research2009;19(3):176‐9. [ER4:18375045; PUBMED: 19319002] ">Glud 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectrophotometric imaging system with hand–held skin probe (SIAscope V) and integrated software (software Dermetrics Version 2.0, Astron Clinica Ltd., Great Britain) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs (no further information)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0036" title="TerstappenK , SuurkulaM , HallbergH , EricsonMB , WennbergAM . Poor correlation between spectrophotometric intracutaneous analysis and histopathology in melanoma and nonmelanoma lesions [Erratum appears in J Biomed Opt. 2013 Jun;18(6):069804]. Journal of Biomedical Optics2013;18(6):061223. [ER4:15466138; PUBMED: 23296145] ">Terstappen 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SIAscope (MedX Health Corp, Canada)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spectrophotometric imaging system with hand–held skin probe (SIAscope, version NR) and integrated software </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs and lesion score using Primary Care Scoring Algorithm (6 or more points regarded as suspicious) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SIAscope (MedX Health Corp, Canada)</b> </p> <p><b>(MSI‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAscopy with MoleMate (software image management system) viewing platform and integrated Primary Care Scoring Algorithm </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SIAgraphs and lesion score using Primary Care Scoring Algorithm (6 or more points regarded as suspicious) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Oblique Incidence Diffuse Reflectance Spectroscopy (DRS‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Light probe coupled to imaging spectrograph, camera, and computer to store images.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ANN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnostic category (e.g. CN, MM, DN, BCC, cSCC)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nevisense (SciBase III, Sweden)</b> </p> <p><b>(EIS‐CAD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrical Impedance spectroscopy imaging system with integrated image analysis software</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The system measures the overall electrical resistance and reactance at 35 different frequencies </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SVM (non‐probabilistic binary linear classifier)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The system computes both a score (0 – 10) and a dichotomous output (EIS negative/positive) at a fixed cut‐off. The fixed threshold is set at 4, i.e. scores &lt; 4 are EIS‐negative and scores of ≥ 4 are EIS positive </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a> </p> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>*Classifier excluded at random</p> <p>Key: ANN – artificial neural network; BCC – basal cell carcinoma; cSCC – cutaneous squamous cell carcinoma; CAD ‐ computer‐assisted diagnosis; CN – common naevus; DN – dysplastic naevus; EIS ‐ electrical impedance spectroscopy; KNN – K–nearest neighbour; NR – not reported; MM – malignant melanoma; MSI – multispectral imaging; SVM – support vector machine </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Characteristics of included Spectroscopy‐based CAD (Spectro‐CAD) systems</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Summary estimates of sensitivity and specificity for CAD according to target condition</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index test, target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cases/Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summary sensitivity (95% CI) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summary specificity (95% CI) %</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Main analyses: Invasive melanoma and</i> <i>atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1063/8992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.1 (84.0 to 94.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.3 (63.6 to 82.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286/2401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (83.7 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.6 (24.8 to 64.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>368/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.0 (94.7 to 98.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.6 (31.6 to 35.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Individual CAD systems: Invasive melanoma and</i> <i>atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DB–MIPS (Derm–CAD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>502/1903</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95.2 (89.5 to 97.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89.1 (78.7 to 94.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Skin View (Derm–CAD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45/220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.0 (65.8 to 89.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.4 (40.1 to 54.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MelaFind (MSI–CAD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196/1798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.1 (91.9 to 98.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.8 (12.3 to 56.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Main analyses: Basal cell carcinoma</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (94.7 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3 (24.5 to 28.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Secondary target condition: invasive melanoma alone</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Derm–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120/950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.8 (84.2 to 94.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.5 (60.2 to 66.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MSI–CAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116/386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.5 (43.0 to 93.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.7 (38.5 to 79.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.2 (95.4 to 99.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.0 (36.0 to 40.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b><i>Secondary target condition: any skin cancer or lesions requiring excision</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EIS–CAD (Nevisense*)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>644/2389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.5 (91.3 to 95.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.6 (30.4 to 34.8)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>*For EIS‐CAD the only evidence available was for one system</p> <p>Key: CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐based computer‐assisted diagnosis; EIS‐CAD ‐ electrical impedance spectroscopy‐based computer‐assisted diagnosis; MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Summary estimates of sensitivity and specificity for CAD according to target condition</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Comparisons of CAD with dermoscopy for detection of the primary target condition: invasive melanoma and atypical intraepidermal melanocytic variants</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Test</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cases</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pooled sensitivity (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pooled specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Derm‐CAD versus image‐based dermoscopy – indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Derm‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.1 (84.0 to 94.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.3 (63.6 to 82.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.3 (83.4 to 97.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.5 (57.3 to 97.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.21 (−11.2 to 4.79), P = 0.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−14.1 (−34.4 to 6.06), P = 0.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Derm‐CAD versus image‐based dermoscopy – direct comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Derm‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.1 (89.1 to 96.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.8 (68.2 to 89.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.9 (85.1 to 97.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.3 (56.5 to 97.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.17 (−6.61 to 6.95), P = 0.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−7.44 (−28.4 to 13.6), P = 0.49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>MSI‐CAD versus image‐based dermoscopy – indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MSI‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (83.7 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.6 (24.8 to 64.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.0 (66.5 to 80.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.7 (43.5 to 72.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.9 (9.58 to 28.2), P = 0.003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−15.0 (−40.7 to 10.6), P = 0.26</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>MSI‐CAD versus image‐based dermoscopy – direct comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MSI‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.8 (92.4 to 98.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.8 (12.4 to 56.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.0 (66.5 to 80.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.7 (43.5 to 72.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.7 (15.2 to 30.2), P &lt; 0.001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−28.9 (−56.3 to −1.48), P = 0.039</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Melafind (MSI–CAD) versus Image‐based dermoscopy – indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MelaFind</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.4 (94.0 to 98.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.3 (12.1 to 55.6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.5 (64.6 to 79.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.7 (42.6 to 58.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.5 (16.5 to 32.4), P &lt; 0.001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−20.9 (−45.5 to 3.75), P = 0.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b><i>Melafind (MSI‐CAD) versus Image‐based dermoscopy – direct comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MelaFind</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.5 (91.8 to 98.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.8 (8.38 to 48.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Image‐based dermoscopy</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.5 (64.6 to 79.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.7 (42.6 to 58.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.9 (16.0 to 31.9), P &lt; 0.001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−27.9 (−50.1 to ‐5.66), P = 0.014</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b><i>Derm‐CAD versus MSI‐CAD ‐ indirect comparison</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Derm‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90.1 (84.0 to 94.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.3 (63.6 to 82.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MSI‐CAD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.9 (83.7 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.6 (24.8 to 64.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Difference (95% CI), P value</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.83 (−5.04 to 10.7),</p> <p>P = 0.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>−30.7 (−53.8 to −7.64), P = 0.009</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Key: CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐ based computer‐assisted diagnosis; MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis; P ‐ probability. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Comparisons of CAD with dermoscopy for detection of the primary target condition: invasive melanoma and atypical intraepidermal melanocytic variants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Sensitivity and Specificity of CAD systems in Unreferred Populations</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>Derm‐CAD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD System</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DB‐MIPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0042" title="WollinaU , BurroniM , TorricelliR , GilardiS , Dell'EvaG , HelmC , et al. Digital dermoscopy in clinical practise: a three‐centre analysis. Skin Research and Technology2007;13(2):133‐42. [ER4:17941010; PUBMED: 17374053] ">Wollina 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89.5 (68.6 to 97.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84.0 (79.7 to 87.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign="top"> <p><b>MSI‐CAD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD System</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TP</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MoleMate SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 (82.4 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.1 (68.7 to 75.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MoleMate SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 (78.5 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.7 (68.4 to 74.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MoleMate SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0039" title="WalterFM , MorrisHC , HumphrysE , HallPN , PrevostAT , BurrowsN , et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ2012;345:e4110. [ER4:15466154; PUBMED: 22763392] ">Walter 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.0 (75.0 to 97.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.5 (69.1 to 75.6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SIAscope</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013186-bbs2-0034" title="SgourosD , LallasA , JulianY , RigopoulosD , ZalaudekI , LongoC , et al. Assessment of SIAscopy in the triage of suspicious skin tumours. Skin Research and Technology2014;20(4):440‐4. [ER4:17941094; PUBMED: 24517201] ">Sgouros 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83.9 (67.4 to 92.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.2 (23.2 to 70.9)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Any ‐ any skin cancer or lesion requiring excision (secondary objective); CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐based computer‐assisted diagnosis; FN ‐ false negative; FP ‐ false positive; MEL ‐ invasive melanoma and atypical intraepidermal melanocytic variants (primary objective); MM ‐ malignant (invasive) melanoma only (secondary objective); MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis; TN ‐ true negative; TP ‐ true positive </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Sensitivity and Specificity of CAD systems in Unreferred Populations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Direct comparisons of single CAD studies with dermoscopy for diagnosis of melanoma and other types of skin cancer</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Sensitivity (true positives/cases) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI) </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Specificity (true negatives/non cases) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Difference (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>MSI–CAD study comparisons: invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>MSI–CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In–person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>MSI–CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In–person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0009" title="BonoA , BartoliC , CascinelliN , LualdiM , MaurichiA , MogliaD , et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology2002;205(4):362‐6. [ER4:15465870; PUBMED: 12444332] ">Bono 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3 (53/66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.9 (60/66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−10.6 (−22.8 to 1.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49.0 (121/247)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.5 (184/247)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−25.5 (−33.5 to −17.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>MSI–CAD study comparisons:</i> Invasive melanoma</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>MSI‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>MSI‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0001" title="AsciertoPA , PallaM , AyalaF , DeMicheleI , CaracoC , DaponteA , et al. The role of spectrophotometry in the diagnosis of melanoma. BMC Dermatology2010;10:5. [ER4:19728329; PUBMED: 20707921] ">Ascierto 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.7 (8/12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (12/12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−33.3 (−60.9 to −2.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.2 (32/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45.2 (19/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.0 (10.1 to 48.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>MelaFind</i> <br/> <i>(MSI‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Melafind</i> <br/> <i>(MSI‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0015" title="FriedmanRJ , Gutkowicz‐KrusinD , FarberMJ , WarychaM , Schneider‐KelsL , PapastathisN , et al. The diagnostic performance of expert dermoscopists vs a computer‐vision system on small‐diameter melanomas. Archives of Dermatology2008;144(4):476‐82. [ER4:15465921; PUBMED: 18427041] ">Friedman 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (21/21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81.0 (17/21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.1 (−0.15 to 40.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.5 (23/78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44.9 (35/78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−15.4 (−29.6 to −0.23)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Derm–CAD comparisons: invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>Derm‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>Derm‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (39/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.6 (33/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3 (−1.06 to 29.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.8 (267/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3 (263/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47 (−1.55 to 4.64)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a><b>*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.9 (24/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3 (26/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−7.41 (−24.6 to 8.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48.0 (207/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71.9 (310/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−23.9 (−30.1 to −17.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Unnamed system</i> <br/> <i>Derm‐CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Unnamed system</i> <br/> <i>Derm–CAD</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0023" title="MenziesSW , IngvarC , CrottyKA , McCarthyWH . Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Archives of Dermatology1996;132(10):1178‐82. [ER4:21450627; PUBMED: 8859028] ">Menzies 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.9 (40/45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91.1 (41/45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−2.22 (−15.7 to 11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75.6 (90/119)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70.6 (84/119)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.04 (−6.21 to 16.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> <br/> <i>(Derm‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> <br/> <i>(Derm‐CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>In‐person dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0003" title="BauerP , CristofoliniP , BoiS , BurroniM , Dell'EvaG , MiccioloR , et al. Digital epiluminescence microscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. A statistical comparison between visual and computer inspection. Melanoma Research2000;10(4):345‐9. [ER4:15465861; PUBMED: 10985668] ">Bauer 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9 (39/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.6 (33/42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3 (−1.06 to 29.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.8 (267/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3 (263/273)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47 (−1.55 to 4.64)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> </b> </p> <p><b><i>(Derm–CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>DB‐MIPS</i> </b> </p> <p><b><i>(Derm–CAD)</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>Image‐based dermoscopy</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0031" title="SeidenariS , PellacaniG , PepeP . Digital videomicroscopy improves diagnostic accuracy for melanoma. Journal of the American Academy of Dermatology1998;39(2 Pt 1):175‐81. [ER4:15466116; PUBMED: 9704824] ">Seidenari 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.5 (29/31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.6 (25/31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.9 (−4.62 to 30.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.9 (56/59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.9 (56/59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−9.44 to 9.44)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>CAD‐based diagnosis vs CAD‐aided diagnosis: invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐based diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐aided diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐based<br/> diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CAD‐aided<br/> diagnosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a><b>*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.9 (24/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.1 (20/27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.8 (−6.4 to 34.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48.0 (207/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81.9 (353/431)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−33.9 (39.6 to −27.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0020" title="HauschildA , ChenSC , WeichenthalM , BlumA , KingHC , GoldsmithJ , et al. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. Journal der Deutschen Dermatologischen Gesellschaft2014;12(7):606‐14. [ER4:17941085; PUBMED: 24944011] ">Hauschild 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.9 (63/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.5 (51/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.5 (7.3 to 30.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.2 (6/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46.2 (30/65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−36.9 (−49.9 to −22.0)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><b>*</b>Patient‐based analysis, unlike other studies in the table which were lesion‐based. The <a href="./references#CD013186-bbs2-0013" title="DreiseitlS , BinderM , HableK , KittlerH . Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial. Melanoma Research2009;19(3):180‐4. [ER4:15465907; PUBMED: 19369900] ">Dreiseitl 2009</a> study did report lesion‐based for the accuracy of CAD‐only Derm‐CAD, used in the meta‐analysis for Derm‐CAD accuracy to detect invasive melanoma or atypical intraepidermal melanocytic variants (data presented in <a href="#CD013186-fig-0010">Figure 10</a>). </p> <p>Key: CAD ‐ computer‐assisted diagnosis; CI ‐ confidence interval; Derm‐CAD ‐ digital dermoscopy‐based computer‐assisted diagnosis; MSI‐CAD ‐ multispectral imaging‐based computer‐assisted diagnosis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Direct comparisons of single CAD studies with dermoscopy for diagnosis of melanoma and other types of skin cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0010"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Sensitivity and specificity of oblique incidence diffuse reflectance spectrometry CAD (OIDRS–CAD) studies for primary target condition: invasive melanoma and atypical intraepidermal melanocytic variants</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index test, target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI) %</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0016" title="Garcia‐UribeA , ZouJ , DuvicM , Cho‐VegaJH , PrietoVG , WangLV . In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Research2012;72(11):2738‐45. [DOI: 10.1158/0008‐5472.can‐11‐4027; ER4:21450592] ">Garcia Uribe 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.0 (59.6 to 98.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89.7 (83.2 to 93.9)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Sensitivity and specificity of oblique incidence diffuse reflectance spectrometry CAD (OIDRS–CAD) studies for primary target condition: invasive melanoma and atypical intraepidermal melanocytic variants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013186-tbl-0011"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Sensitivity and specificity of electrical impedance spectroscopy CAD (EIS–CAD) studies for each primary target condition</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index test, target condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False positives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>False negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>True negatives</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity (95% CI) %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity (95% CI) %</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Invasive melanoma and atypical intraepidermal melanocytic variants</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.1 (93.2 to 99.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.3 (23.8 to 33.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.6 (93.7 to 98.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.7 (32.5 to 37.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Basal cell carcinoma</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0025" title="MohrP , BirgerssonU , BerkingC , HendersonC , TrefzerU , KemenyL , et al. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma. Skin Research and Technology2013;19(2):75‐83. [PUBMED: 23350668] ">Mohr 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (84.5 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.4 (14.1 to 21.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (92.6 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.3 (26.3 to 30.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b><i>Cutaneous Squamous cell carcinoma</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013186-bbs2-0022" title="MalvehyJ , HauschildA , Curiel‐LewandrowskiC , MohrP , Hofmann‐WellenhofR , MotleyR , et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: An international, multicentre, prospective and blinded clinical trial on efficacy and safety. British Journal of Dermatology2014;171(5):1099‐107. [PUBMED: 24841846] ">Malvehy 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>841</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (64.6 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.4 (41.3 to 45.7)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Sensitivity and specificity of electrical impedance spectroscopy CAD (EIS–CAD) studies for each primary target condition</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/full#CD013186-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013186-tbl-0012"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 Derm‐CAD Microderm (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>793</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">2 Derm‐CAD DBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1903</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">3 Derm‐CAD DBMIPS vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>405</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">4 Derm‐CAD DEMMIPS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">6 Derm‐CAD SkinView (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">7 Derm‐CAD SkinView (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">8 Derm‐CAD NevusDr (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>870</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">9 Derm‐CAD NevusDr (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>870</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">10 Derm‐CAD ImageJ (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3021</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">11 Derm‐CAD IBAS2000 (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">12 Derm‐CAD Nevuscreen (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">13 Derm‐CAD SolarScan (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>786</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">14 Derm‐CAD SolarScan (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>786</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">15 Derm‐CAD No name (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">16 Derm‐CAD No name (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>864</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">17 Derm‐CAD No name (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">18 Derm‐CAD No name (BCC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">19 Derm‐CAD DBMIPS_UNREF (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">20 MSI‐CAD SIAscope_UNREF (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>766</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">21 MSI‐CAD SIAscope_UNREF (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>766</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">22 MSI‐CAD SIAscope_UNREF (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>766</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">23 MSI‐CAD SpectroShade (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">24 MSI‐CAD SpectroShade (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>347</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">25 EIS‐CAD‐Nevisense (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2389</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">26 EIS‐CAD‐Nevisense (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2389</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">27 EIS‐CAD‐Nevisense (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2389</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">28 EIS‐CAD‐Nevisense (BCC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2389</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">29 EIS‐CAD‐Nevisense (cSCC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1943</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">30 MSI‐CAD Melafind (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">31 MSI‐CAD Melafind (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1798</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">32 MSI‐CAD Melafind_vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">34 MSI‐CAD SIAscopy (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">35 MSI‐CAD SIAscopy (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">36 MSI‐CAD SIAscope Only_UNREF (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">37 DRS‐CAD OIDRS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">38 DRS‐CAD OIDRS (Any + dysplastic) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">39 DRS‐CAD OIDRS (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">40 MSI‐CAD TS (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">41 MSI‐CAD TS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">42 CAD–DRS–TS vs Dermoscopy (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">46 PersonDERM‐DigidermDBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">47 ImageDERM‐DigidermDBMIPS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">48 ImageDERM‐DigidermDEMMIPS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">49 PersonDerm‐DigidermImageJ (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">50 ImageDerm‐DigidermNevuscreen (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">51 ImageDerm‐DigidermNR (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">52 ImageDerm‐DigidermNR (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">53 PersonDERM‐DRS‐SpectroShade (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">54 ImageDERM‐DRSMelafind (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">55 ImageDERM‐DRSMelafind (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">56 ImageDERM‐DRSSIA (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">57 PersonDERM‐DRSTS (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">58 Derm‐CAD (direct comparison only) (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2233</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">59 Image‐based Dermoscopy (for Derm‐CAD comparison) (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>765</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">60 In‐person based Dermoscopy ‐ Derm‐CAD studies (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">61 MSI‐CAD (direct comparison only) (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1059</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">62 Image‐based Dermoscopy (for MSI‐CAD comparison) (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">63 MSI‐CAD All systems (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2401</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">64 Derm‐CAD All systems (invasive melanoma or atypical intraepidermal melanocytic variants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8992</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">65 Derm‐CAD MoleExpert (Any lesion requiring excision) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>870</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">66 Derm‐CAD All systems (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">67 Image‐based Dermoscopy ‐ Derm‐CAD studies (invasive melanoma) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">68 MSI‐CAD All (Melafind) (invasive melanoma or atypical intraepidermal melanocytic variants), CAD + Clinician (diagnostic aid) only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">69 MSI‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">70 MSI‐CAD Melafind (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">71 Derm‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD + Clinician (diagnostic aid) only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>589</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">72 Derm‐CAD All (invasive melanoma or atypical intraepidermal melanocytic variants), CAD only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8403</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013186/references#CD013186-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013186&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013186-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013186-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013186-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD013186-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013186-note-0002">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD013186-note-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013186-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013186-note-0018">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013186\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013186"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013186\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013186\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013186"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013186\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013186"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013186\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013186\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013186"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=u3GUW7vS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013186&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013186';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013186/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013186/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013186%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716736149"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013186/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716736153"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013186/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da6c05e6f9368',t:'MTc0MDcxNjczNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 